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ABSTRACT 
 
Laura Stanley Pietrosimone: Loading Characteristics and Responses in Male Athletes with 
Patellar Tendinopathy 
(Under the direction of Darin A. Padua) 
 
 
Context: Clinical management of tendinopathy is difficult, as tendon pathoetiology occurs on a 
continuum with inconsistent associations between structural pathology and pain. Tendon is 
highly responsive to mechanical load; however, load mismanagement can trigger homeostatic 
imbalances that lead to the development of tendinopathy. There is a need to characterize loading 
profiles and responses of individuals along the tendinopathic continuum to inform improved 
clinical management strategies. Objective: To evaluate differences in biomechanical and loading 
volume profiles and to determine the effects of an acute bout of patellar tendon isometric loading 
exercise on lower extremity landing biomechanics in male athletes with patellar tendinopathy. 
Participants: 43 male athletes with and without unilateral patellar tendinopathy. Interventions: 
All participants (SYM, ASYM, CON) performed double- and single-limb jump-landing tasks 
and one-week physical activity monitoring period. Additionally, participants in the SYM and 
ASYM groups underwent a randomized cross-over protocol on two additional testing days to 
examine the acute effects of an isometric patellar tendon loading exercise protocol on landing 
biomechanics. Main Outcome Measures: Loading magnitude variables included tri-planar hip 
and knee kinematics, kinetics, and energetics for the involved limb. Load frequency and duration 
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variables included steps/day and amount of moderate-to-vigorous-physical activity/day, 
respectively. Load volume was estimated from load magnitude and frequency variables using 
validated equations. Results: SYM participants demonstrated patterns of under-loading, 
specifically in sagittal plane knee motion, patellar tendon force, and energy absorption during 
landing, and reduced load volume, compared to CON participants. There was no evidence of 
over-loading on any load magnitude, frequency, or duration variable for the ASYM participant. 
There was no acute effect of the isometric exercise protocol on any biomechanical measure for 
both the SYM and ASYM groups. Conclusions: Load magnitude, frequency, duration, and 
volume are all important metrics to measure and monitor in athletes at different stages of the 
continuum of patellar tendinopathy. Future research should evaluate the effects of isometric 
exercise protocols on movement profiles using longer duration exercise prescription and on 
individuals with higher magnitudes of tendon pain. Future research should continue to develop 
load monitoring strategies to improve tissue capacity and self-reported function in individuals 
with patellar tendinopathy. 
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CHAPTER 1: INTRODUCTION 
 
Patellar tendinopathy is prevalent in individuals who are physically active, particularly 
athletes who participate in sports with repetitive jumping manueveurs.1–5 While some athletes are 
able to maintain sport participation, the long-term consequences of chronic tendinopathy include 
reduced physical activity and quality of life,6,7 with up to 53% of individuals with symptomatic 
patellar tendinopathy quitting their sport due to chronic tendon pain.8 Clinical management of 
tendinopathy is difficult, as tendon pathoetiology occurs on a continuum with inconsistent 
associations between structural pathology and pain.9–11 Tendon is highly responsive to 
mechanical load; however, load mismanagement can trigger homeostatic imbalances that lead to 
the development of structural pathology and/or symptoms.10 While laboratory-based assessments 
have established some evidence of altered biomechanics in adults with a history of patellar 
tendinopathy, there is a lack of literature directly comparing biomechanical movement profiles of 
symptomatic and asymptomatic individuals with patellar tendon structural pathology. 
Furthermore, the laboratory environment cannot account for the influence of cumulative external 
load incurred during real-world physical activity on variables associated with the development of 
patellar tendinopathy. 
Therefore, despite strong evidence of the load-response characteristics of tendon,10,12 
there is a critical gap in our knowledge of how cumulative external load influences the 
development and progression of tendinopathy. Filling this gap would give rise to innovative 
controlled load management strategies that aim to mitigate the progression of tendon pathology
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 and consequent reduction in physical activity. Additionally, while eccentric-based 
strength-training protocols have traditionally been utilized in the treatment of chronic 
tendinopathies,13–15 emerging evidence supports the use of isometric exercise for individuals with 
symptomatic patellar tendinopathy. Isometric exercise has recently been shown to improve pain 
and self-reported function in adults with patellar tendinopathy,16–18 resulting in excellent patient 
compliance and tolerance when implemented in-season.16 However, the acute effects of 
isometric patellar tendon loading on landing biomechanics is unknown. Determining the effects 
of this novel exercise intervention on movement characteristics in clinical populations may allow 
for improved subgrouping of patients into impairment-based rehabilitation programs and 
subsequently improve clinical effectiveness. 
The overall objective of this study is to determine the effects of an acute bout of patellar 
tendon isometric loading exercise on lower extremity landing biomechanics, and to evaluate 
differences in biomechanical profiles of individuals at varying stages of the tendon pathology 
continuum using both laboratory and real-world movement assessments. Our approach will 
utilize a randomized cross-over study design to assess acute intervention effects on lower 
extremity kinetic and kinematic biomechanical variables during landing, and a cross-sectional 
quantification of one-week cumulative external load using wearable technology. 
Aim 1. To ascertain the impact of symptomatic PTA and asymptomatic PTA on lower extremity 
landing kinematics and kinetics. 
Aim 2. To ascertain the impact of symptomatic PTA and asymptomatic PTA on cumulative 
external load during a one-week monitoring period. 
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Aim 3. To investigate whether an acute isometric patellar tendon loading exercise protocol 
changes lower extremity landing kinematics and kinetics in individuals with symptomatic and 
asymptomatic PTA. 
The proposed project is innovative because it will be the first to establish the effects of 
patellar-tendon specific loading exercise on biomechanical movement profiles of individuals 
along the continuum of tendon pathology, and the first to monitor cumulative external load in a 
tendinopathic population. Long-term, an efficacious real-world monitoring system will enhance 
clinical practice by allowing for timely identification of trends in loading that may influence the 
development of structural pathology and altered biomechanics in multiple patient populations. 
 
Specific Aims, Research Question Objectives, & Hypotheses 
Specific Aim 1. To ascertain the impact of symptomatic PTA and asymptomatic PTA on lower 
extremity landing kinematics and kinetics. 
 Research Questions 
1.1 Do individuals with symptomatic PTA and asymptomatic PTA demonstrate different 
sagittal and frontal plane knee and hip joint angles during the loading phase of each 
landing task compared to individuals who are asymptomatic and without PTA (healthy 
control group)? 
1.2 Do individuals with symptomatic PTA and asymptomatic PTA demonstrate different 
internal sagittal and frontal plane knee and hip joint moments during the loading phase 
of each landing task compared to individuals who are asymptomatic and without PTA 
(healthy control group)? 
1.3 Do individuals with symptomatic PTA and asymptomatic PTA demonstrate different 
peak vertical ground reaction force magnitudes and vertical ground reaction force 
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loading rates during the loading phase of each landing task compared to individuals who 
are asymptomatic and without PTA (healthy control group)? 
1.4 Do individuals with symptomatic PTA and asymptomatic PTA demonstrate different 
peak patellar tendon force magnitudes and patellar tendon force loading rates during the 
loading phase of each landing task compared to individuals who are asymptomatic and 
without PTA (healthy control group)? 
1.5 Do individuals with symptomatic PTA and asymptomatic PTA demonstrate 
differences in inter-limb symmetry for kinetic variables during the loading phase of each 
landing task compared to individuals who are asymptomatic and without PTA (healthy 
control group)? 
 
 Hypotheses 
Hypothesis 1: Individuals with symptomatic PTA and asymptomatic PTA will 
demonstrate different lower extremity landing kinematics and kinetics compared to 
healthy controls. 
1.1 Individuals with symptomatic PTA will demonstrate lesser sagittal plane knee and hip 
flexion displacement on the involved limb, while individuals with asymptomatic PTA 
will demonstrate greater sagittal plane knee and hip flexion displacement on the involved 
limb compared to the matched limb of healthy controls. 
1.2 Individuals with symptomatic PTA will demonstrate lesser net sagittal plane knee and 
hip internal extension moment on the involved limb, while individuals with 
asymptomatic PTA will demonstrate greater net sagittal plane knee and hip internal 
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extension moment on the involved limb compared to the matched limb of healthy 
controls. 
1.3 Individuals with symptomatic PTA will demonstrate lesser peak vertical ground 
reaction force on the involved limb, while individuals with asymptomatic PTA will 
demonstrate greater peak vertical ground reaction force on the involved limb compared to 
the matched limb of healthy controls. 
1.4 Individuals with symptomatic PTA will demonstrate lesser peak patellar tendon force 
on the involved limb, while individuals with asymptomatic PTA will demonstrate greater 
peak patellar tendon force on the involved limb compared to the matched limb of healthy 
controls. 
1.5 Individuals with symptomatic PTA will demonstrate greater magnitude inter-limb 
asymmetry in kinetic variables during the loading phase of the landing tasks compared to 
individuals with asymptomatic PTA and healthy controls. 
Rationale 
Previous research has investigated biomechanical profiles of individuals with either 
structural or symptomatic evidence of patellar tendinopathy when performing sport-specific 
tasks, such as jumping and landing.19–24 However, the volume of published research in the area 
of biomechanical profiles of individuals with patellar tendinopathy is much smaller than that of 
other patient populations, such as individuals following anterior cruciate ligament injury. 
Previous studies have demonstrated differences in lower extremity kinematics, kinetics, and 
energetics between individuals with and without patellar tendinopathy symptoms,19–22 as well as 
between asymptomatic individuals with and without structural abnormalities.23,24 However, there 
are no studies to-date that have compared biomechanical characteristics that control for both 
 6 
patellar tendon structure and tendinopathy symptomology, and simultaneously include a healthy 
control group (no structural pathology or symptomology). This study is the first to compare 
biomechanical profiles of three distinct groups: individuals who are asymptomatic with a PTA, 
symptomatic with a PTA, and asymptomatic without PTA (health control). Through this design, 
we will be able to assess the independent effects of both structural pathology and pain on 
biomechanical profiles during sport-specific tasks. The clinical relevance of this design is that 
strives to determine if biomechanical profiles are different between individuals at differing stages 
along the continuum of tendon pathology, which could inform the development of enhanced 
impairment-based, individualized treatment programs. 
Target Journal 
The manuscript reporting the results of this specific aim will be prepared for submission 
to Medicine & Science in Sports & Exercise (MSSE) (Impact Factor: 4.041). Previous studies 
reporting biomechanical profiles of tendinopathic populations have been published in 
MSSE,23,25,26 so the results of our study, which uniquely controls for both structural and 
symptomatic deficits, will provide an important continuation of work that has been selected by 
MSSE for publication in the past. 
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Table 1.1. Summary of Aim 1 
 
Research Question Objectives Dependent Variables Statistical Analysis 
 The following DVs will be assessed 
for involved PTA limbs and 
matched healthy control limb. 
 
1.1 Do individuals with 
symptomatic PTA and 
asymptomatic PTA demonstrate 
different sagittal and frontal plane 
knee and hip joint angles during the 
loading phase of each landing task 
compared to individuals who are 
asymptomatic and without PTA 
(healthy control group)? 
Knee flexion angle 
Knee valgus angle 
Hip flexion angle 
Hip adduction angle 
 
95% confidence interval waveform 
comparisons 
 
1.2 Do individuals with 
symptomatic PTA and 
asymptomatic PTA demonstrate 
different internal sagittal and frontal 
plane knee and hip joint moments 
during the loading phase of each 
landing task compared to 
individuals who are asymptomatic 
and without PTA (healthy control 
group)? 
Internal knee extension moment 
Internal knee abduction moment 
Internal hip flexion moment 
Internal hip adduction moment 
95% confidence interval waveform 
comparisons 
 
1.3 Do individuals with 
symptomatic PTA and 
asymptomatic PTA demonstrate 
different peak vertical ground 
reaction force magnitudes and 
vertical ground reaction force 
loading rates during the loading 
phase of each landing task 
compared to individuals who are 
asymptomatic and without PTA 
(healthy control group)? 
Peak vGRF 
 
95% confidence interval waveform 
comparisons 
1.4 Do individuals with 
symptomatic PTA and 
asymptomatic PTA demonstrate 
different peak patellar tendon force 
magnitudes and patellar tendon 
force loading rates during the 
loading phase of each landing task 
compared to individuals who are 
asymptomatic and without PTA 
(healthy control group)? 
Peak patellar tendon force (FPT) 
Patellar tendon force impulse 
95% confidence interval waveform 
comparisons 
1.5 Do individuals with 
symptomatic PTA and 
asymptomatic PTA demonstrate 
differences in inter-limb symmetry 
for kinetic variables during the 
loading phase of each landing task 
compared to individuals who are 
asymptomatic and without PTA 
(healthy control group)?  
Internal knee extension moment 
Vertical ground reaction force 
Patellar tendon force 
95% confidence interval waveform 
comparisons 
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Specific Aim 2. To ascertain the impact of symptomatic PTA and asymptomatic PTA on 
cumulative external load during a one-week monitoring period. 
 Research Questions 
2.1 Do individuals with symptomatic PTA and asymptomatic PTA demonstrate different 
average steps-per-day during a one-week monitoring period compared to individuals who 
are asymptomatic and without PTA (healthy control group)? 
2.2 Do individuals with symptomatic PTA and asymptomatic PTA demonstrate different 
cumulative patellar tendon loads compared to individuals who are asymptomatic and 
without PTA (healthy control group)? 
 Hypotheses 
Hypothesis 2: Individuals with symptomatic PTA and with asymptomatic PTA will 
demonstrate different average daily and cumulative loading volume during a one-week 
monitoring period than healthy controls, such that: 
2.1 Individuals with symptomatic PTA will demonstrate less loading volume than both 
individuals with asymptomatic PTA and healthy controls. 
2.2 Individuals with asymptomatic PTA will demonstrate greater cumulative patellar 
tendon loads than both individuals with symptomatic PTA and healthy controls. 
Rationale 
Musculoskeletal injury is a primary factor related to reduced participation in physical 
activity, which can result in numerous negative health outcomes.27,28 Overuse injuries, such as 
tendinopathy, typically result from the mismanagement of load over time. As a mechano-
responsive tissue, normal tendon readily adapts to loading with degradation and synthesis of 
tendon matrix, and previous research has demonstrated that tendon can respond favorably to 
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controlled loading in certain athletic populations.29–31 However, loading frequency, intensity, and 
duration may influence tendon response, particularly in the presence of maladaptation (structural 
pathology and/or symptomology).10 Therefore, quantification of key objective physical activity 
characteristics, as outlined by the FITT principle32,33 may provide critical information on tendon 
adaptation to load that is currently not systematically evaluated in standard clinical practice 
around patellar tendinopathy.  
A limitation of traditional biomechanical assessments in the area of musculoskeletal 
injury and sports medicine is the exclusive use of laboratory measures (i.e. three-dimensional 
motion capture) to study associations between movement characteristics and injury. While 
considered the gold-standard movement assessment tool, three-dimensional motion capture only 
provides a brief, controlled snapshot of an individual’s biomechanical profile, which does not 
account for cumulative loading repetition or the influence of overall physical activity exposure. 
Therefore, real-world physical activity monitoring is a critical missing piece in the study of 
overuse injury development. Previous literature has demonstrated associations between high 
training and competition workloads and injury.34,35 Specifically, high training load volume 
(training hours/week, match/week) increases the risk of patellar tendinopathy in adolescent male 
and female volleyball athletes (OR: 1.72-3.38).36 Additionally, in a cohort of collegiate female 
volleyball athletes, cumulative season training load was negatively association with post-season 
VISA-P scores (r=-0.512, p=0.043), indicating that athletes with higher loads during the 
competitive season reported more post-season patellar tendon pain. (Stanley et al, in progress)  
The utility of quantifying physical activity outcomes in this population is to obtain a more 
objective understanding of the associations between cumulative external load and clinical 
manifestations of patellar tendinopathy (i.e. structural pathology and pain). Recent studies have 
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quantified physical activity metrics in various pathologic populations. Individuals with chronic 
ankle instability were found to participate in 24 less minutes of physical activity per day than 
healthy counterparts37, and individuals following ACLR took on average 2000 less steps-per-day 
than healthy controls.38 In a population of adults with osteoarthritis (OA), combined laboratory- 
and real-world based knee joint loading metrics were better able to distinguish between 
individuals with and without OA than traditional laboratory-based assessments alone.39 
Therefore, based on the foundational knowledge of tendon as a mechano-responsive tissue, and 
growing evidence of altered real-world loading in pathological populations, measuring and 
monitoring real-world loading metrics is a critical component in the study of overuse injuries. 
 
Target Journal 
The manuscript reporting the results of this specific aim will be prepared for submission 
to the American Journal of Sports Medicine (AJSM) (Impact Factor: 4.517). There is a growing 
interest among sports medicine professionals to utilize wearable sensor technology for pre-injury 
prevention to monitor athletes following injury. Therefore, we feel that the results of this study, 
which will be the first to-date to investigate real-world loading difference in individuals with 
varying stages of patellar tendinopathy, fit with the mission of AJSM to be a leading journal in 
sports medicine.  AJSM has also recently published a study38 investigating real-world loading 
comparisons between un-injured controls and individuals following anterior cruciate ligament 
reconstruction (ACLR), indicating that this area of patient-management is of interest to their 
editors and readership.  
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Table 1.2. Summary of Aim 2 
 
Research Question Objectives Dependent Variables Statistical Analysis 
2.1 Do individuals with 
symptomatic PTA and 
asymptomatic PTA demonstrate 
different average steps-per-day 
during a one-week monitoring 
period compared to individuals who 
are asymptomatic and without PTA 
(healthy control group)? 
Average steps-per-day 
Average MVPA-per-day 
 
One-way ANOVA 
 
2.2 Do individuals with 
symptomatic PTA and 
asymptomatic PTA demonstrate 
different cumulative patellar tendon 
loads compared to individuals who 
are asymptomatic and without PTA 
(healthy control group)? 
Cumulative FPT One-way ANOVA 
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Specific Aim 3. To investigate whether an acute isometric patellar tendon loading exercise 
protocol changes lower extremity landing kinematics and kinetics in individuals with 
symptomatic and asymptomatic PTA. 
 
Research Questions 
3.1 Does an acute isometric patellar tendon loading exercise protocol change sagittal 
and frontal plane knee and hip joint angles during the loading phase of the 
double-limb landing task in individuals with symptomatic PTA compared to those 
with asymptomatic PTA? 
3.2 Does an acute isometric patellar tendon loading exercise protocol change net 
internal sagittal and frontal plane knee and hip joint moments during the loading 
phase of the double-limb landing task in individuals with symptomatic PTA 
compared to the asymptomatic PTA? 
3.3 Does an acute isometric patellar tendon loading exercise protocol change peak 
vertical ground reaction force during the loading phase of the double-limb 
landing task in individuals with symptomatic PTA compared to the asymptomatic 
PTA? 
3.4 Does an acute isometric patellar tendon loading exercise protocol change peak 
patellar tendon force during the loading phase of the double-limb landing task in 
individuals with symptomatic PTA compared to the asymptomatic PTA? 
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Hypotheses 
Hypothesis 3. The acute isometric patellar tendon loading exercise protocol will elicit 
different changes in lower extremity landing kinematics and kinetics in individuals with 
symptomatic PTA compared to the asymptomatic PTA. 
3.1 The acute isometric patellar tendon loading exercise protocol will increase sagittal 
plane knee and hip joint angles in the symptomatic PTA group, relative to the 
asymptomatic PTA. 
3.2 The acute isometric patellar tendon loading exercise protocol will alter sagittal 
plane knee and hip joint moments, specifically greater internal knee extension 
moment and lesser internal hip flexion moment, in the symptomatic PTA group, 
relative to the asymptomatic PTA. 
3.3 The acute isometric patellar tendon loading exercise protocol will increase peak 
vertical ground reaction force in the symptomatic PTA group relative to the 
asymptomatic PTA. 
3.4 The acute isometric patellar tendon loading exercise protocol will increase peak 
patellar tendon force in the symptomatic PTA group relative to the asymptomatic 
PTA. 
Rationale 
 Approximately 20-30% of asymptomatic athletes demonstrate patellar tendon structural 
abnormalities.1,40–42 Furthermore, there is an approximate four-fold increased risk of symptom 
development in individuals with a patellar tendon abnormality.43 Due to the prevalence of 
structural- and symptom-based impairments in athletes participating in sports marked by high 
frequency and intensity loading on the knee joint, determining the effectiveness of targeted 
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treatment strategies is critical. Tendon is a visco-elastic tissue that readily responds to loading 
via mechanotransduction processes;12 therefore, using exercise-based therapies to promote 
positive adaptation when tendon is structurally compromised both before and after symptom 
onset is supported. Isometric patellar tendon loading exercise has recently been shown to both 
acutely and chronically decrease tendon pain, improve quadriceps strength, and improve self-
reported knee function during sport in individuals with symptomatic patellar tendinopathy.16–18 
 However, the effects of this targeted tissue-specific loading protocol on lower extremity 
biomechanics has not yet been investigated. Athletes with symptomatic patellar tendinopathy 
demonstrate load avoidance movement strategies during sport-specific tasks, including 
reductions in sagittal plane knee displacement and mechanical energy absorption, lesser vertical 
ground reaction force, and lesser internal knee extension moment.19,21,22 This study will be the 
first to test the acute effects of an isometric patellar tendon loading exercise protocol17 on 
landing biomechanics in individuals across the tendon pathology continuum (both asymptomatic 
and symptomatic individuals with structural abnormalities). Using isometric loading 
interventions to acutely change movement biomechanics may provide an important next step in 
rehabilitation paradigms for tendinopathy as a method to promote improve load-tolerance during 
and stimulate positive mechano-transductive responses in individuals with tendon pathology. 
Target Journal 
 The manuscript reporting the results of this specific aim will be prepared for submission 
to the Journal of Orthopedics and Sports Physical Therapy (JOSPT) (Impact Factor: 2.55). 
Tissue-specific loading interventions are common in clinical practice for the treatment of 
tendinopathies. Therefore, the results of this specific aim have the potential to aid in the 
advancement of therapeutic interventions to treat individuals with patellar tendinopathy and are 
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appropriate for JOSPT, as this journal seeks to publish clinically-relevant studies specific to 
common orthopedic conditions. Additionally, this journal is housed within my professional 
organization, the American Physical Therapy Association (APTA). 
 
Table 1.3. Summary of Aim 3 
 
Research Question Objectives Dependent Variables Statistical Analysis 
3.1 Does an acute isometric patellar 
tendon loading exercise protocol 
change sagittal and frontal plane 
knee and hip joint angles during the 
loading phase of the double-limb 
landing task in individuals with 
symptomatic PTA compared to 
those with asymptomatic PTA? 
 
The following kinematic variables 
will be calculated for initial contact, 
peak, and displacement across the 
loading phase of the landing task 
for the involved PTA limb: 
Knee flexion angle 
Knee valgus angle 
Hip flexion angle 
Hip adduction angle 
Between groups: 2x2 mixed-model 
repeated-measures analysis of 
variance ANOVA on change scores 
for involved limbs from pre- to 
post-intervention 
3.2 Does an acute isometric patellar 
tendon loading exercise protocol 
change net internal sagittal and 
frontal plane knee and hip joint 
moments 
 during the loading phase of the 
double-limb landing task in 
individuals with symptomatic PTA 
compared to those with 
asymptomatic PTA? 
The following kinetic variables will 
be calculated across the descending 
phase of the landing task for the 
involved PTA limb: 
Peak Internal knee extension 
moment 
Peak Internal knee abduction 
moment 
Peak Internal hip flexion moment 
Peak Internal hip adduction 
moment 
Between groups: 2x2 mixed-model 
repeated-measures analysis of 
variance ANOVA on change scores 
for involved limbs from pre- to 
post-intervention 
3.3 Does an acute isometric patellar 
tendon loading exercise protocol 
change peak vertical ground 
reaction force during the loading 
phase of the double-limb landing 
task in individuals with 
symptomatic PTA compared to 
those with asymptomatic PTA? 
Peak vGRF 
 
a. 2x2 mixed-model repeated 
measures ANOVA on change 
scores for involved limbs peak 
vGRF from pre- to post-
intervention 
 
3.4 Does an acute isometric patellar 
tendon loading exercise protocol 
change peak patellar tendon force 
during the loading phase of the 
double-limb landing task in 
individuals with symptomatic PTA 
compared to those with 
asymptomatic PTA? 
Peak patellar tendon force (FPT) 
Patellar tendon force impulse 
a. 2x2 mixed- model repeated 
measures ANOVA on change 
scores for involved limbs peak FPT 
and FPT impulse from pre- to post-
intervention 
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Figure 1.1. Overview of the proposed study methodology to assess the acute effects an isometric 
patellar tendon loading exercise protocol on lower extremity landing biomechanics, and to 
quantify cumulative external load metrics over a one-week training period. 
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Independent Variable 
1. Patellar Tendon Structural and Symptom Profile 
a. Symptomatic / PTA vs. Asymptomatic / PTA vs. Asymptomatic / No PTA 
Dependent Variables 
1. Biomechanical Variable Change Scores following the Isometric Patellar Tendon Loading 
Exercise Intervention collected over the loading phase of the double-limb landing task; 
Baseline Biomechanical Variables 95% Confidence Interval Waveform Comparisons 
over the entire stance phase of the double-limb landing task: 
i. Sagittal plane knee joint angle 
ii. Frontal plane knee joint angle 
iii. Sagittal plane hip joint angle 
iv. Frontal plane hip joint angle 
v. Net internal sagittal plane knee joint moment 
vi. Net internal frontal plane knee joint moment 
vii. Net internal sagittal plane hip joint moment 
viii. Net internal frontal plane hip joint moment 
ix. Vertical ground reaction force 
x. Patellar tendon force 
xi. Patellar tendon force impulse 
2. Cumulative External Load Variables from 1-Week Load Monitoring Period 
a. Average daily steps-per-day 
b. Average moderate-to-vigorous-physical-activity per day 
c. Cumulative patellar tendon force estimation (cFPT) 
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CHAPTER 2: REVIEW OF LITERATURE 
 
The Landscape of Musculoskeletal Injury in Youth Sports 
 
The last half-century has witnessed a steady rise in sports participation among youth 
athletes.44 In the United States, high school sports participation increased by approximately 80% 
between 1971 and 2005,44 which has been attributed to growing opportunities for females in 
sport and the growing emphasis on health promotion in youth.45,46 In a large cross-sectional, 
nationally representative sample, approximately 62% of high school students (70% of males; 
53% of females) reported participating in at least one sport.47 Nearly 8 million boys and girls 
participated in organized high school sports during the 2014-2015 school year.48 The importance 
of physical activity in youth populations has been recognized by national and international 
governing bodies as a priority from health behavior and economic perspectives. The World 
Health Organization recommends at least sixty-minutes of moderate to vigorous physical activity 
(MVPA) per day for youths aged 5-17, and notes that greater than sixty minutes-per-day may 
provide additional health benefits.49 Physical activity and sports participation in the youth 
population has been associated with numerous positive health and social behaviors47 and 
continued physical activity into adulthood,46 lowering the risk of a variety of disease conditions, 
including cardiovascular disease, diabetes, and various cancers.50  
 Despite the well-accepted benefits of promoting physical activity in youth populations, 
an unintended consequence of rising youth sports participation is the increased potential for 
sports-related injury. Epidemiologic data demonstrates an overall increase in pediatric and
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 adolescent sports-, recreation-, and exercise-related (SRE) injuries, due to both acute and 
chronic mechanisms.51 During the 2014-2015 school year, high school athletes in the United 
States suffered an estimated 1.2 million injuries.52  
Of particular concern is the high prevalence of musculoskeletal (MSK) injury in youth 
athletes. MSK injury diagnoses constitute the majority of self-reported SRE injuries in both high 
school and collegiate populations.53–55 In a large-scale national survey, 64% of reported sport-
related injury episodes occurred among individuals aged 5-24, and were reported as 
approximately 41% higher than national estimates of injuries that require emergency department 
visits.53  Additionally, the majority of reported SRE injuries were to the upper (31.2%) and lower 
(38.9%) extremities.53 The consequences of MSK injuries sustained at a young age are 
numerous, including economic, social, and long-term outcomes. In the United States, MSK SRE 
injuries comprise up to 64% of all emergency department visits by individuals 19 years old and 
younger.56 While there is limited data describing long-term health impacts of injuries sustained 
in young athletes, this is an area gaining increasing interest due to the rise in youth sport 
participation. In fact, recent evidence demonstrates that athletes with a history of MSK injury or 
a current MSK injury score lower than uninjured counterparts on validated quality of life 
measures, including health problems and social functioning, and report less perceived physical 
capability.57–60 
While MSK injuries sustained through acute, traumatic mechanisms, such as anterior 
cruciate ligament (ACL) injury, are debilitating, costly, and result in time loss for sport 
participation,61–63 chronic, overuse MSK injuries are often equally as challenging and 
burdensome on both healthcare practitioners and patients alike. Most overuse injuries have a 
multi-factorial pathoetiology, rendering difficult diagnosis and treatment pathways. Patellar 
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tendinopathy, a common overuse injury in athletes, is a challenging condition to treat due to its 
varied clinical presentation, specifically the inconsistently-present clinical indicators of pain and 
structural pathology. Tendinopathies result from mismanagement of external load, typically in 
the direction of tissue overloading.9,64 Traditional management of lower limb tendinopathies 
emphasized notable reductions in external load until full resolution of symptoms was achieved.65 
Eccentric exercise protocols, particularly for chronically symptomatic tendinopathies, constitute 
the common standard of care for tendinopathy,14,66 and are likely one of the most widely-spread 
implemented treatment paradigms in rehabilitative musculoskeletal clinical practice. However, 
evidence supporting a continuum of tendon pathology, described by progressive stages of 
structural pathology, suggests that one-size-fits-all eccentric exercise protocols may not be 
appropriate to prescribe for all stages of tendinopathy.10 Emerging evidence demonstrates 
positive effectiveness of isometric loading exercise protocol on pain and self-reported function in 
athletes with patellar tendinopathy.16–18 However, to-date there is no literature describing the 
effects of an acute patellar tendon loading exercise protocol on lower extremity biomechanics, 
despite demonstrated differences in lower extremity biomechanics between individuals with and 
without patellar tendinopathy symptoms,19–22 as well as between asymptomatic individuals with 
and without structural abnormalities.23,24 Finally, advances in wearable technology allow for 
quantification of physical activity metrics that provide objective insight into cumulative external 
loading. Recent evidence demonstrates that individuals with a history of knee injury participate 
in less physical activity than to healthy, uninjured peers.38 It is likely that the quantification of 
cumulative physical activity is a critical piece missing from current investigations of factors 
related to the development and treatment of tendinopathy, and is an area that should be explored 
based on the well-accepted load-responsiveness of tendon. 
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This review will focus on three primary areas around the topic of patellar tendinopathy to 
support the current study: 1) epidemiology and pathoetiology, 2) intrinsic and extrinsic factors, 
and 3) exercise-based intervention paradigms. Overall, the aims of this study seek to contribute 
to the current understanding of the continuum of tendon pathology,10 and inform our 
understanding of modifiable factors that can be directly applied to the clinical management of 
tendinopathy. 
SECTION 1: Injury Epidemiology & Pathoetiology 
Epidemiology of Patellar Tendinopathy 
 
 Patellar tendinopathy is a chronic, overuse injury condition resulting from excessive 
tissue load.67,68 Epidemiological studies have demonstrated a 2.5 – 14.4% prevalence of patellar 
tendinopathy in a diverse group of sports requiring high loading rates and power demands.4,5 In 
particular, individuals participating in sports involving repetitive jumping and landing have been 
shown have the highest rates of patellar tendinopathy, due to the repetitive load placed on the 
tendon tissue. The prevalence in elite and recreational adult basketball athletes has been reported 
to be as high as 32% and 12%, respectively; a similar prevalence has been noted in elite (45%) 
and recreational (14%) volleyball athletes.4,5 Athletes participating in other sports, such as track 
and field (running and high/long jump athletes), tennis, and skiing, have also been shown to 
readily develop tendinopathy.67  
 Sex differences in the incidence of patellar tendinopathy have been highlighted in 
numerous epidemiological studies. In both adolescent36 and adult69 athlete populations, males 
have been reported to develop PT more readily than females. In a cross-sectional multi-sport 
investigation of elite adult athletes, the prevalence of current patellar tendinopathy was 
significantly higher among males (13.5%) than females (5.6%).5 Though not as thoroughly 
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studied as adult populations, an approximate 7% prevalence of patellar tendinopathy in 
adolescent (ages 14-18) athletes has been noted.1 Moreover, in young elite volleyball athletes, 
boys have been shown to have four-times higher risk of developing PT than girls, independent of 
training and match exposure.36 While the sex discrepancy appears to be consistent in different 
age groups and sports, due to increased sport participation among young females,46 continued 
evaluation of both sexes should be pursued. For example, a high prevalence (26.6%) of anterior 
knee pain has been documented in female adolescent athletes assessed over three-years during 
pre-participation screenings, including higher prevalence in high-school (34.4%) versus middle-
school (23.5%) aged athletes,70 suggesting that young females should be monitored closely 
during sport participation. Additionally, as athlete’s progress from junior to senior sporting 
levels, the incidence of patellar tendinopathy increases,71 likely due to the cumulative chronic 
load from aggregated years of sport participation. Moreover, Hall et al (2015) demonstrated an 
increased risk of patellar tendinopathy in youth athletes who specialize in a single sport (OR: 
1.27 – 4.0).72 
 Unlike an acute traumatic knee injury, the onset and progression of patellar tendinopathy 
does not typically result in immediately removal from sport. However, its progression and lack 
of resolution over time can lead to reduced capacity for sports participation at an athletes’ normal 
frequency and intensity. Cook et al. (1997) demonstrated that over one-third of athletes who 
present with symptomatic patellar tendinopathy are unable to return to sport within six months.7 
Additionally, approximately 50% of athletes who develop recalcitrant patellar tendinopathy 
retire from sport due to the condition.5 Like many chronic musculoskeletal conditions, persistent 
tendinopathy often results in an overall reduction in physical activity6, which may initiate a 
cascade of secondary negative health consequences over a lifespan. Due to the complex 
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pathoetiology of tendinopathy, however, it is thought that the effects of chronic tendinopathy on 
performance, self-perceived function, and quality of life are likely underestimated.36   
The prevalence of patellar tendinopathy in youth athletes, particularly in those who 
participate in sports involving high frequency and intensity of repetitive jumping and landing, 
and are exposed to high cumulative training volumes, necessitates continued attention from the 
sports medicine clinical and research communities. This may be of particular importance during 
a period when youth sports participation is increasing exponentially in the United States, not 
only to reduce onset and progression of pathology, but to also ensure that young individuals are 
able to maintain healthy levels of physical activity as they mature. Knowledge of risk factors for 
patellar tendinopathy provides avenues to improve treatment strategies to decrease the burden of 
this condition in young athletes, which in turn will promote lifelong physical activity. 
Models of Tendon Pathoetiology 
 
The management of tendinopathy in clinical settings can be challenging, due largely to 
the varied clinical presentation, specifically inconsistent relationships between tendon structural 
pathology, function, and pain.10 Multiple models are represented in existing literature that outline 
the pathoetiology of tendinopathy. These models all suggest that the development of 
tendinopathy occurs along a continuum, but that distinct factors initiate the pathoetiologic 
cascade. Specifically, collagen matrix disruption, inflammation, and tendon cell response have 
been identified in previous literature as key factors driving tendinopathic processes.73 
One of the earliest models suggested that tendinopathy initially develops from the occult 
disruption of the tendon collagen matrix.73 Disruption and/or tearing of the collagen matrix is 
thought to precede the onset of pain; subsequently, the inability of disrupted tendon collagen 
matrix to perform its normal mechano-transductive role leads to under-loading and degenerative 
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pathology.73,74 This model suggests that degenerative pathology is irreversible, and is considered 
end-stage pathology. A limitation to this model is that it does not consistently describe phases of 
tendon adaptation that may precede degeneration, which is a critical facet when identifying 
injury prevention strategies in high-risk population. 
Further, inflammatory models are aligned around the notion that inflammatory substances 
drive tendinopathic processes. While widely accepted amongst clinical and scientific groups, 
there are several limitations to this model. One of the key limitations is the lack of cellular 
inflammation that is present in pathological tendons. For decades, it was thought that the primary 
source of pain in tendinopathy was due to inflammation within the tendon (i.e. ‘tendinitis’). 
However, numerous studies have clearly demonstrated that there is a lack of intra-tendinous 
inflammation present in tendinopathy. Two key investigations conducted by Khan et al (1996) 
and Sanchis-Alfonso (2001) provide strong evidence to support this shift.75,76 In both of these 
studies, biopsies of patellar tendons from individuals with recalcitrant symptoms were taken at 
the time of surgery. Histochemical analysis indicated consistent changes to the structural matrix, 
including poorly aligned irregular collagen fibers, shift from Type I to Type III collagen, 
increased swollen tenocytes, fibrils, and fluid, and heightened expression of matrix-degrading 
cytokines (i.e. TNF-alpha). Interestingly, there was a complete lack of inflammatory cells and 
biomarkers. Instead, both studies noted the presence of neuronal-sprouting and increased 
vascularity within the pathologic tendon. Other studies have reported similar findings, 
specifically that neovascularization is commonly present in pathologic, symptomatic tendons.76 
Sanchis-Alfonso (2001) proposed that the pain experienced in tendon pathology is likely not 
from intra-tendinous inflammation, but instead from the heightened neovascularization that 
occurs in an attempt to repair and remodel over-stressed tendon.76 
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In summary, early models of tendon pathology were defined by two distinct 
classifications of tendon status: tendinitis (acute) and degenerative tendinosis (chronic).65 The 
distinction between these two classifications was based largely on duration of symptoms and key 
aspects of the clinical exam.  Specifically, tendinitis was classified based on the following key 
constructs: 
• Acute onset with short duration of symptoms 
• Inflammatory processes within the tendon proper (-itis), resulting in pain 
• Lack of obvious structural changes to the extracellular matrix (ECM) 
• Notable tenderness to palpation and observable/palpable focal swelling on physical exam 
Degenerative tendon pathology (tendinosis) was classified based on the following key 
constructs: 
• Chronic, recalcitrant symptomology (>6+ months) 
• Notable changes to the extra-cellular matrix, including collagen disorganization or a 
complete loss of matrix integrity 
• Irreversible structural changes that are unable to respond to load-based treatments 
• +/- tenderness to palpation and observable/palpable focal swelling on physical exam 
The Continuum of Tendon Pathology 
 
Current evidence describing the pathoetiology of tendinopathy has evolved from these 
previous models, such that tendon pathology is now commonly described to occur over a 
continuum, from early reactive stages (acute) to later stages of dysrepair and degeneration 
(chronic).9 In the context of clinical management of tendinopathy, treatments are most effective 
when they are tailored to match the stage of tendinopathy, as there is evidence that tendons at 
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different stages of the pathologic continuum may require different treatment approaches.10 In 
fact, the prescription of inappropriate interventions to a tendon may lead to a worse outcome.77 
Therefore, a shift in the model of tendon pathology to that of a continuum model has 
been largely supported over the last decade.9,10 This model defines tendon pathology across three 
continuous stages, and contends that the movement from one stage to another is largely 
determined by imposed or external loading stimulus. There is considerable evidence 
demonstrating that external load is one of the primary etiological factors that influences tendon 
structural properties.9,78,79 Biological tissue homeostasis has been described by Dr. Scott Dye 
(1996) as the envelope of function, or “the range of load that can be applied across an individual 
tissue in a given period without supraphysiologic overload or structural failure.”64 Tendon health 
is intimately related to mechanical homeostasis. Tendon adaptation occurs through 
mechanotransduction, the physiological process by which the body translates mechanical load 
into a cellular response that leads to structural change.12 (see Section 3) Evidence describing 
structural changes that occur when a tendon is mechanically stimulated, or increasing the 
capacity of the tendon,80,81 supports the continuum model that tendon pathology does develop 
along a continuum, without discrete “onset” and “resolution” points. Since external loading is a 
modifiable construct, understanding how tendon responds to both acute and cumulative loading, 
particularly in athletes at an elevated risk of developing overuse injuries, may improve tailored 
intervention delivery focused on load-based management. 
The continuum model contends that load is not necessarily deleterious, but that the proper 
dosage and monitoring of load that is anabolic versus catabolic to tendon health is critical. The 
modification of load in the presence of pain is essential in order to promote positive versus 
negative adaptation, and to avoid a cascade of pathophysiological consequences82 that amplify 
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the difficulty of clinical management. The three stages described by Cook et al. in the continuum 
model are: reactive, dysrepair, and degenerative tendinopathic stages (Table 2.1). 
Table 2.1. Characteristics of stages of tendon pathology described in the continuum model from 
Cook et al (2009).9 
 
 Proposed 
Etiology 
Histological Features Clinical 
Features 
Imaging Features 
Reactive 
Tendinopathy 
Acute spike in 
tensile and/or 
compressive load, 
or direct blow to 
tendon 
Proliferation of cells & 
matrix, changing shape of 
cells (­ chondroid, 
thickening) 
 
Tendon swelling due to 
increased bound water to 
proteoglycans.  
Acute onset 
following 
spike in 
external 
loading 
 
Initially diffuse 
anterior knee 
pain 
Fusiform swelling 
 
Diffuse 
hypoechogenicity on 
US 
Tendon 
Dysrepair 
Continued 
external overload 
Progressive matrix 
breakdown 
 
Increased cell production, 
including chondrocytic cells 
 
Increased proteoglycan 
production leading to 
collagen separation and 
matrix disorganization 
Chronically 
overloaded 
 
Pain more 
localized 
Matrix and collagen 
disorganization 
(wavier pattern) 
 
Fusiform swelling 
 
Increase areas of 
focal 
hypoechogenicity 
 
Small increases in 
neovascularization 
Degenerative 
Tendinopathy 
Chronic external 
overload 
Notable matrix and cellular 
changes/heterogeneity, 
including areas of cell death 
(acellularity) 
 
Proliferation of 
neovascularization 
Focal tendon 
swelling and 
pain 
 
History of 
repeated bouts 
of tendon pain 
 
Distinct hypoechoic 
regions on US 
 
Large vessels on 
Doppler US 
 
High intratendinous 
signal on MRI 
 
In the reactive stage, if a temporary alteration in external load (decrease in magnitude, 
frequency, or duration) is made, a tendon in this stage has the ability to positively adapt, 
becoming stronger (Wolff’s Law) via remodeling and repair, and remain a functional, non-
pathologic, non-symptomatic tendon. In the dysrepair stage, the modification of loading 
parameters can still be effective at allowing the tendon to recover and move back towards the 
reactive and normal stages. If a tendon in the dysrepair stages is continually loaded above 
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optimal levels, a catabolic pathway is promoted, stress-shielding occurs, and, over time, it is 
more likely to enter a degenerative stage. However, once in the degenerative stage, continued 
overload to the tendon has become catabolic, as the magnitude/frequency/duration of load has 
exceeded tendon’s tolerance and allowed inadequate time to recover, remodel, and repair. There 
is an approximate four-fold increased risk of symptom development in individuals with a patellar 
tendon abnormality.43 Evidence suggests that there is little capacity for tendon structure to 
reverse back to a normal structural state once in a degenerative state.10,83,84 
However, the emergence of an additional tendinopathic stage on the continuum, 
‘reactive-on-degenerative tendinopathy’ has been supported by evidence demonstrating portions 
of degenerative tendon that are surrounded by structurally intact tendon.10 The hypothesis around 
the mechanism of ‘reactive-on-degenerative tendinopathy’ is that structurally intact tendon 
assumes the bulk of loading (as degenerative tendon is mechanically dormant) via stress-
shielding, and therefore may pass through intermittent stages of reactivity. Recent work by 
Docking et al (2015) demonstrates that degenerative tendon compensates for its inert structure by 
increasing cross-sectional area to maintain adequate aligned fibrillar structure around the 
periphery of the degenerative region.80 As a result, the tendon maintains its capacity for load-
transmission and can be targeted through load-based therapies. Importantly, sound progressive 
loading paradigms that address both pain and load-capacity in reactive-on-degenerative 
tendinopathies should be prescribed in order to maximize tendon resilience and prevent 
progressive structural pathology and functional disability (Figure 2.1). 
In summary, while tendon structural abnormalities on imaging do not always correlate 
with the presence of tendon pain and dysfunction,82,85 the progression and worsening of tendon 
structural pathology over time has been shown to be the greatest risk factor for the development 
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of pain.86,87 Therefore, clearly defining the symptom and structural characteristics that may 
influence the progression of tendinopathy is of critical importance in the management of 
tendinopathy.  
Figure 2.1. The continuum of tendon pathology (image from: Cook et al, Br J Sports Med, 
2016)10 
 
 
 
 
 
 
 
 
 
 
 
 
 
Differential Diagnosis: A Critical Feature of Evaluation of Anterior Knee Pain 
 
One of the key components to identifying appropriate treatment pathways for individuals 
with patellar tendinopathy is a sound differential diagnosis. In the context of the proposed study, 
clearly defining diagnostic criteria for patellar tendinopathy is a critical feature of pursuing the 
study aims to compare landing biomechanics between distinct pathologic and healthy 
populations. 
Common Differential Diagnoses for Non-Traumatic Anterior Knee Pain 
 
Patellar tendinopathy is one of several conditions that presents clinically as non-traumatic 
anterior knee pain. The breadth of differential diagnoses is expected, due to the multiple 
anatomic tissues located around the knee joint and the biomechanical demands placed on the 
knee joint during activity.  The most common differential diagnoses for non-traumatic anterior 
knee pain include, but are not limited to: patellofemoral pain syndrome, medial plica syndrome, 
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chondromalacia, pes anserine or supra/infrapatellar bursitis, iliotibial band syndrome, fat pad 
impingement, and osteoarthritis.88,89 Furthermore, in pediatric and adolescent populations, 
additional differential diagnoses must be considered, including osteochondroses (Osgood-
Schlatters disease and Sinding-Larsen-Johansen disease, osteochondritis dissecans, inflammatory 
disorders, referred pain (i.e. slipped capital femoral epiphysis or Perthe’s disease), 
osteosarcomas, or patellofemoral instability.88,89 In both clinical and research environments, a 
thorough clinical exam to rule-out conditions that are non-mechanical in nature and require 
referral should always occur first. If patellar tendinopathy is suspected, a systematic assessment 
of signs and symptoms should be confirmed. 
Defining Tendon Pathology: Evidence from Previous Literature 
 
Symptom Characteristics Associated with Patellar Tendinopathy 
 
Patellar tendinopathy is characterized by several hallmark features that have been well-
described in previous literature11,67,90: 1) localized pain at the proximal patellar tendon, just 
inferior to the inferior patellar pole11,91, and 2) load-dependent pain that is provoked with high 
demands on the knee extensor mechanism.5,92,93 Specifically, load-related tendon pain typically 
occurs immediately upon the initiation of loading, and resolves once the load is removed or at 
rest. Tendon pain also increases with increasing load magnitude and loading rates of activities 
involving high energy storage and release across the extensor mechanism, such as during deep 
squatting or repetitive hopping.11,94 Occasionally, during the course of an exercise bout, tendon 
pain may subside, as the tendon “warms-up”; however, pain typically reemerges following 
cessation of activity and may last for several hours to days.94 
Both pain location and dose-dependent nature of pain are critical features that 
differentiate tendinopathy from other common anterior knee pain conditions, such as 
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patellofemoral pain syndrome (PFPS) or infrapatellar fat pad (IFP) impingement. Unlike patellar 
tendinopathy, PFPS is characterized by diffuse anterior knee pain under or around the patella, 
provocation with lower-loading activities and prolonged knee flexion positioning, and reduction 
of symptoms with joint alignment correction, such as via taping or manual 
repositioning.11,70,89,95,96 Additionally, while there is evidence of tissue communication between 
the IFP and the patellar tendon97 (i.e. cytokine production,98 neovascularization,76,99,100 and 
structural connections75,101102), pain derived from IFP impingement is typically located adjacent 
to the tendon and is more commonly provoked with knee hyperextension or direct palpation.  
Finally, in the context of evaluating young athletes with suspected patellar tendinopathy, 
developmental conditions involving tendon-growth plate interfaces, such as Osgood-Schlatters 
disease (tibial tuberosity) and Sinding-Larsen-Johansson disease (inferior patellar pole), should 
be considered. These two developmental, traction-apophysitis conditions are most common in 
pre-pubertal cohorts during periods rapid growth.89,103 In the present study, the pubertal status of 
invited participants will be confirmed using validated measures104–106, with the goal of 
minimizing the potential that either of the aforementioned developmental conditions may be the 
source of patellar tendon pain in the symptomatic group. 
The criteria selected to characterize patellar tendon pain and delineate a symptomatic 
group assignment for participants in the current study are supported by previous literature (Table 
5).  Tendon pain is most commonly utilized clinically to diagnose patellar tendinopathy, 
regardless of the degree of structural pathology.107 While the pathophysiological theories for the 
pain associated with patellar tendinopathy are complex and multi-factorial,82 identification of key 
clinical features that can be easily quantified by clinicians to classify tendon pain is essential. 
Traditionally, positive pain on palpation was considered the hallmark sign of patellar 
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tendinopathy. However, the sensitivity (68%) and specificity (9%) of palpation is poor, and thus 
palpation is not considered as a robust diagnostic tool.108 In addition to patient history, including 
detailed questioning of activity-related stimulants of symptoms, pain maps109 and provocation 
tests110 are commonly used to differentiate patellar tendon pain from other conditions. 
 
Table 2.2. Criteria to characterize symptomatic patellar tendinopathy in current study 
Criteria for Symptomatic 
Patellar Tendinopathy 
Key Previous Literature Notes 
1. Localized Load-
Dependent Pain 
Blazina et al. (1973) 
Roels et al. (1978) 
Stages 1-4 (pain 
location/provocation) 
Cook et al. (2000) Junior basketball athletes 
Rudavsky & Cook (2014) Topical review 
2. Single-limb decline 
squat (SLDS) pain that 
remains localized to 
tendon 
Purdam et al. (2003) 
 
 
Adolescent (14-18 years) 
male and female basketball 
athletes 
Malliaras et al. (2006) Adult volleyball athletes 
Cook et al. (2005) Adult volleyball athletes 
 
Blazina et al (1973) outlined the first diagnostic classification system for tendinopathy, 
highlighted by subjective report of symptoms during jumping and landing sport activities.91  Due 
to the non-specific nature of global measures of this subjective assessment, additional studies 
sought to develop more objective measures, including standard squatting. Though a common 
functional test utilized in clinical evaluations, a standard squat is considered inadequately 
specific as a patellar tendon pain provocation test due to a lack of sufficient knee extensor 
mechanism loading. During a standard squat, end-range active ankle dorsiflexion motion is 
typically achieved prior to sufficient knee extensor mechanism loading.110  However, Purdham et 
al (2003) demonstrated that a single-limb decline squat (SLDS) (Figure 2.2) had superior ability 
to discriminate a change in pain scores following heavy training in adolescent athletes, compared 
to a standard double limb or single limb squat on a flat surface.110 Furthermore, the authors 
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emphasize that when using the SLDS provocation test, the test should be conducted with 
participants squatting between 50-60 degrees of knee joint flexion,110 where maximum force 
development through the patellar tendon has been reported.111 Additionally, larger magnitudes of 
knee flexion excursion (70-80 degrees) engage the patellofemoral joint and result in peak 
patellofemoral compressive forces112; therefore, avoiding a knee flexion angle greater than 60 
degrees during the SLDS test should be confirmed. The SLDS has been reported to have a low 
standard error of 5% on repeated assessment.110 
Figure 2.2. The Single Leg Decline Squat (SLDS). Participants are instructed to squat to 
approximately 60 degrees of knee joint flexion on a 25-degree decline board and rate the 
magnitude and location of pain. (image from: Malliaras et al, J Orth Spor Phys Ther, 2015)11 
 
In summary, clear definitions for inclusion criteria to define symptomatic patellar 
tendinopathy are critical to determine the independent influence of pain and structural pathology 
on primary biomechanical outcomes of interest, and, furthermore, the effectiveness of the 
isometric patellar tendon loading exercise protocol.  
Structural Characteristics Associated with Patellar Tendinopathy 
Structural pathology is the second hallmark sign utilized to define tendon pathology. 
Ultrasonographic (US) and magnetic resonance imaging (MRI) techniques are used clinically for 
diagnosis, monitoring treatment outcomes, and to predict future symptom development.113,114 It 
should be stated that, as with the utilization of diagnostic imaging for any medical condition, 
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imaging should always be accompanied by a sound history, clinical exam, and evaluative testing. 
The goal of diagnostic musculoskeletal imaging is to visualize bodily tissues in order to 
objectively characterize features that may be indicative of pathology. 
Overview of Tendon Composition 
 
Healthy tendon is primarily comprised of Type I collagen which is highly organized and 
well-aligned in parallel longitudinally within the tendon, providing tendon with high tensile 
strength.115 Small amounts of Type III collagen and Type X collagen are also present in tendon, 
primarily at tendon-bone interfaces.116 Tendon fibroblasts, or tenocytes, are spindle-shaped cells 
located along collagen fibers, and are the primary cell modulating the tendon structural 
environment via mechanotransduction.12,117  Proteoglycans (primarily decorin and biglycan) 
support the tendon extracellular matrix, aid in regulation of collagen fiber formation, and control 
fibril diameter.118 Proteoglycans and water constitute a large majority of the tendon extracellular 
matrix. In healthy tendon, the biochemical contrast between collagen and water in tendon results 
in little to no signal on MRI, and a homogenous, parallel orientation of well-organized fibrillar 
structure on US.119 
Compositional Changes Associated with the Development of Tendinopathy 
 
Several key histologic features of structural tendon pathology are commonly described in 
the literature that can be quantified using diagnostic imaging modalities. Driven by increased 
number of cells and alterations in cell shape (rounded tenocytes), these changes include: tendon 
thickening, changes in echogenicity, fibrillar disorganization, and neovascularization.119 On 
imaging, pathological tendon typically appears with localized widening of the tendon, focal 
hypoechoic regions, irregular fiber structure, and/or neovascularization.120 While MRI and US 
imaging modalities are adept at identifying neovascularization in tendon, for the purpose of this 
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study, the presence or absence of neovascularization will not be utilized as an inclusion criteria 
for a patellar tendon abnormality. Detection of neovascularization via Doppler signal on US can 
demonstrate poor inter-day reliability,121 and as it is easily influenced by exercise.122 
Additionally, the selection of US for use in the current study is attributed to its accessibility, 
feasibility, and ease of interpretation. While MRI is reported to have excellent reproducibility, 
soft tissue contrast, and captures multi-planar images,113 it is costly, inaccessible, and not 
required for the purposes of the study aims. Furthermore, advances in ultrasonographic imaging, 
including probe technology and image processing software that allows thorough visualization of 
tendon fibrillar structure, suggest that US imaging is an efficacious tool in tendon imaging.114  
Ultrasound Assessment of Tendon Structure 
Historically, conventional ultrasound imaging techniques have been utilized to evaluate 
tendon status, through measurement and grading of cross-sectional area (CSA) and 
echogenicity.119,123,124 Hypoechoic regions are suggestive of poor tendon quality, and have been 
linked to symptomatology in numerous populations.125,126 Cook et al.1 demonstrated that in 
junior basketball players, 79% of the patellar tendons categorized on clinical evaluation as 
having “current tendinopathy” also had a hypoechoic region on US imaging. Additional 
ultrasonographic assessments, including Doppler sonography, have been utilized to investigate 
neovascularization of tendon, and have been shown to associated with the presence of 
symptomatic Achilles tendinopathy.3,121,127 
However, the inconsistent presence of structural pathology and clinical symptoms of 
tendinopathy is well-accepted in current literature and clinical practice.1,41,128,129 Khan et al.130 
found only moderate associations between conventional US findings and clinical assessment of 
individuals with chronic Achilles tendinopathy, and that baseline US findings did not predict 
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two-year patient-reported function. Additionally, in a group of competitive club runners, while 
conventional US detected increased tendon thickness, there were no associations with self-
reported symptoms of Achilles tendinopathy.129 Limitations to conventional US include error 
related to probe placement and handling during scan acquisition, and slight changes or error in 
transducer position (tilt and rotation) can generate anisotropy artifact that may mimic images 
visualized with actual pathology.114 However, a recent systematic review found that diagnostic 
US assessments for tendon size demonstrate acceptable inter- and intra-rater reliability.131 
Therefore, based on the evidence, the use of US to classify tendon pathology (Figure 2.3) in the 
current study is well-supported. 
 
Figure 2.3. Algorithm for criteria decision-making to characterize patellar tendon structural 
pathology using conventional ultrasound imaging in current study (from Docking and Cook, 
2015).80 
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Application to Subject Inclusion Criteria: The Importance of Clear Definitions for Patellar 
Tendon Pain and Structural Pathology 
Utilizing a systematic approach to the evaluation of tendon pain and tendon structural 
pathology is an important feature of the current study. Previous research demonstrates varied 
outcomes when assessing biomechanical characteristics of individuals with tendon pain and/or 
structural pathology. For example, Rosen et al. (2015), having defined load-dependent pain as 
pain with jumping or squatting activities in the previous three months, found lesser peak knee 
and hip flexion angle and knee and hip flexion displacement during a landing task than 
asymptomatic controls.21 However, Siegmund et al (2008), having defined tendon pain only on 
point-tenderness on palpation, reporter greater hip flexion angle and acceleration during a 
jumping task than asymptomatic controls.20 These divergent findings provide an example of how 
observed outcomes may differ when consistent, clearly defined criteria for symptomology are 
not upheld. Therefore, the aim of the current study is to utilize evidence-based, systematic 
criteria to define participant status and group assignment (symptomatic with PTA, asymptomatic 
with PTA, healthy control) in order to elucidate the independent effects of pain and structural 
pathology on key biomechanical outcomes. Support from previous literature for the key 
biomechanical outcomes of interest for the current study will be outlined in the following section 
of this review. 
 
SECTION 2: Intrinsic and Extrinsic Factors Associated with Patellar Tendinopathy 
 Numerous studies have investigated factors, including intrinsic and extrinsic factors, 
associated with the development of patellar tendon structural pathology and symptomatic 
tendinopathy. Intrinsic risk factors are factors or characteristics inherent to the individual, such 
as anthropometrics and biomechanics. Extrinsic risk factors are factors or characteristics external 
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to the individual but which may influence or act on the individual, such as training load. When 
interpreting risk factors, it is important to consider the association between a factor with tendon 
structural pathology and/or symptomatic tendinopathy, as these two outcomes do not always 
occur concurrently. 
Intrinsic Factors 
 
 Multiple studies have investigated whether certain anthropometric factors increase or 
decrease an individual’s risk of patellar tendinopathy.92 Interestingly, the association between 
anthropometric characteristics and patellar tendinopathy is not consistent. Lesser quadriceps132 
and hamstring2,132 extensibility have been associated with structural pathology and a higher risk 
for symptomatic patellar tendinopathy. Waist girth (>83cm) has been identified as a risk factor 
tendon structural pathology in males, which is thought to be driven by both mechanical and 
biochemical effects of heavier weight.133 Other anthropometric characteristics, such as lesser 
closed-chain ankle dorsiflexion range of motion,134 lower arch height,135 younger age, and taller 
height4 have all been associated with patellar tendinopathy. Vertical jump height is a common 
performance measure assessed in athletes, and several studies have demonstrates associations 
between greater jump height performance and patellar tendinopathy36,136 and structural 
pathology.2  
An individual’s biomechanical profile is another type of intrinsic factor associated with 
patella tendinopathy. Biomechanics are believed to be particularly important given in regards to 
tendinopathy as an individual’s biomechanics directly influences tendon loading and is highly 
modifiable. Biomechanical profiles that characterize risk factors and injury mechanism factors 
associated with lower extremity musculoskeletal injury are readily reported in the literature. 
Existing biomechanical literature is especially robust in the area of biomechanical factors 
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associated with traumatic knee injuries, specifically anterior cruciate ligament (ACL) injury. The 
use of biomechanical analyses allows for the quantification of multiple aspects of human 
movement, including kinematics and kinetics, to better understand injury risk factors and 
mechanisms, and to inform prevention strategies for both primary and secondary injury events. 
An important distinction to acknowledge when assessing and conducting biomechanical analyses 
is that between risk factor analysis and mechanism analysis. Injury risk factor analysis utilizes 
prospective study design, first identifying biomechanical characteristics of an individual’s 
movement and then monitoring that individual over time to record any subsequent injury 
events.137 From this design, risk factors can be identified and used to help predict future injury. 
Mechanism analyses seek to evaluate biomechanical variables that are present at the time of an 
injury event.138 In other words, the mechanistic approach quantifies how excessive stress to a 
biological tissue leads to tissue failure and injury. Clear expression of biomechanical profiles as 
either injury risk factors or injury mechanism factors is critical. In his model of sports injury 
prevention, van Mechelen (1992) outlines the necessity of clearly identifying and delineating risk 
factors and mechanisms that influence injury in order to develop appropriate targeted injury 
prevention strategies.139 In the context of this review, risk factors and mechanistic factors 
associated with patellar tendinopathy will be clearly defined. 
 Compared to the large volume of biomechanical literature around ACL injury, there is 
much less available concerning biomechanical factors associated with patellar tendinopathy. 
Additionally, biomechanical literature around patellar tendinopathy typically only evaluates 
individuals with structural pathology or tendon pain compared to asymptomatic healthy controls, 
which limits direct comparison of the independent and combined influence of structural 
pathology and pain on biomechanics. Furthermore, diagnostic criteria for structural pathology 
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and pain frequently differ between studies, making comparison and integration of reported 
outcomes difficult. Finally, the majority of studies utilize small sample sizes and very specific 
participant populations (i.e. elite sport-specific athletes), which decreases external validity of 
findings. Nonetheless, it is clear from current literature that there are not clear landing strategies 
between individuals with patellar tendinopathy and in those that go on to develop patellar 
tendinopathy. Due to the load-responsive nature of tendon and high propensity for developing 
tendinopathy with high, repetitive external loading, understanding how landing characteristics 
differ between individuals at different stages of the tendinopathic continuum is important to 
inform injury prevention and best practice rehabilitative strategies. 
 An important consideration when using biomechanical profiles to assess severity of a 
MSK injury is that biomechanical characteristics of a given task do not always correlate with 
performance of the task. This has been demonstrated in numerous studies examining individuals 
with patellar tendinopathy, where no differences in vertical jump height performance exists 
between groups, despite different biomechanical strategies.220 For example, the symptomatic 
basketball athletes studied by Siegmund et al. compensated with altering ankle and hip 
kinematics to achieve similar jump-heights as the asymptomatic athletes. That said, jump height 
may be a critical factor in predisposing an athlete to future tendinopathy due to the high knee 
extensor moments and subsequent patellar tendon loading. In a 5-year prospective study of elite 
adolescent volleyball,140 male athletes who went on to develop symptomatic tendinopathy 
performed significantly better on a baseline countermovement jump (38.0±5.8 cm) than those 
who remained asymptomatic (34.6±5.5 cm; p=0.03). Furthermore, after accounting for gender 
and years of volleyball training, the odds of developing symptoms were 2.09 (1.03-4.25) for 
every one centimeter of additional height on the countermovement jump.  
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 The following portion of this review aims to summarize the current body around 
biomechanics in individuals with symptomatic and/or structural patellar tendinopathy in order to 
inform the key biomechanical variables of interest selected for the current study.  
Ankle, Knee, and Hip Kinematic & Kinetic Characteristics Associated with Symptomatic 
Patellar Tendinopathy 
 The following section will describe lower extremity kinematic and kinetic characteristics 
that have been associated with patellar tendinopathy. Kinematic characteristics of highly 
dynamic movements, such as jumping and landing, are relevant in the context of patellar 
tendinopathy based on the anatomy of knee extensor mechanism. Designed as a “pulley system” 
across the anterior knee, the patellar tendon experiences high tensile loads as the knee joint 
moves through increasing degrees of sagittal plane motion. However, at certain regions of the 
patellar tendon, specifically as the tendon wraps around a bony segment (i.e. proximal patellar 
tendon at the inferior patellar pole), high compressive loads are added to the overall load in the 
tendon. Combined tensile and compressive load has been described as a key mechanical factor 
leading to tendinopathy,141 as evidenced by alterations in tissue composition from fibrous to 
fibrocartilaginous, changes in tenocyte shape, and an increase in aggregan and type II collagen in 
areas of compression within tendon.142,143 Additionally, knee joint angle directly influences the 
line of action of the patellar tendon relative to the longitudinal axis of the tibia, such that 
contraction of the knee extensor mechanism will either invoke anterior (more extended knee) or 
posterior (more flexed knee) movement of the tibia.144  Furthermore, the patellar tendon is 
oriented anteriorly at knee flexion angles less than 60° and posteriorly as knee joint flexion 
increases,145 which may lead to greater compressive stress on the posterior aspect of the patellar 
tendon by the patella. The variable change in patellar tendon moment arm distance throughout 
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different degrees of sagittal plane joint motion directly influences the amount of quadriceps 
muscle force production required to combat external knee flexion moment on the lower 
extremity from the ground reaction force.144,146,147 Therefore, it is hypothesized that kinematic 
patterns, particularly sagittal plane motion at the knee, are associated with the development of 
patellar tendinopathy, and that once symptomatic, alterations in joint motion may exist as a 
compensatory movement strategy due to pain. 
Kinematics Associated with Symptomatic Patellar Tendinopathy 
 
 Biomechanical assessments of kinematic variables are most commonly reported from 
landing assessments via comparisons of individuals with and without symptomatic patellar 
tendinopathy. Sagittal plane knee joint motion is the most commonly cited variable, as the 
majority of energy absorption and force generation at the knee occurs in the sagittal plane,148 and 
do the aforementioned implications of sagittal plane knee position on patellar tendon strain. In 
several studies, individuals with symptomatic patellar tendinopathy demonstrate trends towards 
lesser sagittal plane ankle, knee, and hip motion than asymptomatic healthy control 
participants.19,20 However, in a their systematic review and meta-analysis, van de Worp et al. 
report the inconsistencies in landing kinematics between those with and without symptoms. 93 It 
is possible that slightly differing definitions for symptomology between the study’s cohorts may 
contribute lack of large group differences in these previous studies, further warranting the 
importance of clear and consistent definitions of pain when conducting studies on pathologic 
populations. 
In a more recent study, utilizing the largest comparative cohort size in current patellar 
tendinopathy biomechanics research (30 recreationally-active participants per group), Rosen et al 
(2015) found that symptomatic participants, compared to asymptomatic participants, landed with 
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lesser peak knee joint flexion (74.8±13.2° vs. 82.5±9.0°, respectively) and had lesser sagittal 
plane knee joint excursion (71.6±8.4° vs. 79.7±8.3°, respectively) during the stance phase of a 
jump-landing task.21 Additionally, the symptomatic participants demonstrated lesser peak hip 
flexion and hip flexion excursion than the asymptomatic participants. Interestingly, no 
differences knee and hip frontal and transverse plane kinematics, nor in tri-planar ankle 
kinematics were noted between groups, suggesting that adaptations in sagittal plane motion in 
the presence of tendon pain may be the dominant movement compensation strategy chosen by 
those with symptoms to reduce combined tensile and compressive tendon loads. Sorenson et al 
(2010) found no statistically significant differences in sagittal plane knee joint excursion between 
symptomatic and asymptomatic elite male volleyball athletes.19 However, the lack of group 
differences in this study may be attributable to lack of statistical power (n=7 and n=6 athletes per 
group, respectively), the inclusion of one athlete with bilateral pain, and the nature of the task 
(single limb approach jump analysis). 
Similarly, symptomatic versus asymptomatic elite dancers performing a “saut-de-chat” 
single-limb landing technique demonstrated similar sagittal plane ankle, knee, and hip joint 
angles at initial contact (p>0.05), varying by less than two degrees at each joint between groups. 
In this study, the landing approach angle was calculated as the angle between the floor and the 
L5-S1 reflective marker at the time of initial contact to generate an estimate of gross body 
position during the landing task.149 Interestingly, despite no statistically significant group 
differences in landing angle, landing angle explained 67% of the braking impulse value (r=-
0.817), with symptomatic participants demonstrating greater braking impulse even at similar 
landing angles as asymptomatic participants. It is possible that these individuals chose a 
movement pattern to avoid greater sagittal plane knee joint excursion to minimize symptom 
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exacerbation and compensated with higher braking forces across the lower extremity.  This 
finding provides further support of the relationship between compensatory kinematic and kinetic 
patterns in athletes with patellar tendon pain. 
 Knee joint velocities and accelerations during landing have also been previously explored 
in this population. In a matched comparative cohort of adult male basketball athletes, those with 
symptomatic jumper’s knee demonstrated decreased knee flexion acceleration and a longer-
duration landing time than healthy controls, despite no group differences in knee joint flexion 
velocity or displacement during a countermovement jump.20 Additionally, the symptomatic 
athletes demonstrated greater maximum hip and trunk flexion angle and hip flexion acceleration 
than healthy controls, which is suggestive of a strategy to decrease the moment arm between the 
trunk and knee.20 This positioning subsequently reduces the external knee flexion moment 
imposed on the lower extremity at ground contact, thus reduced the necessary internal knee 
extension moment and extensor mechanism force production requirement.150 Similarly, Bisseling 
et a. (2007) found that symptomatic volleyball athletes landed with lower knee velocities and 
slower ankle plantarflexion and knee extension moment development.22  Applying force over a 
longer period of time reduces the magnitude of an applied load (F=dt), and may therefore reduce 
the stress applied to a given tissue, in this case the painful patellar tendon.146 Evaluating joint 
accelerations may have implications in further identifying compensatory movement strategies 
employed by individuals with patellar tendon pain.  
 Associations between ankle joint dynamics and knee loading is a commonly investigated 
biomechanical concept with regards to lower extremity injury.148,151–154 Existing literature around 
patellar tendinopathy consistently demonstrates that ankle kinematics do not differ between 
symptomatic versus asymptomatic individuals.21,155 Rosen et al (2015) found no significant 
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differences at the ankle in any plane-of-motion at initial contact, peak, or maximum angular 
displacement in recreational athletes performing a double-limb jump-landing task.21 Similarly, in 
a study by Richards et al (2002), albeit a very small sample size of asymptomatic (n=7) and 
symptomatic (n=3) national elite male volleyball players, no differences in ankle kinematics 
were noted between groups during a spike jump task.155 Interestingly, in a blinded logistic 
regression model, the only ankle kinematic or kinetic variable to correctly predict the presence or 
absence of patellar tendinopathy in this cohort was foot inversion moment. In a previous study of 
the same cohort of athletes investigating the predictive capacity of knee dynamics for current 
patellar tendinopathy, Richards et al (1996) found that a combination of kinematic and kinetic 
variables correctly predicted the presence or absence of tendinopathy at the time of testing, 
including larger knee flexion angle at initial contact, peak vGRF and vGRF loading rate, internal 
knee extension moment development, and tibial external rotation moment.156 The collective 
results of these studies suggest that there is likely a combination of ankle and knee dynamics that 
are linked to patellar tendinopathy. However, due to the cross-sectional nature of these study, the 
ability of these biomechanical factors to predict which athletes will go on development 
tendinopathy in the future is not feasible. 
Kinetics Associated with Symptomatic Patellar Tendinopathy 
 
 In addition to the few number of studies that have reported differences in sagittal plane 
knee kinematics between individuals with and without tendon pain, kinetic variables have also 
been explored in this population. It is important to recognize analyses being conducted on 
double- versus single-limb tasks, as outcomes may differ based on the nature of the task. Both 
Bisseling et al. (2007) and Sorenson et al. (2010) analyzed double-limb landing tasks, and 
demonstrated that symptomatic athletes tend to choose a load-avoidance strategy, supporting the 
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expected notion that individuals avoid loading painful tissues during high-energy movements. 
Bisseling et al.22 demonstrated that symptomatic volleyball athletes chose a landing technique 
that avoids high patellar tendon loads, specifically with lesser internal knee extension moment on 
the involved limb and reduced knee flexion velocity, compared to both those with a history of 
patellar tendinopathy and healthy control participants. Though their study utilized a small sample 
size (N=13), Sorenson et al.19 found that individuals with patellar tendinopathy had 
approximately a 30% reduction in net joint work and power and approximately 22% lower peak 
vGRF than healthy control participants, suggesting reduced mechanical energy absorption and 
force attenuation on the symptomatic limb. 
 Conversely, during the single-limb saut-de-chat in dancers, dancers with symptomatic 
patellar tendinopathy demonstrated greater peak vGRF (36%) and vGRF impulse (15%) and 
greater posterior GRF (82%) and posterior GRF impulse (126%) compared to healthy 
controls.149 It is possible that during single-limb tasks, when an individual does not have another 
limb to rely upon, distinguishing movement characteristics that may precede or be associated 
with the presence of pain is more overtly recognizable. In this study, higher lower extremity 
loading during a single-limb task in the symptomatic group may suggest that individuals with 
patellar tendon pain are less capable of attenuating external forces when required by the nature of 
the task to rely solely on the symptomatic limb. However, as with all non-prospective studies of 
individuals with pain or pathology, a direct cause and effect relationship cannot be established; 
therefore, we cannot conclude whether or not symptom onset drives biomechanical alterations, or 
conversely, if aberrant biomechanics lead to the development of pain and structural pathology. 
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Ankle, Knee, and Hip Kinematic & Kinetic Characteristics Associated with Patellar Tendon 
Structural Pathology 
Due to the increased likelihood of developing symptomatic patellar tendinopathy when a 
PTA is present,43,157 evaluating the biomechanical profiles of an asymptomatic with PTA group 
provides an opportunity to gain insight into movement characteristics that may precede symptom 
onset. However, there are very few previous studies have investigated kinematic and kinetic 
characteristics of individuals with patellar tendon structural pathology. 
 In a recent systematic review by van de Worp et al. (2014), a quantitative analysis 
determined that greatest differences in kinematic and kinetic variables during landing tasks were 
present in studies that compared healthy controls to asymptomatic individuals with patellar 
tendon structural abnormality (PTA).93 Previous work has compared biomechanics during both 
horizontal and vertical landing phases of jump-landing tasks. The majority of previously reported 
differences between individuals with a PTA and controls are during horizontal landing phases, in 
which individuals are moving forward. These differences are thought to be attributed to greater 
magnitudes of posteriorly directed ground reaction forces during horizontal landings, requiring 
greater internal knee extension moment to decelerate the limb and prepare for subsequent 
vertical movement.25,97 
Furthermore, Edwards et al. (2012) demonstrated that peak patellar force is higher during 
the horizontal deceleration phase versus vertical phase of a landing task.158 Therefore, it is 
necessary to consider the type of landing task being analyzed in existing literature, and the 
presence or absence of group differences may be influenced by task specificity and mechanical 
demand. Additionally, current evidence indicates that future research examining landing 
mechanics that may be associated with the development or progression of patellar tendinopathy 
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should include a dynamic task that incorporates a horizontal landing component, as the demand 
of the horizontal task on the MSK system may better differentiate factors associated with 
tendinopathy. 
 In a comparative cohort of junior pre-elite male basketball athletes with and without 
PTA, several kinematic variables were found to be predictive of the presence of a PTA, 
including hip joint excursion and knee flexion angle at initial ground contact. Individuals with a 
PTA extended their hip joints when landing and had greater knee flexion angles at initial ground 
contact.24 A similar hip kinematic pattern has been noted in adult athletes with PTA performing 
the same task.23 Combined with greater hip flexion angle at initial ground contact,23,24 this 
movement strategy is thought to increase the demand on the knee extensor mechanism to 
counteract the more posterior position of the body’s center of mass when transitioning from the 
loading to propulsive phases of a jump. Edwards et al. (2010) also found that the adult male 
athletes with PTA demonstrated greater knee flexion angles at initial ground contact but moved 
through less knee flexion excursion throughout the loading phase. Interestingly, neither of these 
studies reported internal knee moments, which have been shown to differ between individuals 
with and without patellar tendon pain.19,22 Further investigation of differences in internal knee 
and hip joint moments, moment development, and energetics between individuals with and 
without PTA is warranted, as high internal loads to the patellar tendon are thought to be 
associated with the progression of structural pathology and pain. 
Patellar Tendon Biomechanical Loading Characteristics Associated with Patellar 
Tendinopathy 
The knee extensor mechanism must deal with high magnitudes of kinetic energy during 
landing tasks, with upwards of 7x BW of force placed on the patellar tendon.23,159 The high and 
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frequent application of patellar tendon load during sport-specific activities has been associated 
with the development of tendinopathy.156 Recent literature has suggested that methods that 
directly estimate patellar tendon load are more specific than using traditional kinetic 
assessments, such as ground reaction forces, and may better discriminate the magnitudes of 
tendon load in one type of landing task compared to another and between pathological groups. 
 The characterization of patellar tendon loading during landing tasks has been investigated 
in several previous studies. In a group of asymptomatic male athletes with normal patellar tendon 
structure (confirmed via ultrasound), Edwards et al. (2012) quantified traditional kinematics and 
kinetics, as well as estimated patellar tendon loads, during the horizontal and vertical phases of a 
stop-jump task.158 Several findings from this study provide important insight regarding relevant 
variables of knee joint loading when studying chronic overuse injuries such as patellar 
tendinopathy. 
 First, in a comparison of the two landing phases, individuals demonstrated greater peak 
patellar tendon force (FPT), patellar tendon force loading rate (LR FPT), peak posterior ground 
reaction force, and peak internal knee extension moment during the horizontal landing compared 
to the vertical landing. Interestingly, these outcomes were observed despite lower peak vGRF 
during the horizontal landing phase.158 These findings suggest that in biomechanical analyses, 
using the peak vGRF as a surrogate for FPT may largely underestimate the actual load placed on 
the patellar tendon, further justifying the methodology of estimating patellar tendon force.144,160 
Additionally, this study justifies the inclusion of loading rate variables, not just of ground 
reaction forces but also of the force development within the patellar tendon, as both the 
magnitude and rate of force development has implications to create tissue overloading. 
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 Furthermore, Janssen et al. (2013) investigated whether factors previously associated 
with the development of tendinopathy, including demographics, clinical measures, strength, and 
biomechanics, affect patellar tendon loading during dynamic tasks. In this group of elite, healthy 
volleyball athletes performing a lateral stop-jump task, male participants with greater quadriceps 
strength, increased ankle dorsiflexion velocity, and increased trunk flexion velocity were 
predicted to sustain higher patellar tendon forces (R2 = 52.0%) and faster patellar tendon force 
loading rate (R2 = 69.8%).26 This study provides further evidence of the utility in quantifying 
patellar tendon force variables in this population. 
 Understanding the function of the patellar tendon during physiological loading conditions 
is important when studying knee biomechanics. This knowledge may be especially relevant in 
the study of patellar tendinopathy pathogenesis and treatment, as the nature of applied load to 
tendon tissue is associated with tendon’s adaptive properties, particularly when exposed to 
highly repetitive loads.83 
Advances in dynamic imaging technology has permitted three-dimensional modeling of 
human subjects in vivo during tasks reflective of every-day movements. DeFrate et al. (2007) 
quantified three-dimensional patellar tendon kinematics during a weight-bearing single-limb 
lunge in healthy participants (no knee pathologies).145 There are several key findings from this 
study that are of relevance to this review. First, as the knee moves through flexion (0-110°) the 
patellar tendon was found to change its orientation in both the sagittal and coronal plane. Large 
changes in patellar tendon length were observed from 0-30°, and subsequently very small 
changes in length from 30° to 110°, supporting previous literature that has reported greater 
patellar tendon stiffness at increasing knee flexion angles. Though modelling the patellar tendon 
two-dimensionally, Edwards et al. (2012) found that peak FPT for both the horizontal and vertical 
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landings occurred between approximately 55-60°.158 These studies provide support for the 
propensity for patellar tendon overloading during dynamic tasks involving repetitive sagittal 
plane knee joint motion. Furthermore, pairing knowledge of tendon kinematics and kinetic under 
physiological loading conditions with three-dimensional lower extremity joint kinematics and 
kinetics may provide a more comprehensive approach to understanding movement strategies of 
individuals at risk for or with patellar tendinopathy. 
 To this end, Edwards et al (2010) investigated landing strategies of asymptomatic athletes 
with a confirmed PTA compared to healthy controls, including both a traditional kinematic and 
kinetic assessment as well as estimation of patellar tendon force.23 Interestingly, during both 
horizontal and vertical stop-jump tasks, the PTA and healthy control groups demonstrated no 
statistically significant differences in peak FPT, LR FPT, or peak vGRF. However, the PTA group 
employed a different overall landing strategy at both the knee and hip during the horizontal 
landing phase. Specifically, the PTA group had greater knee flexion at initial ground contact but 
lesser knee flexion excursion, greater hip flexion at initial contact but lesser hip flexion 
excursion, and earlier recruitment of the hamstring muscles compared to the controls.23 The 
authors suggest that this altered kinematic strategy in the PTA group may result in higher 
compressive and tensile loads on the patellar tendon due to the distribution of the center of mass 
and subsequent combined loads and demand on the knee extensor mechanism. From a muscle 
recruitment standpoint, early hamstring recruitment at larger hip and knee flexion angles at initial 
contact is thought to invoke a large posterior shearing forces across the knee joint, thereby 
increasing the demand on the knee extensors to counteract this knee flexion moment. This study 
provides important insight into a compensatory landing strategy adopted by individuals with 
patellar tendon structural pathology who are not yet symptomatic. Furthermore, it suggests that 
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there is value in developing strategies to identify compensatory movement patterns in high-risk 
individuals such that injury prevention strategies can be optimally implemented. 
Application to Selection of Biomechanical Variables of Interest 
 
What remains to be investigated is how kinematics and kinetics, including patellar tendon 
force, may differ between individuals with a confirmed PTA but with or without symptoms 
compared to healthy controls. The biomechanical variables selected for evaluation and analysis 
in the current study (Tables 1.1 and 1.2) will allow thorough examination of three key 
characteristics related to the knee extensor mechanism function and patellar tendon 
pathoetiology, including: 
1) Sagittal and frontal plane knee motion, which influence the line of action and moment 
arm of the patellar tendon force vector, as well as the imposed combined tensile and 
compressive forces on the tendon 
2) Kinetic variables (internal moments and ground reaction forces), which describe the 
loading demands (force-generation requirements) on the knee extensor mechanism. 
3) Patellar tendon force variables, which have been demonstrated to provide a more 
specific estimation of the actual load placed on the tendon during dynamic tasks, 
therefore serving as an important adjunct variable of interest to traditional kinetic 
variables (internal moments and ground reaction forces). 
Exploring landing strategies of these specific groups will improve the ability of clinicians to 
develop targeted, individualized interventions for implementation based on where an individual 
is on the continuum of tendon pathology. 
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Extrinsic Factors 
 
 Extrinsic factors, such as training surface and shoe wear have not been identified as risk 
factors, despite their clinical relevance as risk factors for other MSK overuse conditions, such as 
lower extremity bony stress injuries.161,162 Perhaps the most consistently identified extrinsic 
factors associated with tendinopathy is an individual’s training load. Specifically, an individual’s 
training magnitude, frequency, and duration have been associated with tendinopathy in multiple 
studies.34,61,69,70 In elite adolescent volleyball athletes, high training load volume (hours and sets 
per week) (OR: 1.72-3.38) and years of volleyball participation (OR: 2.22) associated with an 
increased risk of patellar tendinopathy.36 Furthermore, Visnes et al (2013) found that in elite 
adolescent volleyball players followed prospectively for five years, those that developed 
symptomatic patellar tendinopathy (n=28) trained significantly more (14.4±2.5 hours/week) 
compared to those who remained asymptomatic (n=122) (11.8±2.7 hours/week; p=0.001).140 In 
adult female basketball athletes, those with structural pathology trained approximately 2.6 more 
hours per week and reported lower self-reported physical function than those without 
pathology.163 Further evidence in the Achilles tendon literature demonstrates significantly higher 
cumulative incidence of both Achilles tendinopathy (adjusted OR: 31.2) and tendon rupture 
(adjusted OR: 14.9) before the age of 45 in former male elite long distance runners and sprinters, 
respectively, compared to non-athletes.164 Training load, therefore, is identified clearly in 
existing literature as a critical factor associated with the pathoetiology of patellar tendinopathy.  
Physical Activity and Training Load Monitoring in Sport 
 The concept of monitoring athlete training load in sport has been of interest to 
performance specialists for many decades, specifically from the perspective of maximizing 
human physical performance capacity and recovery.165 The earliest concepts of training load 
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monitoring in sport is best illustrated endurance sports, such as distance running, in which 
methodology was developed to manipulate and quantify the components of training that we now 
refer to as the FITT principle (frequency, intensity, time, type).165 From these early efforts came 
advanced metrics by which training loads can be assessed more thoroughly and objectively, 
prompting an exciting area of research and practice for clinicians and scientists.165 
The categories and definitions commonly used in load monitoring literature must first be 
defined to ensure consistent interpretation of outcomes. External load is defined as any external 
stimulus applied to the individual measured independently of internal characteristics, such as 
duration of game (minutes) distance run (miles), or steps-per-day. Internal load is defined as the 
relative physiological and psychological response experienced by an athlete in response to an 
external load, such as heart rate, rating of perceived exertion (RPE), blood lactate 
concentrations.165–168 Numerous benefits of athlete load monitoring have been established, 
including explaining changes in performance, understanding training responses, and identifying 
areas of potential non-functional overreaching.168 The desire to measure and monitor both 
external and internal training load is of interest to coaches, athletes, medical practitioners, and 
researchers alike who have a collective interest in performance, injury prevention, and recovery. 
While load monitoring may not exclusively explain an athletes’ response to exercise, the 
quantification of objective and subjective characteristics of an individuals’ load response 
provides greater insight into factors that may be associated with the cascade of overreaching / 
overtraining, or the development / progression of a musculoskeletal injury.167,169 
There are emergent recommendations for load monitoring to become a regular 
component of managing all patients, not just elite athletes; this particularly applies to patient 
populations where the mismanagement of load may have deleterious effects on the trajectory of 
 55 
recovery and long-term resilience.170 Recent research has demonstrated strong associations 
between external training loads and injury incidence in elite adult athlete populations,34,35,165,171–
173 specifically explored in cricket, soccer, and Australian football. The interplay between 
training load and injury development / progression characterizes the accepted models for the 
development of overuse injuries, such as patellar tendinopathy, as its pathoetiology thought to 
arise from load mismanagement.9,12,68,117 However, emerging evidence reiterates that high 
training volume and intensity are not always deleterious; specifically, moderate training loads 
may be protective against injury to certain tissues, which has been described by Tim Gabbett as 
the “training injury prevention paradox”.171,173 Both high and low external loads have been 
associated with injury risk,174 suggesting that there may be an optimal load threshold for 
individual athletes, consistent with Dye’s Envelope of Function64 and the inverse-U illustration. 
This recent work in training load management has led some to believe that “overuse” may not be 
the best terminology to characterize non-traumatic injury development; instead, the terminology 
“training load error” injury may be more appropriate.175  
Physical Activity and Training Load Monitoring of Individuals with Lower Extremity 
Musculoskeletal Injury Conditions 
The use of wearable technology to quantify objective load metrics, both in clinical and 
research settings, has grown exponentially in the last two decades.176 The majority of studies to-
date have been designed to better quantify the influence of physical activity on systemic health 
outcomes, such as obesity, cardiovascular health, and diabetes, in both younger and older 
populations.177–180 Interestingly, the application of wearable technology in the context of 
musculoskeletal injury has been slower to develop, but its momentum has increased due to 
advances in technology.167 Implementation of wearable technology in an athletic environment 
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can be challenging due to constraints that may include time, manpower, lack of knowledge, or 
financial constraints;167 however, recent work supports the utility and relevance of external load 
monitoring-based data to the understanding of factors that may be related to injury incidence, as 
well as outcomes following injury. 
The majority of the existing training load literature has explored the aforementioned 
relationships in adult populations. In general, there is a lack of evidenced-based support for 
whether these same relationships exist in a younger adolescent population. Several studies report 
training load variables in specific populations of young athletes, including youth track and field 
athletes,181 baseball pitchers,182 and cricket fast bowlers,183 have demonstrated associations 
between high training loads or insufficient recovery and injury. As described in this review, the 
development of patellar tendinopathy in athletes is likely as result of a “training load error”, and 
its progression related to the mismanagement of external load over time. In an effort to better 
understand the factors related to the development of patellar tendinopathy, as well as how 
individuals with varying levels of the condition (structural +/- symptoms) may differ, objectively 
quantifying and monitoring external load is critical. The youth population may be especially 
vulnerable to training load errors as they transition from junior to senior level play, participate on 
multiple teams (i.e. school and club based) simultaneously, and mature physically following 
puberty. 
A study conducted by Visnes and Bahr (2013) tracked training volume prospectively for 
four-years via self-reported training diaries in elite volleyball players aged 16-18.36 The 
development of symptomatic patellar tendinopathy associated with higher overall training 
volumes, specifically number of hours and matches played. This important study supports the 
relevance of quantifying load variables in a young population at risk for patellar tendinopathy. A 
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limitation of this study is that the diagnosis of patellar tendinopathy was made via self-reported 
history of pain for twelve weeks and tenderness to palpation, with no quantification of pain on 
loading (i.e. single-limb decline squat) or assessment of tendon structural abnormalities. 
Therefore, the question still remains regarding how training load may associate differently in 
athletes across the continuum of tendon pathology (e.g. pain and/or structural abnormalities) and, 
furthermore, if potential differences in cumulative external load associate with differences in 
biomechanical movement profiles that are modifiable through structured interventions. 
Esmaeili et al. (2016) only found small and inconsistent effects of training load on 
Achilles and patellar tendon structure.184 However, the measure of training load in this study was 
session rating of perceived exertion (sRPE); while a valid and reliable measurement that 
associates with injury risk and fatigue in athletes,167,185 sRPE may not be directly related to 
changes in tendon structure as it does not directly quantify a specific measurement of cumulative 
external load, such as steps-per-day. Therefore, quantify cumulative external load in a population 
of individuals with tendinopathy is still needed. 
The use of load monitoring to describe populations with MSK injury conditions is an 
exciting area of research and is likely to add to the body of literature seeking to understand 
factors related to long-term health outcomes. As described previously in this review, the ability 
to quantify variables related to “real-world movement” is a critical missing piece that may be 
imperative to better understand the trajectory of recovery, resolution of impairments, and 
durability patients over time, particularly once they are no longer involved in clinical-supervised 
rehabilitation. Additionally, monitoring load in a real-world environment provides unique insight 
into an individual’s activity in the setting in which they spend the majority of their time versus 
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exclusively evaluating and developing management strategies based on laboratory or clinical 
evaluations alone. 
In a recent study, Bell et al. (2017)38 took this exact approach to explore differences in 
physical activity between individuals following ACL reconstruction (ACLR) and healthy 
matched controls. This study utilized the ActiGraph wGT3X-BT accelerometer over a one-week 
monitoring period, which is the same methodology proposed in the current study. Both steps-per-
day and minutes of moderate-to-vigorous physical activity (MVPA) were significantly lower in 
the ACLR group compared to the health control group, despite groups reporting similar levels of 
physical activity on self-reported function questionnaires. 
The findings from this study have several important implications in the context of the 
current study. First, Bell et al (2017) demonstrated the feasibility of utilizing a hip-worn 
ActiGraph accelerometer in a young, active population for a one-week monitoring period. 
Additionally, it appears that cumulative external load and self-reported function do not always 
associate, further supporting the importance of not relying exclusively on patient self-reported 
function in the context of understanding the influence of the patient condition / pathology on 
real-world physical activity. This may be particularly important in a youth population, as recall 
of prior physical activity may be unreliable,165 and due to the varied nature of a young 
individual’s daily life (i.e. attending classes, extra-curricular activities, sports activities, etc.). 
Finally, the design of and findings from this study are in line with the aims of the current study. 
Though performed in a post-ACLR population, it is the first to objectively quantify cumulative 
external load in a pathologic population in which long-term outcomes have been readily 
associated with tissue (in this case, knee joint) response to load over time. The current study aims 
to utilize a similar approach to determine if there are differences in cumulative external load 
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between individuals with symptomatic PTA, asymptomatic PTA, and asymptomatic without 
PTA for the purpose of better understanding modifiable factor, particularly that manipulation of 
cumulative loading, that may move an individual along the continuum of tendon pathology. 
Application to Physical Activity Monitoring Methods 
The application of physical activity monitoring is relatively new in the context of 
musculoskeletal injury and rehabilitation, yet its relevance to patellar tendinopathy is clear. 
Strong evidence discussed in the prior section supports the association between high training 
loads and a greater risk for the onset or progression of patellar tendinopathy in young athletes. 
Therefore, using objective variables, such as steps-per-day, to further quantify cumulative 
loading past traditionally-measured variables, such as years of participation and duration of 
practice/competition, may help better describe associations between physical activity and 
tendinopathy. Finally, using a hip-mounted accelerometer used to assess physical activity over a 
one-week monitoring period is accepted in the current literature as an appropriate wear position 
and duration, respectively, to obtain an estimate of cumulative physical activity in a youth 
population. The current study is the first to our knowledge to apply physical activity monitoring 
methods to a young population of individuals with patellar tendinopathy. With the increased 
availability and societal use of physical activity monitors, there is an exciting opportunity for 
clinicians to utilize this technology to improve both prevention and treatment strategies for 
musculoskeletal conditions, moving movement analysis from strictly laboratory-based 
assessments to clinical and real-world monitoring strategies. 
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SECTION 3: Exercise-Based Intervention Paradigms for Patellar Tendinopathy 
 
Mechanotherapy: Implications for Treatment of Tendinopathies 
 
As introduced in Section 1, biological tissue homeostasis has been described by Dr. Scott 
Dye (1996) as the envelope of function, or “the range of load that can be applied across an 
individual tissue in a given period without supraphysiologic overload or structural failure.”64 
This model outlines the relationship between magnitude and frequency of load to illustrate 
optimal tissue function when maintained within the zone of homeostasis. In the zone of 
homeostasis, there is appropriate external loading to foster internal responses that promote 
positive tissue adaptation. In this model, Dye identifies four key areas: 1) under-loading, 2) 
homeostasis, 3) supra-physiological load, and 4) structural failure (Figure 2.4).64 
As with any living organisms, human 
musculoskeletal tissues are most efficient and best 
protected when operating under homeostatic 
conditions.  When the stress to a tissue exceeds its 
internal tolerance, or ability to withstand a load, it 
enters a zone during which temporary or structural 
micro-failure or permanent injury may occur. 
Conversely, reducing the magnitude or frequency of 
load to the tissue can result in under-loading of the tissue, which, in the case of tendon, has been 
shown to result in a loss of mechanical strength and even structure if unloading continues for a 
prolonged period of time.117 
Overuse injuries occur when loading exceeds a tissue’s homeostatic boundary. Similarly, 
a tissue may be under-loaded, such as in the case of lower extremity muscle atrophy due weight-
Figure 2.4: The Envelope of Function64  
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bearing restrictions. Individuals who develop symptomatic knee injuries may have exceeded the 
load tolerance across the joint, leading to tissue breakdown. The knee, which can be described as 
the transitory joint between the femur and tibia, is highly responsible for dissipating lower 
extremity loads; therefore, in the presence of aberrant biomechanics, the knee may be highly 
vulnerable to injury. Furthermore, following knee injury, it may be critical to reestablish tissue 
homeostasis in order to correct biomechanical faults and prevent progression of pathologic 
processes. 
Tendon health is intimately related to mechanical homeostasis; therefore, Dye’s envelope 
of function model is readily applicable to the development of tendinopathy. Tendon adaptation 
occurs through mechanotransduction, the physiological process by which the body translates 
mechanical load into a cellular response that leads to structural change.12 Mechanotransduction is 
characterized by three key components12: 
1. Mechanocoupling: the literal perturbation of a cell when a load is applied. This 
perturbation stimulates the release of calcium and other cytokines into the gap junctions 
to initiate the cascade of events across cell membranes. 
2. Cell-to-cell communication: the cellular communication between cells. A message from 
the cell receiving the direct stimulation (location 1) travels via gap junctions and ion 
channels to the next cell (location 2), which is rapidly repeated. These mechanisms are 
responsible for how the “load message” is relayed from one area of the tendon to another. 
3. Effector response: the response of cellular tissue receiving the message to create either an 
anabolic or catabolic response 
Mechanotransduction is the underlying mechanism for how mechanical load influences a 
tissue’s cellular response. Mechanotherapy is, therefore, a term used to describe how load can be 
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manipulated to influence the mechano-transductive events within a tissue. In his review of 
Mechanotherapy application in rehabilitation, Khan suggests that understanding the cellular 
response to loading should be at the foundation of how clinicians prescribe both rest and tendon-
specific loading.12 
Historical Perspective: Eccentric Exercise for the Treatment of Tendinopathies 
 
Combining knowledge of the continuum of tendon pathology with an understanding of 
the cellular response of tendon to loading provides the rationale for exercise prescription for 
individuals with tendinopathy. Eccentric-based strength-training protocols have traditionally 
been utilized in the treatment of chronic tendinopathies,13–15 particularly following the landmark 
study by Alfredson in the late 1990s, from which developed the “Alfredson eccentric exercise” 
programs used commonly in clinical practice and research investigations.66 
However, recent research suggests that loading interventions, including type and dosage 
of exercise, should be prescribed based on where a tendon falls on the continuum of pathology. 
Cook et al. (2016) suggests that ‘phenotyping’ patients based on the presence of pain, structural 
abnormalities, and dysfunction may help clinicians direct patient-centered treatments and 
improve short- and long-term patient outcomes (Figure 2.1).10 
For example, the prime instigator of a reactive tendinopathy is a rapid increase in loading 
without adequate recovery time, such that there is an acute inflammation in the paratendon 
(synovial sheath) and initial disruption of the tendon matrix.9 Here, eccentric exercise, which 
involves large stresses and resulting strain to tendon tissue, is typically not tolerated and may 
perpetuate symptoms. Instead, a period of initial rest is appropriate in order to reduce or remove 
the offending load and allow adjacent inflammation to subside, followed by the gradual re-
introduction of controlled loading. 
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Conversely, in the degenerative stage of chronic tendinopathy, eccentric exercise has 
been shown to be effective at reducing pain,13–15,186 increase force, stiffness, and Young’s elastic 
modulus,187 decreasing tendon thickness,79 and improved self-reported function.79 It is thought 
that the high tensile stress placed on the tendon during eccentric loading helps to stimulate the 
tendon extracellular matrix (which has reparative capability) and maximize the performance of 
residual healthy tissue. Studies tracking tendon structural response to cumulative load 
demonstrate the capacity for aligned fibrillar structure to compensate for areas of disorganization 
and degeneration by increasing cross-sectional area to maintain sufficient volume of load-
responsive tissue.10,80  From a treatment perspective, it is thus recommended that load-based 
interventions for tendons in this stage should target building load-capacity in the aligned portion 
of the matrix, or “treating the doughnut, not the hole”.10,80 By selecting the appropriate type of 
load-based intervention for individuals with patellar tendinopathy, it is possible to reduce pain 
and/or improve tendon load capacity, which may aid in improving the effectiveness of other 
traditional interventions, such as neuromuscular re-education.82,188,189 
Therefore, it is evident that load-based exercise interventions should be selected based on 
patient characteristics such that implementation is successful. In a youth athlete population, this 
is particularly important, as achieving compliance with rehabilitation interventions can often be 
difficult. In the context of the current study, it is essential to select an intervention that will be 
tolerated by individuals with tendon pain and / or structural abnormalities. 
Treating Symptomatic Patellar Tendinopathy: Evidence for Isometric Loading Exercise 
 
Emerging evidence supports the use of isometric loading exercise for individuals with 
symptomatic patellar tendinopathy. The impetus to explore isometrics as a treatment option 
stemmed from the fact that eccentric loading protocols are often painful to complete and 
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therefore met with poor compliance when implemented in-season for individuals with patellar 
tendinopathy.14,90 Since the onset of symptomatic tendinopathy in athletes is not necessarily a 
season-ending injury, the goal of treatment is to minimize pain in order to facilitate continued 
sport participation. 
The rationale behind using isometric exercise can be summarized in two categories: 
mechanics and neuromuscular characteristics. During isometric exercise, particularly when 
contractions occur over a prolonged time-period, time under tension is maximized, leading to 
greater tendon strain. As a viscoelastic tissue, longer duration and heavier, isometric contractions 
generate larger strain in the tendon tissue, which is thought to be the stimulus for tendon 
adaptation.190–192 Additionally, in mid-ranges of knee joint flexion motion, the length-tension 
relationship of the quadriceps is maximized, such that optimal muscle force can be generated. 
The percentage of motor unit activation has been shown to be greater during isometric versus 
concentric and eccentric contractions.193 Furthermore, compressive stresses on the patellar 
tendon are less at mid-ranges of knee flexion compared to the extremes of knee joint 
flexion.144,145 Therefore, mechanically, loading the tendon isometrically in a mid-range of knee 
flexion has mechanical advantages. In a population of young individuals, who may have a 
greater potential for tendon adaptation, the ability to respond positively to an isometric loading 
protocol may be even more likely.194 
Secondly, isometric exercise is thought to be effective due to its ability to improve 
neuromuscular function via modulation of central-mediated inhibition. Previous studies in 
healthy participants have demonstrated that isometric muscle contractions reduce pain pressure 
thresholds.195,196 In the context of patellar tendon pain, it is theorized that the presence of pain, 
both at rest and during / following exercise, may alter cortical representation, which may alter 
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motor output via changes in the excitatory and inhibitory neural pathways.17 While it is well-
accepted that exercise can change voluntary activation in various,197–201 this is a relative new area 
of investigation in tendinopathy. However, pivotal work by Rio and colleagues over the last five 
years has provided support for the effectiveness of isometric exercise in patellar tendinopathy 
patients. In a within-respondents, single-blinded randomized cross-over trial studying male 
volleyball athletes with symptomatic patellar tendinopathy, Rio et al (2015) investigated both the 
effectiveness of and mechanisms of cortical motor function following both isometric and isotonic 
loading exercise protocols.17 While both protocols were well-tolerated, a one-time acute bout of 
isometric loading exercise demonstrated superior outcomes compared to isotonic exercise in 
improved pain relief, improved self-reported function, increased quadriceps strength, and 
decrease in cortical inhibition.17 Furthermore, pain reduction and quadriceps strength gains were 
sustained 45 minutes following the isometric protocol but not the isotonic protocol. The same 
isometric loading protocol has also demonstrated positive outcomes in pain reduction and 
excellent patient compliance and tolerance when implemented in-season with athletes with 
symptomatic patellar tendinopathy.16  
Application to Isometric Loading Intervention 
In summary, recent evidence demonstrates the effectiveness of isometric loading to 
improve quadriceps strength and decrease pain in individuals with symptomatic patellar 
tendinopathy. Additionally, this isometric loading protocol is tolerated by patients with 
symptoms who are still participating in sport when implemented in-season. However, the effects 
of this targeted tissue-specific loading protocol on lower extremity biomechanics has not yet 
been investigated. Athletes with symptomatic patellar tendinopathy demonstrate load avoidance 
movement strategies during sport-specific tasks, including reductions in sagittal plane knee 
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displacement and mechanical energy absorption, lesser vertical ground reaction force, and lesser 
internal knee extension moment.19,21,22 This study will be the first to test the acute effects of an 
isometric patellar tendon loading exercise protocol17 on landing biomechanics in individuals 
across the tendon pathology continuum (both asymptomatic and symptomatic individuals with 
structural abnormalities). Using isometric loading interventions to acutely change movement 
biomechanics may provide an important next step in rehabilitation paradigms for tendinopathy as 
a method to promote improve load-tolerance, and stimulate positive mechano-transductive 
responses in individuals with tendon pathology.
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CHAPTER 3: EXPERIMENTAL DESIGN & METHODS 
SUBJECTS 
 A total of 45 male participants from the high school, club, and collegiate sport population 
in the Raleigh-Durham-Chapel Hill area and the University of North Carolina at Chapel Hill 
were recruited for this study. Male athletes participating in sports involving large volumes of 
jumping and landing maneuvers were eligible for participation, as this cohort has been identified 
to develop patellar tendinopathy most readily.5,67 Specifically, eligible participants wer of a post-
pubertal age through 28 years of age. Post pubertal age was defined based on the Pubertal 
Development Scale (PDS), a valid and reliable questionnaire-based, non-invasive assessment 
utilized in previous literature to assess pubertal status.105,106,202 (Appendix 1) Furthermore, 
participants were actively participating within an organized sport setting (high school, collegiate, 
club, competitive intramurals) in their respective team’s weekly training and competitions, 
quantified by a Tegner Activity Level Scale of ³ 5 (Appendix 2). Additionally, eligible 
participants demonstrated either the presence or absence of patellar tendon symptoms (SYM vs. 
ASYM) and patellar tendon structural abnormality (PTA) for group assignment (described in 
Session 1: Screening Session to follow). 
The following exclusion criteria were applied to all participants: 
1. Any anterior knee pain with no patellar tendon abnormality on ultrasound assessment. 
2. History of any knee joint surgery ever. 
3. History of other (non-knee) lower extremity surgery in the last 1 yea
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4. History of lower extremity injury in last 6 months (other than patellar tendinopathy). 
5. An injection (corticosteroids, plasma-rich-protein, etc.) to the patellar tendon in the last 3 
months. 
6. Known history of osteoarthritis or current symptoms related to osteoarthritis (i.e. 
stiffness, swelling). 
7. Participation in formal rehabilitation for patellar tendinopathy in prior 3 months. 
8. Known neurological disorders, including: stroke, multiple sclerosis, ALS, diabetic 
neuropathy, epilepsy, traumatic brain injury resulting in loss of consciousness, 
concussion within the last 6 months, cranial neural surgery, balance disorders. 
9. Use of pacemaker or another implantable electronic device. 
10. History of cardiac arrhythmia or any cardiac condition. 
11. History of psychiatric disorder. 
12. History of cancer in the brain or thigh musculature. 
13. Pubertal Development Score <12 (Stages 1-4). 
Participants were recruited via email correspondence and informational packet/flyer 
distribution to local high school, club, collegiate, and competitive intramural teams by the 
principal investigator (PI) (L.S.P.). The PI also made in-person recruitment announcements with 
teams during team meetings and training sessions or following competitions. During recruitment 
and initial screening (in-person, over phone, email), the PI ensured that participants were in-
season prior to being invited to the laboratory for Session 1. 
 
 
 69 
DATA COLLECTION 
Procedures 
 
 The study procedures involved three visits to the Sports Medicine Research Laboratory 
(SMRL) for testing (Sessions 1-3). Session 1 was termed the Screening Session, while Sessions 
2-3 were termed the Intervention Sessions. Each session was separated by 7-10 days.  
 
Overall Study Design 
 
We utilized a cross-sectional design to assess baseline movement profiles (Aim 1) and 
one-week cumulative physical activity load volume using wearable technology (Aim 2), and a 
randomized cross-over study design to assess acute intervention effects on lower extremity 
kinetic and kinematic biomechanical variables during landing (Aim 3), A diagram outlining the 
overall study design is provided in Figure 3.1. A detailed explanation of each session is 
described in the next portion of this chapter. 
Figure 3.1. Overall study design diagram. 
 
Session 1: Screening Session 
 The following procedures outline the screening session. This session took approximately 
30-45 minutes to complete. 
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Participant Demographics, Inclusion / Exclusion Criteria Screening 
Upon the interested study candidate’s arrival to the Sports Medicine Research 
Laboratory, the PI verbally confirmed that the candidate met the appropriate demographic 
inclusion / exclusion criteria. Included in this screening material was the Pubertal Development 
Scale (Appendix 1) to ensure that both age and pubertal status were quantified prior to study 
enrollment. Any candidates who scored at a Stage 1-4 (PDS score <12) were considered to be 
pre-pubertal or pubertal and were excluded from the study. Any candidates who scored at a Stage 
5 (PDS score >12) were considered to be post-pubertal and therefore met the maturity level 
criteria for the study.  If a candidate met all of the aforementioned study inclusion / exclusion 
criteria, he was invited to participate in the study and completed Institutional Review Board 
documentation, physical activity questionnaire (Appendix 3), injury history form (Appendix 4), 
percentage of predicted mature height104 (Appendix 5) and the Victorian Institute of Sport 
Assessment-Patellar Tendon (VISA-P) questionnaires (Appendix 6).203,204 Additionally, 
participant height and weight was obtained with shoes removed, and information regarding leg 
dominance (the self-reported limb the participant would choose to kick a ball for distance) was 
recorded. 
Ultrasound Imaging Screening 
 A LOGIQe US system (General Electric Co., Fairfield, CT) with a high-resolution 12 
MHz linear probe was utilized to image the patellar tendon. A single investigator (L.S.P.) 
performed the examination to image right and left patellar tendons of each participant. The 
participant was positioned on the treatment table in supine with the knee flexed to 90° in order to 
place enough passive tension on the extensor mechanism and avoid possible anisotropy of the 
patellar tendon when concave in full knee extension.205 The location of the inferior patellar pole 
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was marked manually with a pen based on palpation and confirmed during scanning. Ultrasound 
gel was applied to the participant’s anterior knee to improve contact between the probe and skin. 
The US scanning parameters were set to: frequency=12MHz, depth=3cm, gain=50.  
First, the US probe was placed longitudinally in line with the mid-portion of the proximal 
patellar tendon just inferior to the inferior pole of the patella. The probe was tilted medially / 
laterally such that it was perpendicular to the long axis of the patellar tendon to maximize image 
quality. Once the appropriate angulation / tilt of the probe was achieved, the image was frozen 
and saved for analysis. While the probe was in this longitudinal position, the inferior patellar 
pole and a standard distance of 1 centimeter distal to inferior patellar pole were marked on the 
skin, respectively. This location was utilized to acquire transverse ultrasound images. Next, the 
US probe was centered transversely at the inferior patellar pole and tilted superiorly / inferiorly 
such that it was parallel to the short axis of the patellar tendon, and once appropriately 
positioned, the image was frozen and saved for analysis. The same procedure was followed at a 
standard distance of 1 centimeter distal to the inferior patellar pole, respectively. Three 
longitudinal and three transverse images of the patellar tendon were acquired. These procedures 
were repeated for the contralateral limb, such that bilateral patellar tendon US images were 
collected. 
 Maximum length, width, and height (cm) of hypoechoic regions were measured in both 
the sagittal (longitudinal) and axial (transverse) planes using ImageJ software (National Institutes 
of Health, Bethesda, MD). All US images were taken by the principal investigator (L.S.P.), who 
is trained in ultrasonographic assessment of tendon. An expert co-investigator (D.B.) was 
consulted for any questionable images to confirm the presence or absence of PTA based on the 
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aforementioned criteria. These procedures have been reported in previously published 
literature.80,85,205 
Symptom Assessment 
 Following the US assessment, participants were assessed for the presence or absence of 
patellar tendon pain bilaterally through two methods: 
1. The participant was asked if he have any knee pain. If he answer “yes”, the principal 
asked the participant to point to the location of the pain and the location will be 
recorded by the principal investigator on a knee image on the data collection sheet. If 
he answer “no”, this answer was recorded. 
2. The participant was asked to complete a single-limb decline squat (SLDS)110 on a 25° 
degree decline board (Figure 2.2) to approximately 60° of knee flexion. The 
participant was first asked to rate any pain present on a standard numeric rating scale 
(NRS: 0-10), where 0 = no pain, and 10 = worst possible pain.17,206 The participant 
was presented with a pain-map diagram immediately following the conclusion of the 
SLDS (Appendix 6).110 On this diagram, the participant was asked to identify the 
location of pain during the SLDS. The participant chose from a series of pictures that 
were presented simultaneously in a grid-formation; the participant was able to view 
all pictures simultaneously in order to avoid any bias from the order in which the 
pictures were presented to the participant. The participant performed the SLDS 
bilaterally, and completed the same assessments for each limb. If the participant 
reported bilateral pain during the SLDS, the following operational definitions were 
utilized to determine the “involved limb” for the purposes of the study to ensure that 
the individual has a unilateral tendinopathy 
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a. The “worse” limb must be ³ 5/10 on VAS Scale (0-10) 
b. The contralateral limb must be £ 2/10 on VAS Scale (0-10) 
Quadriceps Maximum Voluntary Isometric Contraction Assessment 
Quadriceps strength was assessed by measuring the individual’s maximum voluntary 
isometric contraction (MVIC). We proposed to collect the baseline MVIC during Session 1 
instead of Session 2 in order to avoid any confounding effect of performing the baseline MVIC 
just prior to the intervention period, as it may influence the interpretation of the isolated effect of 
the isometric intervention protocol on the primary biomechanical outcome measures.  
MVIC was assessed on the HUMAC Norm Dynamometer (CSmi, Stoughton, MA). This 
test was performed on the involved limb of participants with SYM-PTA and ASYM-PTA. All 
participants were positioned on the dynamometer with the test limb flexed to 60°. The knee 
flexion position was chosen in order to be consistent with previous studies investigating the 
effects of isometric loading in a patellar tendinopathy cohort,17,18 and to minimize added 
compressive forces across the anterior knee at greater knee flexion angles (i.e. 90°) that may 
instigate pain during contraction.141,145 The thighs, hips and torso were firmly stabilized with 
straps, and the arms will be folded across the torso to isolate the contribution of the quadriceps 
muscle without extremity movement (Figure 3.2). The lever arm was adjusted so that the ankle 
strap was placed 2 finger widths (~3 centimeters) proximal to the lateral malleolus.  The knee 
was positioned so that the lateral femoral epicondyle was aligned with the rotational axis of the 
dynamometer. Measurements of chair position (distance of seat-back position, ankle strap 
position on lever arm) were recorded to ensure consistency between all subsequent assessments 
using the HUMAC system. 
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Figure 3.2. HUMAC Norm Dynamometer participant set-up for intervention 
 
A series of graded submaximal warm-up isometric contractions were performed at 25%, 
50%, and 75%, respectively, of the participant’s perceived maximal effort but not recorded. The 
goal of this procedure was for muscle warm-up and participant familiarization with the task. For 
the MVIC testing, participants were instructed to “kick as hard and as fast as they can” into the 
dynamometer and to maintain maximal effort for approximately two seconds. The PI provided 
standardized verbal encouragement for each trial, and the participant received real-time visual 
feedback of their torque production on a computer monitor display directly in front of the 
dynamometer. Participants performed practice MVIC trials until the torque measurement fails to 
increase more than 10% from the previous trial. At this time, three maximum effort testing trials 
were collected. Each trial lasted approximately two seconds, and participants had sixty-seconds 
rest between each trial. If for a given trial, the participant was able to produce torque greater than 
10% of the previous trial, this trial was repeated. The peak torque (N*m) of the MVIC from the 
three trials was recorded and averaged for analysis. Peak torque was expressed relative to body 
mass (N*m*kg-1).  
Post-Screening Session: Group Assignment 
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Following the conclusion of the screening session, participants were assigned to a group 
(SYM-PTA, ASYM-PTA, or CON). Participants that had symptoms and a patellar tendon 
abnormality were included in the symptomatic group (SYM-PTA). Participants that did not have 
symptoms but had a patellar tendon abnormality were included in the asymptomatic group 
(ASYM-PTA). Participants with no symptoms and no patellar tendon abnormality were included 
in the healthy control group (CON). 
Group assignments were based on the following specific inclusion criteria: 
Inclusion Criteria for Symptomatic Group with Patellar Tendon Abnormality PTA (SYM-PTA) 
The following criteria must be met for symptoms (SYM): 
1. Localized pain: Self-reported pain-location (single-finger pointing) at inferior pole patella 
or along the patellar tendon from inferior pole to tibial tuberosity 
2. Single-limb decline squat (SLDS) pain that stays localized to inferior pole (“G” on pain 
map) or along the patellar tendon from inferior pole to tibial tuberosity (“E” on pain 
map). If the SLDS was positive for pain unilaterally, the painful limb was considered the 
“involved” limb and the non-painful limb was considered the “uninvolved” limb for the 
duration of the study. If the SLDS was positive for pain bilaterally, the following criteria 
was used to determine the “involved” and “uninvolved” limbs for the purpose of this 
study: 
1. The “worse” limb must be ³ 5/10 on VAS Scale (0-10) 
2. The contralateral limb must be £ 2/10 on VAS Scale (0-10) 
The following criteria must be met for patellar tendon abnormality (PTA): 
A patellar tendon abnormality (PTA) was determined from the ultrasound images. A PTA 
will be defined as: 1) presence of a hypoechoic region ≥ 2mm, evident in both the longitudinal 
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and transverse scans, and/or 2) presence of focal thickening/fusiform swelling with or without 
hypoechoic areas, and/or 3) maximum thickness > 7mm. An algorithm for this criteria-based 
decision-making to characterize PTA is reported in previous literature by members of the current 
study team (Cook et al., 2013; Docking & Cook, 2015).80,85 This algorithm for classification of 
patellar tendon abnormality is also supported by additional published studies.43,75,207 The patellar 
tendon was classified as normal if all of these features are absent, and abnormal if a single or 
multiple feature(s) are present (Appendix 8). 
Inclusion Criteria for the Asymptomatic Group with Patellar Tendon Abnormality (ASYM-PTA) 
The inclusion criteria for the ASYM-PTA group are: 
1. Absence of both localized self-reported pain and single-leg decline squat pain (as 
described above). 
2. A unilateral patellar tendon abnormality (PTA) on US imaging, using the same 
criteria as described above. 
Inclusion Criteria for the Health Control Group (CON) 
The inclusion criteria for the CON group are: 
1. Absence of both localized self-reported pain and single-leg decline squat pain (as 
described above). 
2. Absence of a patellar tendon abnormality (PTA) on US imaging, using the same 
criteria as described above. 
Once a participant’s enrollment into the study was confirmed, the participant was 
assigned a study identification number which was used throughout the remainder of the study. 
Within each participant folder, there was a sealed opaque envelope with no external markings208 
and with a piece of paper enclosed with either ‘A’ or ‘B’ written on it, where A = isometric 
 77 
condition, and B = control condition. These letters correspond to the intervention protocol that 
was conducted at the Session 2. For example, if ‘A’ was in the participant’s envelope, the 
participant underwent the isometric condition at Session 2 and the control condition at Session 3. 
Physical Activity Monitoring Period 
 Cumulative external load volume variables were collected during a one-week physical 
activity monitoring period between Sessions 1 and 2. As described above, participants were 
queried during the screening session to ensure that the one-week monitoring period was 
representative of a normal week of physical activity / sports training and competition in order to 
avoid capturing uncharacteristic weeks of physical activity (i.e. family vacation, week off of 
training/competition, etc.). 
Following the conclusion of the screening session data collection (enrollment, ultrasound 
imaging, symptom assessment, quadriceps strength testing), participants were provided with an 
ActiGraph GT9X Link accelerometer (ActiGraph Corporation, Pensacola, FL). The GT9X is a 
solid-state tri-axial accelerometer, magnometer, and gyroscope with sampling frequency 
capability ranging from 30-100Hz with BluetoothÒ capabilities to capture, record, and store 
high-resolution human activity information.209 The ActiGraph GT9X Link accelerometer was 
selected for use in this study because it has been shown to be a valid and reliable accelerometer 
to capture objective data of steps-per-day and minutes of moderate-to-vigorous physical activity 
(MVPA) in young, active cohorts.38,210,211 In a recent study by Bell et al. (2017), the ActiGraph 
wGT3X-BT accelerometer (the older model in the GTX line) was utilized and detected lower 
steps-per-day and MVPA in individuals following anterior cruciate ligament reconstruction 
(ACLR) compared to healthy controls.38 In this study, step count was strongly associated with 
MVPA in both the ACLR group (r=0.914) and control group (r=0.877) (p < 0.05). Therefore, we 
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believed that the selection of this the ActiGraph accelerometer, which is the most commonly 
used validated accelerometer in physical activity research,212 for our young, physically active 
population with and without pathology was appropriate to achieve the aims of the current study. 
 During the one-week monitoring period, participants were asked to wear the 
accelerometer over the right anterior superior iliac spine, affixing it to their clothing using an 
ActiGraph belt-clip (Appendix 9), for a period of seven-days, starting with the day following the 
screening session. A seven-day monitoring period is an accepted duration commonly utilized in 
physical activity literature.38,39,211,213 A multiple-day assessment has been shown to improve 
reliability and decrease variability of objective physical activity data.214,215 For the purpose of 
this study, a valid monitoring period was considered as a minimum of four total days, including 
three weekdays and one weekend day, for at least 8 hours-per-day, which is consistent with 
previous studies.38,212,216 Participants were instructed that they could remove the accelerometer 
for bathing and sleeping, but that it should be worn at all other times throughout the day. 
Participants were provided with an individual docking station that could be connected via USB 
to a standard wall outlet for charging. Participants were asked to charge the accelerometer each 
night to ensure consistent battery life throughout daily wear periods. 
During this instructional session, a demonstration was provided by the PI so that the 
participant felt comfortable with donning / doffing and charging procedures. The GT9X Link 
accelerometer was placed in a standard LCD display mode, showing only date, time-of-day, and 
battery life. The choice to not display the rolling steps-per-day count was so that participants 
were not biased by their daily performance; feedback of daily performance may challenge 
participants to perform more physical activity than normal due to external motivation. 
Additionally, participants were asked to keep a daily physical activity log to record type of 
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activity, time of day, duration (minutes), perceived intensity (modified RPE: 0-10)217 and 
intensity category (light, moderate, or vigorous), and any relevant comments. This log was 
utilized to descriptively characterize physical activity features in conjunction with the primary 
dependent variable for this study, steps-per-day. The log also served as a quality-control check to 
ensure that participants were physically active at the minimum criteria within an organized sport 
setting (high school, collegiate, club, competitive intramurals) as outlined in study inclusion 
criteria. A recent study by Phibbs et al. (2017) demonstrated that a self-reported daily training 
log questionnaire, administered 24-hours after exercise, showed high levels of agreement with 
the criterion measure of session-rating-of-perceived-exertion (sRPE) administered within 30-
minutes after exercise in adolescent athletes.218 Therefore, the inclusion of a training log during 
the one-week load monitoring period was advantageous to capture self-reported activity data 
from participants. 
 To maximize the acquisition of quality data, participants were provided with an 
instructional and troubleshooting guide and the PI’s cellular phone number to utilize in the event 
of any problems that arose during the one-week monitoring period. The participant returned the 
accelerometer to the PI when he returned to the laboratory for Session 2. At this time, the data 
was evaluated for adherence to wear guidelines (days and hours-per-day). If wear guidelines 
were not met, the participant was asked to wear the accelerometer again for the one-week period 
between Sessions 2 and 3.  
Sessions 2 & 3: Intervention Sessions 
 For Sessions 2 & 3, testing procedures and data collection flow were identical with the 
exception of the intervention protocol (isometric or sham-control). Session 2 & 3 each took 
approximately 1-hour to complete. A flow chart outlining data collection procedures for Sessions 
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2 & 2 is provided in Figure 3.3. Prior to the participant’s arrival to the Sports Medicine Research 
Laboratory, a research assistant selected from a pre-filled envelope to determine the intervention 
condition assignment for Session 2 (see above). The principal investigator was blinded to this 
intervention order assignment. 
Figure 3.3. Testing procedures for Sessions 2 & 3. 
 
 
 
Upon arrival to the Sports Medicine Research Laboratory for Session 2, participants 
changed into black spandex shorts and tank-top. Participants wore personal athletic shoes during 
the entire testing protocol. After assuming the correct attire, participants completed a 5-minute 
warm-up on a cycle ergometer within the laboratory at a self-selected pace. 
Participant Arrival to Sports Medicine Research Laboratory
1. Participant returned ActiGraph GT9X device
2. Participant changed into testing clothing
3. Participant performed 5-minute cycle ergometer warm-up
4. 3-D motion capture markers placed on participant
5. Pre-biomechanics single-leg decline squat pain assessment
Pre-Intervention 3-D Biomechanics Assessment
1. Five double limb jump-landing trials
2. Five single limb jump-landing trials on each limb
Pre-Intervention Pain Assessment
1. Single-leg decline squat pain assessment
Intervention Protocol
1. Blind randomization of participant to isometric or sham-control condition 
(session 2); subsequent testing day (session 3) performed alternate condition
2. PI (L.S.P.) blinded to intervention
Post-Intervention Pain Assessment
1. Single-leg decline squat pain assessment
Post-Intervention 3-D Biomechanics Assessment
1. Five jump-landing trials
2. Five single limb jump-landing trials on each limb
3. Post-biomechanics single-leg decline squat pain assessment
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Three-Dimensional Biomechanical Assessment 
 
Following the warm-up period, the participants were escorted to the motion capture area 
for the biomechanical assessment. Participants were then outfitted with 20 retro-reflective 
markers bilaterally on the following bony landmarks: acromion process, anterior superior iliac 
spine (ASIS), greater trochanter, medial and lateral femoral condyles, medial and lateral 
malleoli, calcanei, and the first and fifth metatarsal heads.219 A single marker was placed on the 
manubrium of the sternum and at the L4-L5 vertebral space. Rigid clusters of three or four 
markers were placed at the sacrum and on the thigh, shank, and foot segments bilaterally. A 
static trial was captured with the participant standing with arms positioned at 90° of shoulder 
abduction to estimate the location of the landmarks needed to calculate joint centers.219 After the 
static trial, the single markers on the foot, malleoli, femoral condyles, and greater trochanters 
were removed. If at any time during data collection, a marker(s) were to fall off of the 
participant, the marker(s) were replaced, calibration markers repositioned, and another static 
calibration trial captured. Attention was made to ensure that static calibration trials and data 
collection trials matched by recording each in a data collection notebook during the data 
collection session. This method served as a “double check” against the software system’s output 
during data cleaning and processing. 
The jump-landing tasks (double leg and single leg jump-landings) for this study were 
chosen because they consist of both a horizontal and vertical landing phase. Previous work has 
compared biomechanics during both horizontal and vertical landing phases of jump-landing 
tasks. The majority of previously reported differences between individuals with a PTA and 
controls are during horizontal landing phases, in which individuals are moving forward. These 
differences are thought to be attributed to greater magnitudes of posteriorly directed ground 
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reaction forces during horizontal landings, requiring greater internal knee extension moment to 
decelerate the limb and prepare for subsequent vertical movement.23,26 Additionally, Edwards et 
al. (2012) demonstrated that peak patellar force is higher during the horizontal deceleration phase 
versus vertical phase of a landing task.158 Furthermore, Cruz et al (2013) found that a forward 
vertical jump-landing from a box elicited greater hip and knee flexion, external knee flexion and 
abduction moments, external hip adduction moment, and anterior tibial shear force than drop-
landing and drop vertical jump tasks.220 Additionally, the forward jump-landing task is validated 
for clinical assessments of landing biomechanics.221 Therefore, utilizing a forward jump-landing 
task, which incorporates a horizontal and vertical phase, placed the desired demands on the 
participant that are sought to evaluate differences between individuals at differing stages of 
tendon pathology.   
The participants were fully oriented to the jump-landing task procedures. For the double-
limb jump-landing task, participants performed five trials from a 30-centimeter box that was 
positioned 50% of the participant’s height from the front edge of the force plates.220,221 A total of 
five double-limb jump-landing trials were collected, and the middle three trials were averaged 
for data analysis. If one of the middle three trials was not successful, a subsequent trial was 
utilized for analysis. A successful double-limb jump-landing trial required the participant to 
leave the box with both feet at the same time, land on the force plates, and jump straight up in the 
air as high as possible (maximal vertical jump), and then land on two limbs back on the force 
plate. 
For the single-limb jump-landing task, participants performed three trials over a six-inch 
tall hurdle starting at a distance 50% of the participant’s height from the front edge of the force 
plates. A total of three single-limb jump-landing trials were collected on each limb, and all trials 
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were averaged for data analysis. The participant began each trial by standing on the limb being 
tested. A successful single-limb jump-landing trial requires that the participant clear the hurdle, 
land with the test limb on the force plate, jump straight up as high as possible (maximal vertical 
jump), and then land on two limbs back on the force plate.   
Pain Assessment 
 
Following the completion of the biomechanics assessment, the participant was escorted to 
the other side of the Sports Medicine Research Lab where the HUMAC Norm Dynamometer was 
located (~15 feet away). Retro-reflective markers on the shank, thigh, and hips were removed so 
as not to interfere with the intervention testing procedures. Next, participants performed the 
single-limb decline squat and were asked to report any pain that presented during this task on the 
NRS scale and pain map using the exact procedures described above during the screening 
session. The SLDS was performed on the involved limb only 
Intervention Protocol 
 
 For the intervention protocol, the participant was positioned in the HUMAC chair at the 
exact same chair and body position that was used and recorded during the screening session 
(described above). Once the participant was appropriately positioned, the PI stepped out of the 
laboratory to another location within Fetzer Hall where she was unable to hear or see any 
constructs related to intervention delivery so that she remained blinded to the intervention 
(isometric or sham-control) for each session. Blinding of the PI was chosen in order to remove 
any potential bias that the PI’s knowledge of the condition may have on processing and analysis 
of post-intervention pain and biomechanical assessments. A trained research assistant delivered 
the intervention. The intervention protocols were matched for time and rest. This involved timing 
the contraction (isometric condition) / sham TENS (sham-control condition) period (45 seconds) 
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and the rest period (2 minutes). The research assistant also ensured that the participant remained 
within +/- 5% of the target 70% MVIC throughout the 45-second isometric contraction by real-
time observation of the participant’s visual feedback (HUMAC Norm, CSmi, Stoughton, MA) 
screen during the contraction. The following details outline the procedures for the isometric and 
sham-control conditions. 
Isometric Condition 
The isometric condition protocol was selected based on the work by Rio et al. (2015), 
which demonstrated acute reductions in pain and improvements in quadriceps strength.17 The 
participant performed five sets of a 45-second isometric contraction at 70% of the maximum 
voluntary isometric contraction (MVIC) that was obtained and calculated during the screening 
session. All participants were provided with the same standard instructional script: “During this 
session, you will see a green line displayed on the screen, which represents the amount of force 
that you produce with your quadriceps contraction during the test. You will see two purple lines 
with a dark zone in between them, which are centered around 70% of the maximum value of the 
muscle contraction you were able produce during your first testing session. Your goal is to 
maintain your muscle contraction so that the green contraction line stays as close to the middle 
of the dark zone and does not go above or below the purple lines, for the entire duration of the 
repetition. If the green line goes above or below the purple lines, the clock will stop until the 
green line returns to the dark zone. Focus on using your quadriceps muscle contraction to 
smoothly control the green line. You will maintain this muscle contraction for 45-seconds, 
followed by 2 minutes of rest. We will repeat this same sequence 5 total times.”  
During the 45-second contraction, the participant was provided with visual biofeedback 
on a computer screen positioned directly in front of the chair. Visual biofeedback was provided 
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via an internal feature within the HUMAC Norm software, including a real-time display of the 
70% MVIC target line (green) and +/- 5% error lines (purple) around the 70% MVIC line. The 
display moved in real-time from left-to-right during the 45-second contraction so that there was 
no delay in what the participant is able to see. The participant was instructed to produce a level 
of isometric quadriceps contraction that maintained the isometric torque output line as close the 
target line as possible and always between the two error lines. Following each 45-second 
isometric contraction, the participant had 2-minutes of rest, during which his limb remained 
positioned at 60° knee flexion but no contraction performed. Following 5 consecutive sets, the 
participant completed the isometric intervention and was be un-strapped from the HUMAC 
chair. 
Sham-Control Condition 
 For the sham-control condition, participants were positioned in the identical position that 
used during the screening and isometric condition sessions. However, during this condition there 
was no voluntary quadriceps contraction; instead a sham transcutaneous electric nerve stimulator 
(TENS) unit (Empi SelectÔ TENS Device; Empi, Inc., St. Paul, MN, USA) was utilized as a 
sham intervention. The rationale behind utilizing this type of sham-control condition was to 
avoid any participant-bias that the intervention condition (isometric condition) was the 
experimental condition, as this perception could bias their performance on the post-intervention 
SLDS pain and biomechanics assessments.  
Two (2” x 2”) electrodes were placed on either side (medial and lateral) of the patellar 
tendon (not on the tendon) on the test limb and connected via two lead wire to the sham TENS 
unit that was held and controlled by the trained research assistant. Instructions were given to the 
participant prior to the beginning of the sham-control condition; the same instruction script was 
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used for each participant. The instructions specified that, “A surface electrode has been placed 
on either side of your patellar tendon. I will turn on the stimulation unit to emit a stimulus to 
your patellar tendon. This is a special sub-sensory stimulation treatment, so you will not feel 
anything during this period as the stimulus is set at a very low, non-detectable threshold. Please 
remain still during this 45-second period, letting your leg rest passively in the machine without 
contracting your leg muscles. After the 45-second period, the stimulation unit will be turned off 
and you will have a 2-minute rest period. We will repeat this same treatment/rest sequence 5 
total times.” 
The same intervention parameters were utilized for the sham-control condition (5 sets of 
a 45-second repetition with 2-minutes of rest between each repetition). 
Post-Intervention Protocol Reassessments 
 
 Immediately following the conclusion of the intervention protocol, participants repeated 
the same pre-intervention protocol assessments using identical methodology as described above 
in the following order: 
1. Pain assessment (SLDS board next to HUMAC Norm Dynamometer) 
2. 3-D Biomechanics Assessment (Motion capture area) 
Following the completion of Session 2, participants were reminded of their Session 3 
schedule, ensuring that a date and time has been scheduled appropriately. Sessions 2 & 3 were 
conducted 7-10 days apart (wash-out period) in order to ensure that there were no carry-over 
effects from the intervention condition performed during Session 2. Participants were asked to 
maintain their normal training and competition parameters during this period. Participants were 
reminded via phone and/or email 24 hours prior to the Session 3 date to enhance compliance and 
minimize risk of no-show. Approximately 7-10 days following Session 2, participants returned to 
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the Sports Medicine Research Laboratory for Session 3. Identical procedures were carried out, 
with the exception of the assignment for the intervention protocol. The participants performed 
the intervention condition that they did not perform during Session 2.  
Instrumentation 
 
Three-Dimensional Motion Capture Biomechanical Data Collection Instrumentation 
Three-dimensional marker coordinate data were collected using an optoelectric 
retroreflective ten-camera motion capture system (Bonita 10, Vicon Motion Systems, Centennial, 
CO), sampling at 120 Hz. The ten-camera system is oriented around a 2x2x2 meter capture area 
centered around two floor-embedded force plates (Type 4060-10, Bertec Corporation, Columbus, 
OH) which was utilized to capture ground reaction force data, sampling at 1200 Hz. 
Prior to data capture, the capture area was calibrated using a 5-marker wand to establish 
marker identification within the world, as well as to set the volume origin for the world axes. The 
laboratory’s global axis system is defined as follows: positive x-axis directed anteriorly (anterior-
posterior axis), positive y-axis directed left (medial-lateral axis) and positive z-axis directed 
superiorly (super-inferior axis) with respect to the participant in the capture area. Marker 
coordinate data was streamed to a computer (Dell Precision T5610, Round Rock, TX) and saved 
within Vicon Nexus v1.7.1 motion capture software via a Vicon Ultranet MX Controller (Vicon 
Systems, Centennial, CO). The embedded Bertec force plates were calibrated to the laboratory’s 
global coordinate system (see above) that is delineated during marker system camera calibration. 
Analog force plate data was sampled at 1200 Hz and transmitted through an A/D board which is 
interfaced and synchronized with the Vicon Nexus motion capture software. Marker coordinate 
data and ground reaction force data were then saved within Vicon Nexus to allow real-time 
marker identification. 
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Finally, all marker coordinate (kinematic) and ground reaction force (kinetic) data were 
transferred into The Motion Monitor software (Innovative Sports Training, Chicago, Illinois) to 
build three-dimensional link-segment models for biomechanical data analysis and reduction. 
Physical Activity Monitoring Data Collection Instrumentation 
 The primary outcome variable that will be collected during the one-week monitoring 
period was steps-per-day and MVPA minutes/day. The ActiGraph GT9X Link accelerometer 
(3.5 x 3.5 x 1cm; 14 grams) measures accelerations in the range of +/- 8g and at a sampling 
frequency of 30-100Hz. For this study, the accelerometer was set in raw data capture mode to 
sample raw acceleration data at 30 Hz during daily wear periods.  
DATA PROCESSING & REDUCTION 
Laboratory Biomechanics: Three-Dimensional Motion Capture Data 
 
Marker Identification & Processing 
 Following marker identification and labelling, both marker data and ground reaction 
force data (synchronized) were saved as a .c3d file and exported. Next, the .c3d file was 
imported into The Motion Monitor Software for construction of a link-segment model for each 
trial of each participant. Lower extremity segments were modeled as rigid bodies using three 
non-collinear individual markers for each segment, as follows: 
• Left foot: rigid cluster of four markers 
• Right foot: rigid cluster of three markers 
• Left shank: rigid cluster of four markers 
• Right shank: rigid cluster of three markers 
• Left thigh: rigid cluster of four markers 
• Right thigh: rigid cluster of three markers 
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• Sacrum/pelvis: left ASIS, right ASAI, L5-S1 marker 
Joint Center Calculations 
Within The Motion Monitor software, ankle, knee, and hip joint center coordinates were 
defined based on the adjacent segments, described above, around each respective joint 
bilaterally, taken during the static trial. The ankle joint center was defined as the centroid 
between the medial and lateral malleoli, representing the end-points of the shank segment. The 
knee joint center was defined as the centroid between the medial and lateral condyles, 
representing the end-points of the thigh segment. Hip joint center coordinates were estimated 
from the coordinates of the L5-S1, right ASIS, and left ASIS markers using the Bell method.222  
Kinematic Calculations 
Joint angles were defined based on the position of the distal segment relative to the 
proximal segment using a Cardan angle sequence in the following order of rotation: sagittal (y-
axis), frontal (x-axis’), and transverse (z-axis’). Kinematic variables of interest for this study 
included: bilateral hip flexion (-)/extension (+), hip adduction (+)/abduction (-), knee flexion (+), 
knee varus (+)/valgus (-), and ankle plantarflexion (+)/dorsiflexion (-). 
Kinetic Calculations 
Ground reaction force data and processed segment data were used to calculate net 
internal sagittal and frontal plane knee and hip joint moments using the inverse dynamics 
procedures described and well-accepted in the biomechanics literature.146 Net internal sagittal 
plane knee and hip moments characterize the forces acting about the knee and hip medial-lateral 
axes of rotation, respectively (y-axis). Net internal frontal plane knee and hip moments 
characterize the forces acting about the knee and hip anterior-posterior axes of rotation, 
respectively (x-axis). Vertical ground reaction force (vGRF) were calculated as the vertical 
 90 
component of the ground reaction force vector that aligns with the world z-axis.146 Patellar 
tendon force (FPT) was estimated using previously defined methodology of Nisell and Ekholm 
(1985),160 through with FPT is calculated by dividing the internal knee extension moment by the 
patellar tendon moment arm via the equation (Equation 1): 
!"# = 	 &'((	()*('+,-'	.-,'*	/-/('*01	/-/('*	23/  
(Equation 1) 
where the patellar tendon moment arm was calculated as a function of the knee joint angle as 
described by Herzog and Read (1993).144 
Data Reduction 
All segmental kinematic and kinetic data, as well as ground reaction force and patellar 
tendon force data were processed in The Motion Monitor software. Data was filtered using a 
fourth-order low-pass Butterworth filter with a 20Hz cutoff frequency. All kinematic data was 
interpolated and synchronized with the raw 1200 Hz ground reaction force data. Next, filtered 
segmental biomechanical data and ground reaction force and patellar tendon force data was 
exported from The Motion Monitor software into a custom MatLab software program (MatLab 
R2017b, The MathWorks, Inc., Natick, MA) for further data inspection and reduction. 
Phase Identification 
Biomechanical variables for each limb were evaluated across the entire stance phase. The 
stance phase was defined as the time from initial ground contact (IC), or the time point when the 
vertical ground reaction force (vGRF) exceeds 10N, until toe-off (vGRF <10 N).223  The stance 
phase was further divided into the loading phase (IC through peak knee flexion position) and the 
propulsive phase (peak knee flexion position to toe-off). Peak knee flexion position was defined 
as the time point when the knee reached its maximum flexion angle during the stance phase. 
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Dependent Variable Calculation 
Aim 1: Kinematic (Table 1.1, RQ 1.1) and kinetic (Table 1.1 RQ 1.2 – 1.4) variables for 
Aim 2 were analyzed as continuous normalized waveforms during the stance phase of the 
landing tasks (Kuenze et al. 2014).224 For each kinematic and kinetic dependent variable, the 
within-group mean values were interpolated and normalized over 202 data points (knots) over 
the stance phase of the middle three landing trials for each task using a cubic spline filter. These 
data points represent 0% - 100% of the stance phase of the task (initial ground contact through 
toe-off, respectively). Each knot was calculated as the mean value of the derived knots from each 
of the middle three trials (t1, t2, t3) of each respective task used for analysis (Equation 2): 
&'-*4…676 = 	&'-*489 +	&'-*486 + &'-*48;3  
(Equation 2) 
Limb symmetry indices (LSI) were calculated for all dependent biomechanical variables using 
the following equation (Equation 3):  
=>? = 	 @ ,'A-BA(C	B,/DE','A-BA(C	B,/DF 
(Equation 3) 
where values <1 represent lower magnitude variable on the involved / matched healthy control 
limb compared to the uninvolved / contralateral healthy control limb, and value > 1 represent 
greater magnitude variable on the involved / matched healthy control limb compared to the 
uninvolved / contralateral healthy control limb. The same continuous waveform analyses were 
utilized to compare LSI for dependent variables across the stance phase of each task. 
Aim 3: Kinematic variables (Table 1.3, RQ 3.1) were calculated at initial ground contact, 
peak, and displacement across the loading phase of the landing task for the involved PTA and 
matched healthy control limbs. Net internal joint moment variables (Table 1.3, RQ 3.2) were 
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calculated across the first 50% of the loading phase of the landing task for the involved PTA and 
matched healthy control limb. Finally, vGRF and FPT variables (Table 1.3, RQs 3.3 and 3.4) 
were assessed for their peak magnitude and impulse across the loading phase. 
Real-World Physical Activity: Cumulative External Load Monitoring 
 
Data Processing & Reduction 
 
Data was processed and analyzed using ActiLife v6.0.0 software (ActiGraph 
Corporation, Pensacola, FL), which is the actigraphy data analysis software platform of 
ActiGraph. The Sports Medicine Research Laboratory is equipped with one desktop and six 
laptop licensure keys for ActiLife processing. 
Wear time validation was performed based on the Choi et al. (2011) algorithms,225 
whereby the following parameters were selected within ActiLife software: 
a) Minimum wear time per day: 480 minutes 
b) Minimum days of valid wear time: 4 days 
c) Minimum weekdays of valid wear time: 3 days 
d) Minimum weekend days of valid wear time: 1 day. 
The following processing settings were selected within ActiLife software: 
a) Energy expenditure: Freedson VM3 Combination (2011) 
b) METs: Freedson Adult (1998) 
c) Cut Points and MVPA: Freedson Adult VM3 (2011) 
d) Bouts: checked 
e) Sedentary Analysis: checked 
f) Exclude Non-Wear Time: checked 
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 The number of steps-per-day is calculated within ActiLife software based on the vertical 
acceleration data measured with the GT9X Link monitor. GT9X Link files were uploaded to 
ActiLife software platform and converted into 60-second epoch ‘.agd’ files for analysis of count 
data. Data is cleaned and scored within the ActiLife software. Data files were exported as .csv 
files with the following data: header definitions, desktop summary (summary data for each 
participant), and wear time validation (wear periods for each participant). 
Dependent Variable Calculation 
Aim 2: The dependent variable ‘average steps-per-day’ and ‘average MPVA/day’ (Table 
1.2, RQ 2.1) were extracted from ActiLife software for the one-week monitoring period, and 
normalized to the number of wear days for each participant. The dependent variable ‘cumulative 
patellar tendon load’ (cFPT) (Table 1.2, RQ 2.2) was calculated based on the methodology of 
Maly et al. (2013) that estimated cumulative knee adductor load per day based on laboratory 
biomechanical assessments and steps-per-dayMVPA.39 The number of steps-per-dayMVPA was 
divided by two, since the accelerometer captures steps for both limbs. The following equation 
(equation 4) was utilized: 
cFPT load estimation: ∫ !"#(*) ∗ C*	 × 	(L8MNLOPQRSTU 	V-3	*(+*	B,/D)WT  
(Equation 4) 
where cFPT is the cumulative patellar tendon force per day estimation; FPT(t) is the mean patellar 
tendon force (FPT) across the five jump-landing trials at time (t) from a) initial ground contact, to 
b) toe-off. 
STATISTICAL ANALYSIS 
Means, standard deviations, medians, interquartile ranges, and 95% confidence intervals 
were calculated for all demographic and questionnaire data where appropriate. Alpha was set a 
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priori at a < 0.05 for all statistical analyses. Normality was assessed for all dependent variables 
using the Shapiro-Wilk test and normal Q-Q plot inspection. All statistical analyses were 
completed in SPSS v22 (IBM Inc., Armonk, New York, USA). 
Aim 1:  To ascertain the impact of symptomatic PTA and asymptomatic PTA on lower 
extremity landing kinematics and kinetics. 
To evaluate baseline biomechanical characteristic between the three study groups, 95% 
confidence interval waveforms across the stance phase for each movement task were plotted.224 
Each variable curve was evaluated for areas where the group curve did not overlap in order to 
determine if there was an interaction between the three study groups (SYM-PTA, ASYM-PTA, 
CON) and each kinematic and kinetic dependent variable (Table 1.2). Average Cohen’s d effect 
sizes and mean differences with standard deviations were calculated for all areas of non-overlap 
by taking the average of all data points included in a given area of non-overlap. 
Aim 2: To ascertain the impact of symptomatic PTA and asymptomatic PTA on 
cumulative load volume during a one-week monitoring period. 
Descriptive statistics were calculated for all variables of interest, including means, 
standard deviations, and 95% confidence intervals. A one-way analysis of variance (ANOVA) 
was conducted to determine if there were differences in cumulative load volume variables 
between the three study groups (SYM-PTA, ASYM-PTA, CON). Post-hoc testing using 
Bonferroni post-hoc adjusted t-tests for pairwise comparisons of means for each dependent 
variable were performed for significant findings from each ANOVA model. 
Aim 3:  To investigate whether an acute isometric patellar tendon loading exercise 
protocol changes lower extremity landing kinematics and kinetics in individuals with 
symptomatic and asymptomatic PTA. 
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Descriptive statistics were calculated for all variables of interest, including means, 
standard deviations, and 95% confidence intervals. We established four a priori comparisons to 
investigate both within-group and between-group effects of each intervention condition 
(isometric and sham-TENS). A 2x2 mixed-model repeated measures analysis of variance 
(ANOVA) (group: 2 levels (SYM-PTA, ASYM-PTA); Treatment: 2 levels (isometric and sham-
control) on change scores for each biomechanical dependent variable for the involved limb from 
pre- to post-intervention was utilized to evaluate the effects of each condition on dependent 
variables for the two groups (SYM-PTA, ASYM-PTA). Change scores (D) were calculated for 
each biomechanical dependent variable using the following equation (Equation 5): Xℎ2'Z(	+[-3(	(D) = 	/(2'N\L8 − /(2'N^M 
(Equation 5) 
Cohen’s d effect sizes for each treatment condition were calculated using the following equation, 
when appropriate (Equation 6): X-ℎ('_+	C8` = 	 /(2'8`N\L8 − /(2'8`N^Ma--B(C	+*2'C23C	C(A,2*,-'8` 
(Equation 6) 
where *4is the treatment condition (either isometric or sham-control). 
Post-hoc testing using Bonferroni post-hoc adjusted t-tests for pairwise comparisons of 
means for each dependent variable will be performed for significant findings from each ANOVA 
model. 
POWER ANALYSIS 
An a priori power analysis was completed using G*Power (Version 3.1.9.2; Kiel 
University) to determine the sample size needed to detect significant differences between 
symptomatic and asymptomatic individuals, as well as between individuals with and without 
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patellar tendon structural abnormality, based on previous literature evaluating these populations. 
The power analysis was run for key biomechanical and cumulative external load variables of 
interest and for exercise-response variables. This a priori sample power calculation was 
completed with atwo-tailed = 0.05, 1-b = 0.80 and 1-b = 0.90, and effect sizes as listed below. 
Cohen’s d effect sizes are classified as weak (<0.2), small (0.21-0.50), medium (0.51-0.8), and 
large (>0.80).226 
To-date, no studies have been conducted to examine the effect of knee extension-based 
exercise on biomechanical outcome measures in individuals with patellar tendinopathy 
(symptoms or structural pathology). Edwards et al. (2010) compared biomechanical variable 
between independent groups (PTA versus no-PTA) cross-sectionally and demonstrated 
moderate-to-large differences between groups in peak vGRF, peak knee and hip flexion angle, 
and knee and hip flexion displacement.23 Additionally, previous studies using differing 
intervention paradigms (visual and verbal biofeedback) have shown moderate (d=0.78) to large 
(d=1.85) effects on biomechanical variables (peak vGRF and knee flexion angle, 
respectively).227–229 Rio et al. (2015) found a large effect (d=2.75) pre- to post-isometric loading 
protocol on SLDS pain.17 
We chose to power this study off of our key biomechanical variable of interest. Based on 
this power analysis, a sample size of 15 participants in each group will allow the principal 
investigator to detect, at minimum, a 20% difference in biomechanical profiles between 
participants, with a power of at least 80% and atwo-tailed = 0.05. A study sample with 15 
participants in each of the three groups (SYM-PTA, ASYM-PTA, and CON) was determined to 
provide enough power to detect clinically meaningful differences in biomechanics. 
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CHAPTER 4: RESULTS 
Specific Aim 1 
 
To ascertain the impact of symptomatic PTA and asymptomatic PTA on lower extremity landing 
kinematics and kinetics. 
Results 
No significant differences in height and mass were observed between groups (p > 0.05), 
but the ASYM group was slightly older than the CON group (p=0.045). The VISA-P score was 
significantly lower in the SYM group compared to both the ASYM and CON groups (p<0.001), 
and the mean differences exceeded the MCID (13 points) for this subjective outcome measure.204 
There were no differences in VISA-P score between the ASYM and CON groups (p>0.05). 
 
Double Limb Landing 
Kinematics 
Participants in the SYM group demonstrated lesser magnitude knee flexion angle than the 
CON group throughout the majority of the stance phase (8-76%, d: 1.14±0.12, MD: 
15.83±2.71°). Participants in the ASYM group demonstrated lesser magnitude knee flexion angle 
than the CON group during the early (8-13%, d: 0.99 ± 0.04, MD: 7.99±0.39°; 21-24%, d: 
1.01±0.01, MD: 11.11±0.32°) and late (74-94%, d: 0.96 ± 0.07, MD: 9.55 ± 1.13°) portions of 
the stance phase. There were no differences between the SYM and ASYM groups in sagittal 
plane knee angle.
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Kinetics 
Participants in the SYM group demonstrated lesser internal knee extension moment than 
the CON group during early stance (6.5-9%, d: 1.21± 0.08, MD: 0.04 ± 0.004 N*m[kg*m]-1), as 
well as the ASYM group during mid-stance (38-56%, d: 1.17 ± 0.06, MD: 0.03 ± 0.001 
N*m[kg*m]-1). There were no differences between the ASYM and CON groups in internal 
sagittal plane knee moment.  
There were no differences in vGRF between groups. However, the SYM group 
demonstrated less patellar tendon force during early stance (6-9%, d: 1.15 ± 0.15, MD: 0.85 ± 
0.15 (BW)) than the CON group and during mid-stance (36-60%, d: 1.22 ± 0.08, MD: 0.66 ± 
0.05 (BW)) than ASYM group. There were no differences between the ASYM and CON groups 
in patellar tendon force. Finally, participants in the SYM group had less knee power during early 
stance (6-9%, d: 1.24 ± 0.17, MD: 0.48 ± 0.16 J/s; 18.5-23%, d: 1.34 ± 0.13, MD: 0.17 ± 0.01 
J/s) than the CON group and during early stance (20.5-25%, d: 1.14 ± 0.08, MD: 0.20 ± 0.01 J/s) 
than the ASYM group (Figure 6). There were no differences in knee power between the ASYM 
and CON groups. 
 
Limb Symmetry Index 
 There were no differences in limb symmetry indices for VGRF, FPT, or KP between any 
of the groups across the entire stance phase. Additionally, within each group, there were no areas 
during which the 95% CI did not overlap with 100, suggesting that there was no inter-limb 
asymmetry within each group. 
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Single Limb Landing 
Kinematics 
There were no differences in any sagittal or frontal plane kinematic variable at the hip or 
knee between any of the groups. 
Kinetics 
There were no differences in sagittal or frontal plane knee moments or sagittal plane hip 
moments between any of the groups. Participants in the SYM group demonstrated greater 
internal frontal plane hip abduction moment than the CON group for the majority of the stance 
phase (23-79%, d: 1.10± 0.07, MD: 0.04 ± 0.003 N*m[kg*m]-1). Participants in the ASYM 
group demonstrated greater internal frontal plane hip abduction moment than the CON group 
during the late stance phase (84-91%, d: 1.12± 0.085 MD: 0.02 ± 0.001 N*m[kg*m]-1). 
 There were no differences in VGRF or knee power between any of the groups. 
Participants in the SYM group demonstrated lesser patellar tendon force than the CON group 
during early stance (16-19%, d: 1.08 ± 0.03, MD: 0.90 ± 0.05 (BW)). 
Summary 
 In summary, the overall landing profile of the SYM group during the double-limb landing 
task was consistent with our hypotheses that these individuals would demonstrate patterns of 
under-loading of the involved limb due to symptoms. On average, this group demonstrated 
decreased sagittal plane motion compared to both CON and ASYM groups for the majority of 
the stance phase, and also demonstrated lesser knee loading (internal knee extension moment, 
patellar tendon force, and knee power) than the CON group during the early loading response 
phase of the landing task. Interestingly, the landing profile of the ASYM group was in contrast to 
our hypothesis of an over-loading profile, as noted in previous literature.23 While the ASYM 
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group did demonstrate reduced sagittal plane motion at early- and late- phases of stance 
compared to the CON group, there were no other significant differences in their profiles 
compared to the CON group, and no signs of over-loading for any kinematic, kinetic, or 
energetic variable. Finally, there were minimal differences between groups during the single-leg 
landing task. 
 The results of this aim support the hypothesis that athletes with symptomatic patellar 
tendinopathy tend to unload their involved limb during critical periods of a landing task where 
tissue loads are greatest. However, there was no evidence of over-loading in asymptomatic 
individuals. Despite lacking pain, these individuals may be demonstrating early signs of under-
loading that need to be targeting through controlled loading programs to maximize tissue 
capacity. The results of this study provide further evidence to support an individualized approach 
to movement assessment and retraining in individuals at different stages of the continuum of 
tendinopathy 
.
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Figures 
The following outline all of the waveforms for the double-limb landing task. 
 
Figure 4.1: Mean and 95% confidence interval waveforms for involved limb knee kinematic variables during the double-limb 
jump landing task 
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Figure 4.2: Mean and 95% confidence interval waveforms for involved limb hip kinematic variables during the double-limb 
jump landing task 
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Figure 4.3: Mean and 95% confidence interval waveforms for involved limb knee moment variables during the double-limb 
jump landing 
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Figure 4.4: Mean and 95% confidence interval waveforms for involved limb hip moment variables during the double-limb 
jump landing 
 
 
 
 
 
H
ip
 M
om
en
t V
ar
ia
bl
es
SYM vs. CON ASYM vs. CON ASYM vs. SYM
-0.25
-0.2
-0.15
-0.1
-0.05
0
0.05
0.1
0.15
0.2
0.25
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 10
0
M
om
en
t	(
Nm
/(N
bw
*m
ht
)
%	of	stance	phase
Involved	Limb	Internal	Sagittal	Plane	Hip	Moment
Double	Limb	Landing
SYM	vs.	CON
d =	1.16	±0.06
MD:	0.03	±0.001
-0.25
-0.2
-0.15
-0.1
-0.05
0
0.05
0.1
0.15
0.2
0.25
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 10
0
M
om
en
t	(
Nm
/(N
bw
*m
ht
)
%	of	stance	phase
Involved	Limb	Internal	Sagittal	Plane	Hip	Moment
Double	Limb	Landing
ASYM	vs.	CON
-0.25
-0.2
-0.15
-0.1
-0.05
0
0.05
0.1
0.15
0.2
0.25
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 10
0
M
om
en
t	(
Nm
/(N
bw
*m
ht
)
%	of	stance	phase
Involved	Limb	Internal	Sagittal	Plane	Hip	Moment
Double	Limb	Landing
ASYM	vs.	SYM
-0.08
-0.06
-0.04
-0.02
0
0.02
0.04
0.06
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 10
0
M
om
en
t	(
Nm
/(N
bw
*m
ht
)
%	of	stance	phase
Involved	Limb	Internal	Frontal	Plane	Hip	Moment
Double	Limb	Landing
SYM	vs.	CON
-0.08
-0.06
-0.04
-0.02
0
0.02
0.04
0.06
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 10
0
M
om
en
t	(
Nm
/(N
bw
*m
ht
)
%	of	stance	phase
Involved	Limb	Internal	Frontal	Plane	Hip	Moment
Double	Limb	Landing
ASYM	vs.	CON
-0.08
-0.06
-0.04
-0.02
0
0.02
0.04
0.06
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 10
0
M
om
en
t	(
Nm
/(N
bw
*m
ht
)
%	of	stance	phase
Involved	Limb	Internal	Frontal	Plane	Hip	Moment
Double	Limb	Landing
ASYM	vs.	SYM
105 
  105 
 
Figure 4.5: Mean and 95% confidence interval waveforms for involved limb vertical ground reaction force (VGRF) and 
patellar tendon force (PTF) variables during the double-limb jump landing 
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Figure 4.6: Mean and 95% confidence interval waveforms for involved limb knee power during the double-limb jump landing 
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Figure 4.7: Mean and 95% confidence interval waveforms for vertical ground reaction force (vGRF) limb symmetry indices 
during the double-limb jump landing. 
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Figure 4.8: Mean and 95% confidence interval waveforms for internal knee extension moment limb symmetry indices during 
the double-limb jump landing. 
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Figure 4.9: Mean and 95% confidence interval waveforms for patellar tendon force limb symmetry indices during the double-
limb jump landing. 
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The following outline all of the waveforms for the single-limb landing task. 
 
Figure 4.10: Mean and 95% confidence interval waveforms for involved limb knee kinematic variables during the single-limb 
jump landing task 
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Figure 4.11: Mean and 95% confidence interval waveforms for involved limb hip kinematic variables during the single-limb 
jump landing task 
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Figure 4.12: Mean and 95% confidence interval waveforms for involved limb knee moment variables during the single-limb 
jump landing task 
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Figure 4.13: Mean and 95% confidence interval waveforms for involved limb hip moment variables during the single-limb 
jump landing task 
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Figure 4.14: Mean and 95% confidence interval waveforms for involved limb vertical ground reaction force (VGRF) and 
patellar tendon force (PTF) variables during the single-limb jump landing task 
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Figure 4.15: Mean and 95% confidence interval waveforms for involved limb knee power variables during the single-limb 
jump landing task 
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Specific Aim 2 
 
To ascertain the impact of symptomatic PTA and asymptomatic PTA on cumulative external load 
during a one-week monitoring period. 
Results 
No significant differences in height, mass, or age were observed between groups (p > 
0.05). The VISA-P score was significantly lower in the SYM-PTA group compared to both the 
ASYM-PTA and CON groups (p<0.001), and the mean difference exceeded the MCID (13 
points) for this subjective outcome measure.204 
There were no significant differences between the three groups for the load frequency 
(steps/day, stepsMVPA/day) or duration (MVPA/day) metrics (p>0.05). However, there was a non-
significant trend of fewer steps/day, stepsMVPA/day, and MVPA/day in the SYM-PTA group 
compared to both the CON and ASYM-PTA groups. Total wear time was not significantly 
different between groups (p=0.205). All group comparisons were conducted with and without 
controlling for total wear time, and neither model demonstrated statistical significance (p>0.05). 
Double-Limb Landing 
Participants with SYM-PTA demonstrated load volume than CON for all variables (cFPT, 
cFPTI, cKEMI, cKP, cKW) (p<0.05). There were no significant differences between load volume 
in the SYM-PTA and ASYM-PTA groups or the ASYM-PTA and CON groups (p>0.05). Mean 
differences and Cohen’s d effect sizes are presented in Table 4. The magnitude of the effect for 
SYM-PTA compared to CON was considered to be strong and significant for cFPT (d =0.98), 
FPTI (d = 1.09), KEMI (d = 1.09), cKP (d = 10.4), and KW (d = 1.14). 
The SYM-PTA group demonstrated significantly less load magnitude than the CON 
(p<0.01) and ASYM-PTA (p>0.05) groups for all variables (FPTI, KEMI, KW). There were no 
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statistically significant differences in these baseline biomechanical load magnitude variables 
between the CON and ASYM-PTA groups (p>0.05). The magnitude of the effect for SYM-PTA 
compared to CON was considered to be strong and significant for FPTI (d = 1.40), KEMI (d = 
1.42), and KW (d = 1.53). 
 
 
Single Limb Landing 
The SYM-PTA group demonstrated significantly less load magnitude than the CON 
(p<0.01) group for all variables (FPTI, KEMI, KW). There were no statistically significant 
differences in these baseline biomechanical load magnitude variables between the CON and 
ASYM-PTA groups (p>0.05). Mean differences and Cohen’s d effect sizes are presented in 
Table 6. The magnitude of the effect for SYM-PTA compared to CON was considered to be 
strong and significant for FPTI (d = 1.17), KEMI (d = 1.18), and KW (d = 1.42). 
 
Summary 
 In summary, male athletes with and without patellar tendinopathy did not demonstrate 
difference in loading frequency and duration (steps/day and MVPA/day) during a one-week 
load-monitoring period. However, due to lesser involved limb biomechanical load magnitude 
during laboratory-based assessment of landing, the SYM group demonstrated significant less 
cumulative loading volume than the CON and ASYM groups. There were no signs of over-
loading in the ASYM group compared to CON group for any load metrics (magnitude, 
frequency, duration, volume). 
 The clinical relevance of these findings is that they demonstrate that reductions in load 
magnitude during an isolated task (i.e. landing) are magnified when extrapolated over longer 
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periods of time and real-world activity. These findings highlight the importance of a 
comprehensive approach to load monitoring in individuals with patellar tendinopathy, including 
biomechanical movement profiles, loading volume, and patient-reported outcomes. 
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Tables 
Table 4.1: Descriptive characteristics of the study population (mean ± sd) 
 
*: statistically significant difference than CON group (p<0.001, MD: -21.49 (-29.97, -13.01)) 
^: statistically significant difference than ASYM group (p<0.001, MD: -17.91 (-26.40, -9.44)) 
 
Table 4.2: Descriptive characteristics for study population for load frequency and duration metrics (mean ± sd, 95% CI) 
 Healthy Control 
(n=14) 
Asymptomatic Tendinopathy 
(n=14) 
Symptomatic Tendinopathy 
(n=13) 
 Mean ± SD 95% CI Mean ± SD 95% CI Mean ± SD 95% CI 
Total steps/day 11,195 ± 1,803 10,154, 12,237 10,143 ± 2,646 8,615, 11,671 10,250 ± 2942 8,472, 12,028 
Steps in MVPA/day 7,028 ± 3,329 5,106, 8,951 5,977 ± 2,723 4,405, 7,549 5,487 ± 1716 4,450, 6,524 
Time in MVPA/day (min) 102.42 ± 20.73 90.45, 114.40 97.60 ± 37.67 75.85, 119.36 94.54 ± 29.10 76.96, 112.13 
Time in MVPA/day (%) 13.27 ± 3.41 11.30, 15.24 11.80 ± 5.57 8.58, 15.02 12.76 ± 4.43 10.08, 15.44 
Total wear time (min) 5,298 ± 968 4,739, 5,859 5,217 ± 881 47,08, 5,725 4,598 ± 1,375 4,700, 5,397 
Valid wear days 6.58 ± 0.51 6.28, 6.87 6.43 ± 0.85 5.94, 6.92 5.92 ± 0.31 5.25, 6.60 
 
*Note: the values reported are unadjusted for total wear time. No statistical difference between groups for total wear time 
(p=0.205)  
	
 Healthy 
Control 
(n=14) 
Asymptomatic 
Tendinopathy 
(n=14) 
Symptomatic 
Tendinopathy 
(n=13) 
Age (yrs) 19.64 ± 1.60 21.00 ± 1.96 19.62 ± 1.61 
Height (m) 1.84 ± 0.09 1.84 ± 0.07 1.82 ± 0.05 
Mass (kg) 79.91 ± 12.95 81.63 ± 13.03 83.46 ± 5.12 
Tegner Activity Scale (0-10) 8.00 ± 0.88 8.00 ± 1.04 8.00 ± 1.00 
Pubertal Development Scale (0-12) 11.57 ± 0.65 11.86 ± 0.53 11.39 ±0.87 
VISA-P (0-100) 97.64 ± 3.41 94.07 ± 7.85 76.15 ± 13.37*^ 
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*No statistically significant differences between groups, both with and without controlling for total wear time (minutes) 
(p>0.05). 
 
Table 4.3: Descriptive characteristics (mean ± sd, 95% CI) for load volume variables (based on # of stepsMVPA and involved 
limb biomechanics during the double-limb landing task). 
 
Table 4.3a: 
 Cumulative PTF 
(BW) 
Cumulative PTF Impulse 
(BW*ms) 
Cumulative KEM Impulse 
(Nm*ms) 
Group Mean ± SD 95% CI Mean ± SD 95% CI Mean ± SD 95% CI 
Healthy Control (n=14) -12.3e3 ± 6.17e3 -15.9e3, -
8.74e3 
-2.27e6 ± 1.24 e6 -2.99e6, -1.56 
e6 
-10.7e4 ± 5.96e4 -14.1e4, -7.24e4 
Asymptomatic Tendinopathy 
(n=14) 
-9.97e3 ± 4.63e3 -12.5e3, -
7.45e3 
-1.76e6 ± 0.880e6 -2.26e6, -1.25e6 -8.15e4± 4.04e4 -104.9e4, -5.82e4 
Symptomatic Tendinopathy 
(n=13) 
-7.81e3 ± 
1.94e3* 
-8.98e3, -
6.64e3 
-1.22e6 ± 
0.566e6* 
-1.56e6, -8.75e5 -5.70e4 ± 2.56e4* -7.25e4, -4.15e4 
 
Table 4.3b: 
 Cumulative Knee Power (J*ms) Cumulative Knee Work (J) 
Group Mean ± SD 95% CI Mean ± SD 95% CI 
Healthy Control (n=14) -6.71e3 ± 3.46e3 -8.71e3, -4.72e3 -5.56e5 ± 3.38e5 -7.51e5, -3.60e5 
Asymptomatic Tendinopathy (n=14) -5.31e3 ± 2.59e3 -6.80e3, -3.81e3 -3.70e5 ± 1.72e5 -4.70e5, -2.71e5 
Symptomatic Tendinopathy (n=13) -4.03e3± 1.18e3* -4.74e3, -3.32e3 -2.64e5 ± 1.25e5^ -3.39e5, -1.88e5 
 
*statistically significant difference than the healthy control group (p<0.05) 
^ statistically significant difference than the healthy control group (p<0.01) 
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Table 4.4: Group comparisons for load volume variables (based on # of stepsMVPA and involved limb biomechanics during the 
double-limb landing task). 
 
Table 4.4a: 
 Cumulative Patellar Tendon Force 
(BW) 
Cumulative Patellar Tendon Force Impulse 
(BW*ms) 
Cumulative Knee Extension Moment 
Impulse (Nm*ms) 
 
Group 
Comparisons 
Mean 
Difference 
95% CI Cohen’s d Mean 
Difference 
95% CI Cohen’s d Mean 
Difference 
95% CI Cohen’s 
d 
CON vs. SYM -4.49e
3 -8.76e3, -
.21e3 
0.98 -10.57e5 -19.44e5, -
1.69e5 
1.09 -4.99e4 -9.17e4, -.80e4 1.09 
CON vs. ASYM -2.33e
3 -6.52e3, 
1.87e3 
0.44 -5.17e5 -13.88e5, 3.54e5 0.48 -2.54e4 -6.64e4, 
1.57e4 
0.50 
ASYM vs. SYM -2.16e
3 -6.43e3, 
2.11e3 
0.64 -5.40e5 -14.27e5, 3.48e5 0.73 -2.45e4 -6.63e4, 
1.73e4 
0.72 
 
Table 4.4b: 
 Cumulative Knee Power MVPA (J*ms) Cumulative Knee Work MVPA (J) 
Group Comparisons Mean Difference 95% CI Cohen’s d Mean Difference 95% CI Cohen’s d 
CON vs. SYM -2.68e3 -5.13e3, -.23e3 1.04 -2.92e5 -5.11e5. -.74e5 1.14 
CON vs. ASYM -1.41e3 -3.81e3, 1.00e3 0.46 -1.86e5 -4.00e5, .29e5 0.69 
ASYM vs. SYM -1.27e3 -3.73e3, 1.18e3 0.63 -1.07e5 -3.26e5, 1.12e5 0.64 
Group Legend: CON=healthy control, ASYM=asymptomatic tendinopathy, SYM=symptomatic tendinopathy 
Note: The group listed first is the referent group for each mean comparison. 
 
Table 4.5: Group comparisons for load magnitude variables for the involved (SYM & ASYM) and dominant (CON) limbs 
during the double limb landing task. 
 
Internal Knee Extension Moment 
Impulse (Nm*ms) 
Patellar Tendon Force Impulse 
(BW*ms) 
Negative Knee Work 
(J/kg) 
Mean 95% CI Mean 95% CI Mean 95% CI 
Healthy Control 
(n=15) -29.98 ± 4.91 -32.70, -27.25 -639.20 ± 102.82 -696.14, -582.26 -156.37 ± 34.45 -175.45, -137.29 
Asymptomatic 
Tendinopathy (n=15) -27.13 ± 5.91 -30.41, -23.85 -583.34 ± 129.80 -655.22, -511.46 -126.58 ± 26.81 -141.43, -111.74 
Symptomatic 
Tendinopathy (n=13) -21.19 ± 7.28
*# -16.79, -25.59 -450.81 ± 160.57*# -547.84, -353.78 -98.72 ± 40.67
*# -123.30, -74.15 
 
*statistically significant difference compared to CON group (p<0.01) 
#statistically significant difference compared to ASYM group (p<0.05) 
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Table 4.6: Effect size calculations for group comparisons for load magnitude variables for the involved (SYM & ASYM) and 
dominant (CON) limbs during the double limb landing task. 
 
 Internal Knee Extension Moment 
Impulse 
(Nm*ms) 
Patellar Tendon Force Impulse 
(BW*ms) 
Negative Knee Work 
(J/kg) 
Group 
Comparisons 
Mean 
Difference 
95% CI Cohen’s d Mean 
Difference 
95% CI Cohen’s d Mean 
Difference 
95% CI Cohen’s d 
CON vs. SYM -8.79 -14.37, -3.31 1.42 -188.39 -309.80, -66.97 
1.40 -57.65 -89.10, -
26.19 
1.53 
CON vs. 
ASYM 
-2.85 -8.22, 2.53 0.52 -55.86 -172.86, 61.14 0.48 -29.79 -8.22, 2.53 0.97 
ASYM vs. 
SYM 
-5.94 -11.52, -0.36 0.90 -132.53 -253.94, -
11.12 
0.91 -27.86 -11.52, -0.36 0.81 
 
Legend: SYM: symptomatic tendinopathy, ASYM: asymptomatic tendinopathy, CON: healthy control 
Note: The group listed first is the referent group for each mean comparison. 
 
The following data outline the findings for load magnitude and load volume variables during the single-limb landing task. 
 
Table 4.7: Comparison of groups for biomechanical energetic variables for involved limb during the single-limb landing task. 
 
 
Internal Knee Extension 
Moment Impulse (Nm*ms) 
Patellar Tendon Force 
Impulse 
(BW*ms) 
Negative Knee Work 
(J/kg) 
Mean 95% CI Mean 95% CI Mean 95% CI 
Healthy 
Control (n=14) -40.11 ± 8.89 -45.03, -35.19 -809.80 ± 199.04 
-920.03, -
699.58 
-191,687.81 ± 
41,333.18 
-214,577.36, -
168,798.25 
Asymptomatic 
Tendinopathy (n=14) -33.94 ± 8.36 -38.57, -29.31 -673.06 ± 170.27 
-767.35, -
578.77 
-155,937.52 ± 
50359.60 
-183,825.74, -
128,049.30 
Symptomatic 
Tendinopathy (n=13) 
-28.72 ± 
10.43* -35.02, -22.41 
-569.97 ± 
210.86* 
-697.39, -
442.56 
-122,342.77 ± 
55151.88* 
-155,670.71, -
890,14.82 
 
*statistically significant difference compared to CON group (p<0.01)  
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Table 4.8: Effect size calculations for group comparisons for the involved (SYM & ASYM) and dominant (CON) limbs during the single-
limb landing task. 
 
 Internal Knee Extension Moment 
Impulse (Nm*ms) 
Patellar Tendon Force Impulse 
(BW*ms) 
Negative Knee Work 
(J/kg) 
Group 
Comparisons 
Mean 
Difference 
95% CI Cohen’s 
d 
Mean 
Difference 
95% CI Cohen’s 
d 
Mean 
Difference 
95% CI Cohen’s 
d 
CON vs. SYM -11.39 -19.89, -2.90 
1.18 -239.83 -418.07, -
61.59 
1.17 -69,345.04 114510.00, -
24180.08 
1.42 
CON vs. ASYM -6.17 -14.36, 2.01 0.72 -136.74 -308.50, 35.12 0.74 -35750.29 -79272.33, 7771.76 0.78 
ASYM vs. SYM -5.22 -13.72, 3.27 0.55 -103.09 -281.33, 75.16 0.54 -33594.75 -78759.72, 11570.21 0.64 
 
Legend: SYM: symptomatic tendinopathy, ASYM: asymptomatic tendinopathy, CON: healthy control 
Note: The group listed first is the referent group for each mean comparison. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
124 
  124 
 
 
The following data outline the baseline limb symmetry indices for each of the landing tasks. 
 
Table 4.9: Single-limb landing task limb symmetry indices (means ± sd and 95% confidence intervals) for the involved (SYM & ASYM) 
and dominant (CON) limbs  
 
 Internal Knee Extension 
Moment Impulse (Nm*ms) 
Patellar Tendon Force 
Impulse (BW*ms) 
Negative Knee Work 
(J/kg) 
Group Mean ± sd LSI 95% CI Mean LSI 95% CI Mean LSI 95% CI 
Healthy Control 113.07 ± 
29.97 
96.48, 129.67 114.39 ± 
31.44 
96.98, 131.80 115.69 ± 
31.35 
98.33, 133.05 
Asymptomatic Tendinopathy (n 89.60 ± 19.29 78.92, 100.29 89.35 ± 20.28 78.12, 100.58 94.62 ± 32.30 76.73, 112.51 
Symptomatic Tendinopathy  107.61 ± 
59.56 
71.62, 143.60 108.22 ± 
62.19 
70.63, 145.80 103.28 ± 
72.58 
59.43, 147.14 
 
 
Table 4.10: Double-limb landing task limb symmetry indices (means ± sd and 95% confidence intervals) for the involved (SYM & 
ASYM) and dominant (CON) limbs  
 
 Internal Knee Extension 
Moment Impulse (Nm*ms) 
Patellar Tendon Force 
Impulse (BW*ms) 
Negative Knee Work 
(J/kg) 
Group Mean ± sd 
LSI 
95% CI Mean LSI 95% CI Mean LSI 95% CI 
Healthy Control 101.00 
±15.42 
92.46, 109.54 101.38 ± 
15.41 
92.85, 109.92 103.37 ± 
24.84 
89.62, 117.13 
Asymptomatic Tendinopathy  97.74 ± 21.45 85.86, 109.62 98.20 ± 22.25 85.88, 110.52 96.45 ± 23.57 83.40, 109.51 
Symptomatic Tendinopathy 89.39 ± 31.76 70.20, 108.59 89.21 ± 32.31 69.69, 108.74 92.43 ± 39.99 68.25, 116.60 
 
Legend: SYM: symptomatic tendinopathy, ASYM: asymptomatic tendinopathy, CON: healthy control 
Note: Limb Symmetry Indices (LSI) calculated as: (involved limb/uninvolved limb) * 100, such that values >100 indicate more loading on 
the involved/dominant limb and values <100 indicate less loading on the involved/dominant limb compared to the referent 
uninvolved/non-dominant limb, respectively. 
*no significant differences between groups for LSI variables for either landing task (p>0.05) 
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Specific Aim 3 
 
To investigate whether an acute isometric patellar tendon loading exercise protocol changes 
lower extremity landing kinematics and kinetics in individuals with symptomatic and 
asymptomatic PTA. 
Results 
No significant differences in height, mass, or age were observed between groups (p > 
0.05). The VISA-P score was significantly lower in the SYM group than the ASYM group 
(p<0.001), and the mean difference exceeded the MCID (13 points) for this subjective outcome 
measure (Table 1).204 There were no group x intervention interactions for change in SLDS NRS 
pain (F(1, 26) = 0.555, p=0.463). 
Descriptive characteristics for group and intervention condition are detailed in Table 3. 
For our within-group comparisons, there was one significant group x intervention interaction for 
VGRF (F(1, 26) = 5.33, p = 0.029). However, post-hoc testing with Bonferroni correction (a = 
0.05/4 = 0.0125) demonstrated no statistical significance. Dependent-samples t-tests for each 
group demonstrated no statistical significance (ASYM: t = -1.7, p = 0.107; SYM: t = -1.679, p = 
0.119). Independent t-tests demonstrated no statistical significance significance (isometric: t = -
2.58, p = 0.016; sham-TENS: 0.72, p = 0.460). There were no further significant group x 
intervention interactions (p>0.05). Additionally, the ANCOVA analyses, including baseline 
biomechanical variables as co-variates, demonstrated the same outcome, as there were no 
significant group x intervention interactions observed (p>0.05). 
Summary 
We originally hypothesized that a single dose of an isometric loading intervention would 
result in reduced pain in the SYM group. As a result, we further hypothesized that the SYM 
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group would demonstrate increased loading on the involved limb during the landing task, 
including increased FPT impulse, KEM impulse, negative knee work, and knee power. We did 
not expect to observe any other changes between conditions for either intervention group. In 
agreement with our hypotheses, there were no changes in biomechanics following the sham-
TENS intervention in either group, and there was only one significant change in the ASYM 
group following the isometric intervention (reduced knee flexion angle at IC). Contrary to our 
hypothesis the SYM group did not demonstrate significant changes pain or in knee loading 
biomechanics following the isometric intervention.  
The results of this aim demonstrate that an isometric patellar tendon loading exercise 
protocol did not have acute effects on landing biomechanics in male athletes with symptomatic 
or asymptomatic tendinopathy. Though isometric tendon loading is a tolerable and analgesic 
treatment option for athletes with symptomatic patellar tendinopathy,16–18 our findings suggest 
that patient selection and duration of intervention implementation may be important factors if 
using isometric exercise to influence movement profiles. Future research should examine the 
effects of a longer-duration isometric exercise intervention program on athletes with higher 
tendon pain and associated disability. 
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Tables & Figures 
Table 4.11: Descriptive characteristics of the study population. 
 
 
*statistically significant difference than ASYM group (p<0.001, MD: -18.25 (-26.41, -10.08)) 
 
 
Table 4.12: Single leg decline squat (SLDS) pain scores (NRS: 0-10) during each testing 
session. 
 
 Asymptomatic 
Tendinopathy 
(ASYM) 
(n=15) 
Symptomatic 
Tendinopathy 
(SYM) 
(n=13) 
Age (yrs) 21.13 ± 1.88 19.62 ± 1.61 
Height (m) 1.84 ± 0.07 1.82 ± 0.05 
Mass (kg) 81.45 ± 13.26 83.46 ± 5.12 
Tegner Activity Scale (0-10) 7.93 ± 1.03 8.00 ± 1.00 
Pubertal Development Scale 
(0-12) 
11.87 ± 0.52 11.39 ±0.87 
VISA-P (0-100) 94.40 ± 7.72 76.15 ± 13.37* 
 
  Asymptomatic 
Tendinopathy 
(ASYM) 
(n=15) 
Symptomatic 
Tendinopathy 
(SYM) 
(n=13) 
 Screening Session 0 3.23±1.21 
Isometric 
Intervention 
Session 
Pre-Landing Protocol 0 2.54±1.76 
Pre-Isometric Intervention 0.40±1.55 2.34±2.10 
Post-Isometric Intervention 0.60±1.68 1.62±1.89 
Isometric Intervention Change Score 0.20±0.77 -0.73±0.72 
Sham-TENS 
Intervention 
Session 
Pre-Landing Protocol 0.33±1.29 3.07±1.85 
Pre-Sham TENS Intervention 0.33±1.29 3.03±1.98 
Post-Sham TENS Intervention 0.33±1.29 2.42±1.63 
Sham-TENS Intervention Change Score 0 -0.62±1.12 
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Table 4.13: Descriptive characteristics (mean difference, standard deviation, 95% CI) for each biomechanical variable change score 
for the symptomatic and asymptomatic groups for the isometric and sham-TENS intervention conditions. 
 
 
 
Legend: ∆: change; IC: initial contact; VGRF: vertical ground reaction force; KEM: knee extension moment; FPT: patellar tendon 
force 
*statistically significant at p <0.05. 
 
 
 Isometric Condition Sham-TENS Condition Group x Conditon 
Biomechanical Variable Group Mean ∆ SD 95% CI Mean ∆ SD 95% CI F  p-value 
Knee flexion angle @ IC (°) SYM -2.61 3.02 -4.44, -0.78 -1.67 3.15 -3.57, 0.24 1.56 0.223 ASYM -4.32 4.45 -6.78, -1.86 -1.57 4.14 -3.87, 0.72 
Peak knee flexion angle (°) SYM -3.58 4.91 -6.55, -0.61 -0.79 4.24 -3.35, 1.77 0 0.995 ASYM -4.36 7.45 -8.48, -0.23 -1.57 4.72 -4.19, 1.03 
Knee flexion displacement (°) SYM -0.97 5.99 -4.59, 2.64 0.88 3.97 -1.52, 3.27 0.44 0.511 ASYM -0.04 6.56 -3.67, 3.60 -0.01 4.82 -2.67, 2.65 
Peak VGRF (BW) SYM 0.46 0.47 0.18, 0.75 0.21 0.23 0.08, 0.35 5.33 0.029* ASYM -0.04 0.54 -0.34, 0.26 0.32 0.50 0.04, 0.60 
Peak Internal KEM (N*[kg*m]-1) SYM -0.007 0.26 -0.023, 0.009 0.007 0.03 -0.01, 0.02 2.41 0.132 ASYM 0.005 0.01 -0.003, 0.01 0.002 0.02 -0.01, 0.02 
Peak FPT (BW) SYM -0.14 0.43 -0.40, 0.12 0.20 0.46 -0.08, 0.47 4.06 0.054 ASYM 0.13 0.32 -0.05, 0.31 0.10 0.38 -0.12, 0.31 
Peak knee power (J/s) SYM -0.07 0.38 -0.30, 0.16 -0.03 0.44 -0.29, 0.24 0.21 0.651 ASYM 0.03 0.28 -0.13, 0.18 -0.02 0.38 -0.24, 0.19 
KEM impulse (Nm*ms) SYM -0.44 5.65 -3.85, 2.97 1.63 3.76 -0.64, 3.90 1.86 0.185 ASYM 2.22 4.56 -0.30, 4.75 1.47 3.93 -0.71, 3.65 
FPT impulse (BW*ms) SYM -6.84 123.19 -81.28, 67.60 35.29 80.96 -13.63, 84.21 1.70 0.204 ASYM 51.13 102.60 -5.68, 107.95 33.94 87.62 -14.58, 82.47 
Negative knee work (J/kg) SYM -2.75 26.54 -18.78, 13.29 8.69 25.02 -6.43, 23.81 2.89 0.101 ASYM 11.71 21.50 -0.20, 23.61 3.85 19.99 -7.22, 14.92 
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Table 4.14: Cohen’s d effect sizes for mean differences (pre-post) within each group for the isometric and sham-TENS intervention 
conditions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Isometric 
Condition 
Sham-TENS 
Condition 
Biomechanical Variable Group Cohen’s d Cohen’s d 
Knee flexion angle @ IC (°) SYM -0.37 -0.22 
ASYM -0.92 -0.39 
Peak knee flexion angle (°) SYM -0.30 -0.06 
ASYM -0.38 -0.10 
Knee flexion displacement (°) SYM -0.08 0.07 
ASYM 0.003 0.08 
Peak VGRF (BW) SYM 0.67 0.29 
ASYM -0.04 0.50 
Peak Internal KEM (N*[kg*m]-1) SYM -0.25 0.24 
ASYM 0.18 0.09 
Peak FPT (BW) SYM -0.27 0.33 
ASYM 0.27 0.21 
Peak knee power (J/s) SYM -0.14 -0.05 
ASYM 0.05 -0.03 
KEM impulse (Nm*ms) SYM -0.06 0.23 
ASYM 0.37 0.18 
FPT impulse (BW*ms) SYM -0.05 0.23 
ASYM 0.39 0.19 
Negative knee work (J/kg) SYM -0.07 0.22 
ASYM 0.40 0.09 
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Figure 4.16: Study CONSORT Diagram 
 
 
 
 
 
 
 
 
 
Screened for
Study Enrollment
(n=101)
Symptomatic
(n=39)
Asymptomatic
(n=62)
Symptomatic
with PTA
(n=18)
Asymptomatic
with PTA
(n=17)
Asymptomatic 
without PTA
(n=40)
ASYM-PTA 
Group
(n=15)
CON
Group
(n=15)
SYM-PTA
Group
(n=13)
Excluded
Non-tendinopathic pain (n=21)
Excluded
Activity level (Tegner <5) (n=3)
Hx lower extremity surgery (n=1)
Age > 28 years-old (n=1)
Excluded
Study Group Full (n=25)
Excluded
Bilateral tendinopathic pain (n=5)
Lost due to:
MCL Sprain (n=1)
Personal reasons (n=1)
131 
  131 
 
Figure 4.17: Individual participant SLDS pain (NRS: 0-10) change scores following the isometric (blue open circles) and sham-TENS 
(open red circles) interventions with median group change (black horizontal line). 
    
Figure 4.18: Mean and 95% confidence intervals for change scores for isometric and sham-TENS conditions for the SYM and ASYM 
groups. 
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Figure 4.19: Individual participant pre- and post-isometric intervention SLDS pain scores (NRS 0-10) with mean (dark blue line) and 
95% confidence bounds (shaded area) 
 
      
*Note: 2 participants reported pre- and post-NRS=0   *Note: 13 participants reported pre- and post-NRS=0 
2 participants reported pre- and post-NRS=1 
3 participants reported pre-NRS=1 and post-NRS=0 
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Figure 4.20: Individual participant pre- and post-sham-TENS intervention SLDS pain scores (VAS 0-10) with mean (dark red line) 
and 95% confidence bounds (shaded area) 
 
      
*Note: 2 participants reported pre-NRS=2 post-NRS=1  *Note: 14 participants reported pre- and post-NRS=0 
 1 participant reported pre- and post-NRS=3  
 1 participant reported pre- and post-NRS =2  
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CHAPTER 5: MANUSCRIPT 1 
Differences in Biomechanical Loading Magnitude During a Landing Task in Male Athletes 
with and without Patellar Tendinopathy 
 
INTRODUCTION 
Patellar tendinopathy (PT) is prevalent in individuals who are physically active, 
particularly athletes who participate in sports with repetitive jumping manueveurs.1–5,230 While 
some athletes are able to maintain sport participation, the long-term consequences of chronic 
tendinopathy include reduced physical activity and quality of life.6,7 Previous studies have 
demonstrated differences in lower extremity kinematics, kinetics, and energetics between 
individuals with and without patellar tendinopathy symptoms,19–22 as well as between 
asymptomatic individuals with and without patellar tendon structural abnormalities (PTA).23,24 
However, to-date, there are no biomechanical studies that have compared movement profile 
characteristics while controlling for both PTA symptoms and simultaneously including a healthy 
control group (no PTA or symptoms) using robust inclusion criteria. Determining if 
biomechanical profiles are different between individuals at differing stages along the continuum 
of tendon pathology9 may inform the development of enhanced impairment-based, 
individualized treatment programs.  
Individuals with symptomatic patellar tendinopathy tend to employ a tendon-load 
avoidance movement profile, described as reduced sagittal plane excursion, internal extension 
moment, and mechanical energy absorption at the knee.19–22 Rosen et al. (2015) found that 
symptomatic participants, compared to asymptomatic participants, landed with approximately 
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degrees lesser peak knee joint flexion and had lesser sagittal plane knee joint excursion during 
the stance phase of a double-limb jump-landing task.21 At increasing knee flexion angles, patellar 
tendon tissue strain increases,145 so reducing sagittal plane motion during landing supports the 
expected notion that individuals avoid loading painful tissues during high-energy movements. 
Furthermore, in a separate study, adult male volleyball athletes with symptomatic PT 
demonstrated a landing technique that avoids high patellar tendon loads on the involved limb 
with lesser internal knee extension moment and reduced knee flexion velocity, compared to both 
those with a previous (>5 months of testing) history of patellar tendinopathy and healthy control 
participants.22 Additionally, Sorenson et al. (2010) found that individuals with symptomatic PT 
had approximately a 30% reduction in net joint work and power and approximately 22% lower 
peak vGRF than healthy control participants, suggesting reduced mechanical energy absorption 
and force attenuation on the symptomatic limb.19 
Though the ideal clinical treatment pathways for asymptomatic individuals with PTA is 
yet unclear, the presence of a PTA in asymptomatic athletes has been demonstrated as a risk 
factor for symptom development.41,43,85,231 Several studies have evaluated biomechanics in 
asymptomatic individuals with PTA, suggesting a tendon overloading movement profile. In a 
recent systematic review, van de Worp et al. (2014) found that the greatest differences in 
kinematic and kinetic variables during landing tasks were present in studies that compared 
healthy controls to asymptomatic individuals with patellar tendon structural abnormality 
(PTA).93 In a comparative cohort of junior pre-elite male basketball athletes with and without 
PTA, several kinematic variables were found to be predictive of the presence of a PTA, 
including hip joint excursion and knee flexion angle at initial ground contact. Individuals with a 
PTA extended their hip joints when landing and had greater knee flexion angles at initial ground 
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contact.24 Combined with greater hip flexion angle at initial ground contact,23,24 this movement 
strategy is thought to increase the demand on the knee extensor mechanism to counteract the 
more posterior position of the body’s center of mass when transitioning from the loading to 
propulsive phases of a jump. Furthermore, Edwards et al. (2010) observed individuals with 
asymptomatic PTA land with more knee flexion at initial contact, go through lesser sagittal plane 
knee flexion excursion, and demonstrate aberrant hip-knee sequencing patterns, compared to 
healthy individuals with no symptoms or PTA.23 This stiff movement profile is thought to reduce 
inter-joint force distribution and increase combined tensile and compressive strain across the 
proximal patellar tendon, which has been described as a key mechanical factor leading to 
tendinopathy.141 
There are several unique features to the current study that seek to add to the current body 
of literature around biomechanics and patellar tendinopathy. While previous studies have 
provided important insights into movement profiles of individuals at various points along the 
continuum of tendinopathy, it appears that symptomatic and asymptomatic athletes with PTA 
perform landing tasks with two different movement profiles: under-loading and overloading, 
respectively. Therefore, studying the role of biomechanics in patellar tendinopathy warrants 
examination of both distinct groups compared to healthy individuals. Additionally, previous 
studies use a myriad of diagnostic criteria to define patellar tendinopathy, from self-reported 
questionnaires and reports of pain during sport,21,232,233 pain to palpation,67,136,234 and/or 
ultrasonographic evidence of structural abnormalities,2 which makes comparisons across groups 
and studies challenging. The current study uses an evidence-based battery of tests, including a 
provocative load-based test for symptoms110 and diagnostic imaging for PTA,43,80 to classify 
stages of PT. Finally, no studies to-date have evaluated movement profiles of individuals with 
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patellar tendinopathy across the entire stance phase of a landing task, but instead looking at 
discrete kinematic and kinetic values (i.e. at initial ground contact or at peak), limiting the ability 
to detect potential differences throughout the remainder of the landing task. 
Therefore, the purpose of this study is to compare involved limb biomechanical profiles 
across the stance phase of a double-limb landing task in three distinct groups: individuals who 
are symptomatic with PTA, asymptomatic with PTA, and healthy individuals  
METHODS 
Participants 
Forty-three male participants with and without patellar tendinopathy (PT) were enrolled 
into this study (Table 1). Participants were recruited from the local high school and university 
communities using approved email correspondence and public flyers. All participants were 15-28 
years-old and were required to be actively participating within an organized sport setting, 
quantified by a Tegner Activity Scale of ³ 5, a self-reported questionnaire in which the 
participant identifies the highest level of competition and/or physical activity currently 
performing.235 Additionally, all participants were considered to be post-pubertal, quantified by 
Pubertal Development Scale Stage 5 (score >12).106,202 This study was approved by the 
university’s institutional review board and informed consent was obtained by all participants 
prior to study screening. 
Screening Protocol for Patellar Tendinopathy 
To determine group assignment, all participants underwent a two-part screening protocol. 
Participants were recruited into the symptomatic PT group (SYM-PTA) if they exhibited: 1) pain 
³2/10 on the numeric rating scale (NRS) only in the patellar tendon during performance of the 
Single Leg Decline Squat (SLDS) test110, as selected from a pain map diagram providing a series 
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of pictures with various anterior knee pain locations (if bilateral pain, the “worse” limb must 
have been ³ 5/10 and the contralateral limb must have been £ 2/10 on NRS (0-10)), and 2) 
ultrasonographic (US) evidence of a structural proximal patellar tendon abnormality (PTA), as 
defined by the presence of a hypoechoic region (³ 2mm) and/or a maximum thickness of > 7mm, 
evident on both the longitudinal and transverse scans.80,85 All US images were obtained and 
processed by a single trained investigator (L.S.P.). Participants were recruited into the 
asymptomatic PT group (ASYM-PTA) if they were free of SLDS pain but demonstrated US 
evidence of a PTA. Finally, participants were recruited into the healthy control group (CON) if 
free of SLDS pain and PTA. 
Any participants were excluded if they exhibited any of the following: 1) known 
neurological disorders or cardiopulmonary diseases, 2) a history of any lower extremity surgery, 
3) a history of a lower extremity injury in the prior six-months, 4) an injection to the patellar 
tendon in the prior last three-months, 5) participation in formal rehabilitation for anterior knee 
pain in the prior three-months, 6) presentation of non-tendinopathic knee pain during the SLDS 
test (i.e. patellofemoral pain syndrome presentation), or 7) any other medical condition that 
would prevent them from participation in normal activities of daily living. 
Patient-Reported Outcomes 
The Victorian Institute of Sport Assessment-Patellar Tendon (VISA-P) questionnaire was 
used to quantify self-reported knee function.203,204,236 The VISA-P consists of 8-items regarding 
the presence of pain during various daily and sport-related activities and has demonstrated 
excellent test-retest and interrater reliability.236 All participants completed this questionnaire at 
the time of the screening session. 
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Three-Dimensional Landing Assessment 
Testing Protocol 
On a single testing day, participants visited the laboratory for a three-dimensional 
biomechanical landing assessment. Participants performed a 5-minute warm-up on a stationary 
bicycle at a self-selected pace. 
Double-Limb Jump Landing Task 
Participants were provided with spandex shorts and tops and wore their own athletic 
shoes. Participants performed five trials of a jump-landing task from a 30 cm box that was 
positioned 50% of the participant’s height from the front edge of the force plates.221 The 
participants were instructed to jump forward off the box to a double-leg landing with one foot on 
each force plate, and immediately perform a maximal vertical jump upon landing.221 A minimum 
of one practice trial was performed; practice trials were performed until the participant and 
investigator ensured correct performance of the jump-landing task.  A total of five jump-landing 
trials were collected, and the middle three trials were averaged for data analysis. If one of the 
middle three trials was not successful, a subsequent trial was utilized for analysis. A successful 
trial required the participant to leave the box with both feet at the same time, land on the force 
plates, and jump straight up in the air as high as possible. 
Participants were outfitted with 20 retro-reflective markers bilaterally on the following 
bony landmarks: acromion process, anterior superior iliac spine (ASIS), greater trochanter, 
medial and lateral femoral condyles, medial and lateral malleoli, calcanei, and the first and fifth 
metatarsal heads.219 A single marker was placed on the manubrium of the sternum and at the L4-
L5 vertebral space. Rigid clusters of three or four markers was placed at the sacrum and on the 
thigh, shank, and foot segments bilaterally. A static trial was captured with the participant 
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standing with arms positioned at 90° of shoulder abduction to estimate the location of the 
landmarks needed to calculate joint centers.219 After the static trial, the single markers on the 
foot, malleoli, femoral condyles, and greater trochanters were removed. 
Data Acquisition 
Three-dimensional kinematic data were collected using a ten-camera motion capture 
system (Vicon Motion Systems, Centennial, CO, USA) sampled at 120Hz and filtered using a 
fourth-order low-pass Butterworth filter with a 20Hz cutoff frequency. Kinetic data were 
sampled at 1200Hz using two floor embedded force plates (Bertec Corporation, Columbus, OH, 
USA). Knee and ankle joint center coordinates were defined as the centroid between the medial 
and lateral condyles and malleoli identified during the static trail. Hip joint center coordinates 
were estimated from the coordinates of the L4-5, right ASIS, and left ASIS markers using the 
Bell method.222 Reference frames for the foot, tibia, and femur were defined based on 3D-
coordinates and segments as follows: 1st and 5th metatarsal heads, ankle joint center, and 
calcaneus (foot); medial and lateral malleoli, knee and ankle joint centers, and shank (tibia); 
medial and lateral femoral condyles, knee and hip joint centers, and thigh (femur). Joint angles 
were defined based on the position of the distal segment relative to the proximal segment using a 
Cardan angle sequence in the following order of rotation: sagittal (y-axis), frontal (x-axis’), and 
transverse (z-axis’). 
Data Processing & Reduction 
Marker coordinate and ground reaction force data was transferred into The Motion 
Monitor software (Innovative Sports Training, Chicago, Illinois) to build three-dimensional link-
segment models for biomechanical data analysis and reduction. Lower extremity biomechanics 
for each limb were evaluated during the stance phase, which was defined as the interval from 
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initial contact (IC) to toe-off.223 IC was defined as the time point when the vertical ground 
reaction force (vGRF) exceeded 10N and toe-off as the time point when vGRF dropped below 
10N.223 
Kinematic variables of interest for this study included knee flexion (+)/extension (-). 
Kinetic variables of interest included vertical ground reaction force (VGRF), internal knee 
extension moment (KEM), patellar tendon force (FPT), and knee power. Ground reaction force 
data and processed segment data were used to calculate net internal sagittal and frontal plane 
knee joint moments using inverse dynamics procedures.146 Patellar tendon force (FPT) was 
estimated using previously defined methodology of Nisell and Ekholm, through which FPT is 
calculated by dividing the internal knee extension moment by the patellar tendon moment arm.160 
PT moment arms were calculated as a function of knee joint angles using the methodology of 
Herzog and Read.144 Internal moments were normalized to the product of the participant’s body 
weight and height (N*m[kg*m]-1), while vGRF and FPT was normalized to body weight (BW). 
Knee power (J/s) was calculated as the product of the internal sagittal plane knee moment 
(N*m[kg*m]-1) * knee flexion velocity (°/millisecond).  
Kinematic and kinetic variables were analyzed as continuous normalized waveforms 
during the stance phase of the landing tasks using custom MATLAB code (MatLab R2017b, The 
MathWorks, Inc., Natick, MA). For each dependent variable, the within-group mean values were 
interpolated and normalized over 202 data points over the stance phase using a cubic spline 
filter.237 These data points represent 0% - 100% of the stance phase of the landing task (IC 
through toe-off). 
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STATISTICAL ANALYSIS 
Demographic data was compared across groups using a one-way analysis of variance and 
Tukey post-hoc tests for pairwise comparisons with SPSS v22 (IBM Inc., Armonk, New York, 
USA) (Table 1). Kinematic and kinetic group mean values were calculated for each 1% of the 
landing task, and plotted along with 95% confidence intervals (CI) for each group comparison. 
Statistical significance was defined as any area of the stance phase where the 95% CI did not 
overlap for a minimum of a consecutive 3% of the stance phase.38,237,238 Average mean 
differences (MD) and Cohen’s d effect sizes were calculated for any statistically significant 
areas. Cohen’s d effect sizes were classified as weak (d ≤ 0.2), small (d = 0.2-0.5), moderate (d = 
0.5-0.8), or large (d ≥ 0.8).226  
 
Figure 1: CONSORT diagram for study recruitment and enrollment. 
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Table 1: Descriptive Characteristics of the Study Population 
#: statistically significant difference than CON group (p=0.045) 
*: statistically significant difference than CON group (p<0.001, MD: -21.65 (-29.81, -13.48)) 
^: statistically significant difference than ASYM group (p<0.001, MD: -18.25 (-26.41, -10.08)) 
 
RESULTS 
The CONSORT diagram for recruitment and enrollment is detailed in Figure 1. 
Demographic data are presented in Table 1. No significant differences in height and mass were 
observed between groups (p > 0.05), but the ASYM group was slightly older than the CON 
group (p=0.045). The VISA-P score was significantly lower in the SYM group compared to both 
the ASYM and CON groups (p<0.001), and the mean differences exceeded the MCID (13 
points) for this subjective outcome measure.204 There were no differences in VISA-P score 
between the ASYM and CON groups (p>0.05). 
Kinematics 
Participants in the SYM group demonstrated lesser magnitude knee flexion angle than the 
CON group throughout the majority of the stance phase (8-76%, d: 1.14±0.12, Mean Difference 
(MD): 15.83±2.71°). Participants in the ASYM group demonstrated lesser magnitude knee 
flexion angle than the CON group during the early (8-13%, d: 0.99 ± 0.04, MD: 7.99±0.39°; 21-
24%, d: 1.01±0.01, MD: 11.11±0.32°) and late (74-94%, d: 0.96 ± 0.07, MD: 9.55 ± 1.13°) 
 
 Healthy 
Control 
(n=15) 
Asymptomatic 
Tendinopathy 
(n=15) 
Symptomatic 
Tendinopathy 
(n=13) 
Age (yrs) 19.60 ± 1.55 21.13 ± 1.88# 19.62 ± 1.61 
Height (m) 1.84 ± 0.09 1.84 ± 0.07 1.82 ± 0.05 
Mass (kg) 79.08 ± 12.37 81.45 ± 13.26 83.46 ± 5.12 
Tegner Activity Scale (0-10) 8.07 ± 0.88 7.93 ± 1.03 8.00 ± 1.00 
Pubertal Development Scale (0-
12) 
11.60 ± 0.63 11.87 ± 0.52 11.39 ±0.87 
VISA-P (0-100) 97.80 ± 3.34 94.40 ± 7.72 76.15 ± 13.37*^ 
Screening SLDS Pain (NRS: 0-10) --- --- 3.69 ± 1.25 
Pre-Testing SLDS Pain (NRS: 0-
10) 
--- --- 2.38 ± 1.61 
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portions of the stance phase (Figure 2). There were no differences between the SYM and ASYM 
groups in sagittal plane knee angle. 
Kinetics 
Participants in the SYM group demonstrated lesser internal knee extension moment than 
the CON group during early stance (6.5-9%, d: 1.21± 0.08, MD: 0.04 ± 0.004 N*m[kg*m]-1), as 
well as the ASYM group during mid-stance (38-56%, d: 1.17 ± 0.06, MD: 0.03 ± 0.001 
N*m[kg*m]-1) (Figure 4). There were no differences between the ASYM and CON groups in 
internal sagittal plane knee moment.  
There were no differences in vGRF between groups (Figure 3). However, the SYM group 
demonstrated less patellar tendon force during early stance (6-9%, d: 1.15 ± 0.15, MD: 0.85 ± 
0.15 (BW)) than the CON group and during mid-stance (36-60%, d: 1.22 ± 0.08, MD: 0.66 ± 
0.05 (BW)) than ASYM group (Figure 5). There were no differences between the ASYM and 
CON groups in patellar tendon force. Finally, participants in the SYM group had less knee power 
during early (6-9%, d: 1.24 ± 0.17, MD: 0.48 ± 0.16 J/s; 18.5-23%, d: 1.34 ± 0.13, MD: 0.17 ± 
0.01 J/s) than the CON group and during early stance (20.5-25%, d: 1.14 ± 0.08, MD: 0.20 ± 
0.01 J/s) than the ASYM group (Figure 6). There were no differences in knee power between the 
ASYM and CON groups. 
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Figure 2: Mean and 95% confidence interval waveforms for involved limb sagittal plane knee 
motion during the double-limb jump landing task. 
 
Figure 3: Mean and 95% confidence interval waveforms for involved limb vertical ground 
reaction force during the double-limb jump landing. 
 
Figure 4: Mean and 95% confidence interval waveforms for involved limb sagittal plane internal 
knee moment during the double-limb jump landing. 
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Figure 5: Mean and 95% confidence interval waveforms for involved limb patellar tendon force 
during the double-limb jump landing. 
 
 
Figure 6: Mean and 95% confidence interval waveforms for involved limb knee power during 
the double-limb jump landing. 
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reduced sagittal plane knee joint motion, patellar tendon load, and energy absorption at key 
portions of the stance phase of a double-limb landing task compared to both asymptomatic 
participants with PTA and healthy controls.  A second key finding is that, contrary to our 
hypothesis, asymptomatic participants with PTA did not demonstrate tendon overloading 
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movement profiles, suggesting that the increased mechanical loading may not be major factor 
driving the development of symptomatic tendinopathy. This study is novel in that it is the first to 
directly compare landing biomechanics in three distinct groups with and without tendinopathy, 
defined by both structural and load-based symptom assessments. Our findings have important 
clinical implications to inform rehabilitation programs targeting movement retraining in 
individuals along the continuum of patellar tendinopathy. 
The knee extensor mechanism endures high magnitudes of kinetic energy during landing, 
with upwards of 7x BW of force placed on the patellar tendon.23,159 As such, biomechanical 
analyses that examine tendon load during the entire energy absorption phase of a landing task, 
such as those used in the current study, may provide a comprehensive understanding of the total 
mechanical loading demands. 
Symptomatic Patellar Tendinopathy Group 
The biomechanical profile of the SYM group demonstrates a general pattern of under-
loading. Early in the energy absorption phase of the landing task, the SYM group demonstrated 
lesser internal knee extension moment compared to the CON group (d: 1.12, MD: 0.04 ± 0.004 
N*m[kg*m]-1). In this same early phase of the landing task, we also observed less patellar tendon 
force FPT in the SYM group compared to CON group (d: 1.15, MD: 0.85 ± 0.15 (BW)). Finally, 
there was also less knee joint power during this landing phase in the SYM group compared to 
CON group (d: 1.24, MD: 0.48 ± 0.06 W(Nm)), indicating a reduction in the rate at which the 
internal knee extension moment absorbs during the eccentric phase. Paired with reduced sagittal 
plane motion, this biomechanical profile is suggestive of a quadriceps-avoidance loading pattern, 
reducing the demand on the extensor mechanism (quadriceps muscle/tendon and patellar tendon) 
to control the external knee flexion moment. 
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Our findings of an under-loading biomechanical profile in those with SYM PT is 
consistent with previous research.21,239 Reduced peak knee flexion motion and knee flexion 
excursion during landing tasks have been noted in individuals with current21 and a history of 
previous (≥5 months)239 symptoms compared to healthy controls. Conversely, Richards et al. 
(1996) observed greater knee flexion motion in male elite volleyball athletes with patellar 
tendinopathy.156 However, this is the only study demonstrating elevated sagittal plane kinematics 
in symptomatic individuals, the results of this study should be interpreted cautiously due to the 
low small sample of athletes with tendinopathy (n=3), and the exclusive use of palpation as the 
diagnostic inclusion criteria for tendinopathy.  
Importantly, in previous studies, symptomatic PT has been typically defined based on 
self-reported pain and/or pain with palpation, without confirmation of a PTA. The sensitivity 
(68%) and specificity (9%) of palpation is poor, and thus palpation is not considered a robust 
diagnostic tool.108 Additionally, numerous overuse injury conditions, such as patellofemoral pain 
syndrome, commonly present clinically with activity-related anterior knee pain. Utilizing a 
systematic and comprehensive approach to define PT based on both tendon pain and tendon 
structural abnormality is an important and novel feature of the current study. 
Interestingly, no participants in the SYM group reported pain during testing that 
prevented completion of the jump-landing task, despite the presence of SLDS pain immediately 
prior to testing. However, they did report significantly more pain during activity and sport than 
the other groups, as quantified by the low average VISA-P score (76.15 ± 13.37). While we did 
not account for the duration of activity-related tendon pain, we hypothesize that these 
simultaneous kinetic and energetic alterations were likely learned behaviors over time to reduce 
tendon load due to the presence of activity-relate pain. This finding suggests that closely 
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monitoring activity-related pain and cumulative training load may be an important feature of 
both prevention and treatment programs for PT, as the high frequency of loading during sport-
related activities may be more provocative and more noticeable to a patient than during a single 
bout of landings, as used in this study. 
Asymptomatic Patellar Tendinopathy Group 
Unlike previous studies,23,24 our findings demonstrate that athletes with asymptomatic 
PTA did not demonstrate a biomechanical profile suggestive of over-loading. In contrast, we 
observed patterns of under-loading. The ASYM group demonstrated reduced sagittal plane knee 
motion in the ASYM group compared to CON group during early (8-13% and 21-24%) and late 
(74-94%) phases of the landing task ranging from 8-11° with large effects (d: 0.96-1.01). In 
addition, there were no differences in peak knee flexion angle, VGRF, KEM, PTF, and knee 
power between the ASYM and CON groups. Overall these findings indicate that male athletes 
with asymptomatic PTA did not exhibit any evidence of over-loading across the entire stance 
phase of the landing task, which may have important clinical implication for the best treatment 
approach for this patient population. 
The lack of evidence of over-loading in those with asymptomatic PTA in the current 
study is in contrast with prior research. In a previous study, asymptomatic adult male athletes 
with PTA demonstrated greater sagittal plane knee motion at initial ground contact, but less knee 
flexion displacement compared to healthy controls during the horizontal phase of a landing 
task.23 Additionally, a comparative cohort of junior pre-elite male basketball asymptomatic 
athletes with and without PTA found that asymptomatic athletes with PTA had greater knee 
flexion angles at initial ground contact.24 These movement strategies have been hypothesized to 
facilitate a stiff landing movement profile that increases the demand on the knee extensor 
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mechanism, which may increase the combined tensile and compressive strain across the 
proximal patellar tendon.141 However, our findings demonstrate that those with asymptomatic 
PTA display similar VGRF, KEM, PTF, and knee power loading profiles compared to healthy 
controls and those with symptomatic PTA. 
Due to the cross-sectional nature of this study, we are unable to determine whether the 
observed biomechanical profile of the ASYM group were present prior to the development of the 
PTA or resulted in response to the PTA. Therefore, the hypothesis that the progression of 
asymptomatic to symptomatic PTA may be related to increased PT stress from greater amounts 
of sagittal plane knee motion can neither be supported or refuted from our results. Longitudinal 
studies are needed to determine whether biomechanical movement profiles influence the initial 
development of PTA. One such study has been published which found no significant kinematic 
patterns that differed between athletes who went on to develop patellar tendinopathy.240 
However, of forty-nine participants, only three developed tendinopathy, which was defined 
based on a clinical diagnosis of pain during loading and palpation without any diagnostic 
imaging, so results should be interpreted cautiously in comparison with the present study. 
Interestingly, in the current study, the lesser knee flexion motion in the ASYM vs. CON groups 
was observed with no simultaneous differences in knee loading variables between these groups. 
Early alterations in kinematics may proceed changes in loading, particularly during a double-
limb landing task where the contralateral limb can be utilized to share force dissipation. 
It is possible that, despite the absence of pain in the ASYM group, reduced involved limb 
sagittal plane motion is a biomechanical adaptation occurring in response to an underlying 
catabolic biochemical process within the tendon structure. Normal tendon’s extracellular matrix 
is largely composed of tightly packed, highly-organized Type I collagen, the primary load-
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bearing structure of tendon, and is supported by tenocytes and small proteoglycans.241,242 
Mechanoreceptors in tendon are located primarily at myotendinous junctions and tendon 
insertions. The cell proliferation and matrix disorganization in tendon pathology includes the 
production of larger proteoglycans, which alters mechanotransduction and disrupts tendon 
molecular homeostasis.243,244 It is hypothesized that the asymptomatic tendon may have 
considerable matrix disorganization and disruption of normal mechano-transductive properties, 
but inadequate chemical nociceptive stimulus to cause perceived pain.82 
Therefore, we hypothesize that the reduction in knee flexion motion in asymptomatic 
participants compared to healthy controls may be an underlying avoidance of a joint position that 
places high demand on the abnormal tendon that possesses compromised mechano-transductive 
capabilities. It is also possible that these individuals have a different inherent tissue capacity such 
that even though they experience similar load magnitudes as healthy individuals, their ability to 
withstand those loads without tissue compromise is reduced. Finally, it is possible that loading 
characteristics measured in controlled laboratory settings are failing to tell the entire story of the 
cumulative effects of loading on the development of PT, warranting further investigations into 
how loading in real-world athletic settings may influence the development and progression of 
patellar tendinopathy. 
We believe that our findings are important, as they suggest that interventions for 
asymptomatic individuals with structural abnormalities should not be designed to shield the 
tendon from excessive loading, as these individuals are already demonstrating signals of under-
loading. Our data show that these asymptomatic individuals land with reduced knee flexion and, 
though not statistically significant, are trending towards reduced knee kinetics compared to 
healthy controls.  
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This movement pattern may lead to reduced tissue capacity and subsequent symptom 
development over time. Recent work by Docking and Cook (2015) found that pathological 
tendons have increased cross sectional area of aligned fibrillar structure around areas of 
pathology, suggestive that tendon may actually adapt to pathology.80 This thickening of healthy 
tendon results in sufficient amounts of load-bearing tissue that should be targeted through 
progressive load-based interventions to build overall tissue capacity. While there is evidence 
suggesting that degenerative tendon matrix is unlikely to be reversible, this evolving concept 
focused on “treating the doughnut (aligned structure), not the hole (area of disorganization)”.10 is 
potentially an area that can improve the function and prognosis of asymptomatic individuals with 
structural abnormalities.   
LIMITATIONS 
We acknowledge several limitations to this study. The cross-sectional design of this study 
prevents us from determining whether the observed movement profiles were present prior to the 
development of PTA with or without symptoms in our SYM and ASYM groups, respectively. 
While robust inclusion criteria were utilized to define our tendinopathy groups, we did not 
account for duration of symptoms in the SYM group, which may have influenced how long an 
individual may have developed and instilled aberrant movement profiles in response to persistent 
pain. In addition, our SYM cohort was relatively functional, based on low to moderate pain 
levels reported prior to the biomechanical assessment. We also recognize that more between-
group differences in movement profiles may have been absent due to the relatively sample size 
for each group, as well as the high degree of variability, particularly in the SYM group, whose 
95% CI were wide. While our estimation of patellar tendon force was chosen based on accepted 
models,23,144,158,160 it is possible that these models underestimate the actual force acting through 
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tendon. Finally, this study was conducted only on college-aged males so its findings cannot be 
extrapolated to females or males of a different age range. 
CONCLUSIONS 
Several important inferences can be made from the results of this study that carry 
meaningful clinical implications. Participants with symptomatic tendinopathy demonstrated 
differences in both sagittal plane kinematic and kinetic movement profiles during portions of the 
stance phase of a landing that are associated with high patellar tendon stress and extensor 
mechanism demand, respectively. This study is the first to use magnitude-based inference 
waveform analysis to evaluate landing characteristics in patellar tendinopathy. We believe this 
type of analysis may be more effective at comprehensively evaluating movement characteristics, 
as we were able to highlight group differences in phases of the tasks that would not have been 
exposed using traditional discrete variable analysis. Second, though the periods of reduced 
loading in the symptomatic group were relatively short, if uncorrected over time, an altered 
movement strategy of under-loading may lead to both reduced tissue capacity and reduced 
performance. Future studies should continue investigating the best treatment options to reduce 
pain and re-train normal tendon loading to maximize the quality of load-bearing capabilities of 
tendon.188 Finally, reductions in sagittal plane knee motion of the asymptomatic participants 
compared to the healthy control participants may indicate a compensatory strategy in response to 
underlying tissue pathology. Consequently, regular observation of individuals with structural 
abnormalities who are at higher risk for developing symptoms is warranted. Future research 
should continue investigating both laboratory and real-world movement characteristics of 
individuals at varying stages of the continuum of tendinopathy in order to best design targeted 
rehabilitation strategies to improve tissue resilience and performance. 
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CHAPTER 6: MANUSCRIPT 2 
Load Magnitude and Cumulative Load Volume Differ in Male Athletes with and without 
Patellar Tendinopathy 
 
INTRODUCTION 
Patellar tendinopathy (PT) is prevalent in individuals who are highly physically active, 
particularly athletes who participate in sports with repetitive jumping manueveurs.1–5 
Mismanagement of the volume of load acting on the tissue is believed to be a key factor 
contributing to PT development.9,10 Research involving biomechanical analyses has revealed 
differences in the load magnitude of vertical ground reaction force (VGRF), knee extension 
moment (KEM), and patellar tendon force (FPT) between individuals with and without symptoms 
of PT.19,22,23 A limitation of traditional biomechanics research is that it provides a snapshot of the 
individual’s magnitude of loading in a controlled environment and does not consider the 
frequency and duration of repeated loading over a prolonged time period. Given the importance 
of load volume it may be important to consider the combination of load magnitude, frequency 
and duration to better manage and prevent symptomatic PT.  
Previous literature demonstrates associations between training and competition load 
volumes and injury.34,35 Specifically, high training load volume (training hours/week, 
match/week) increases the risk of PT in adolescent male and female volleyball athletes (OR: 
1.72-3.38).36 Recent evidence demonstrates a reduction in physical activity in cohorts following 
traumatic knee injury surgery and chronic ankle instability compared to healthy, uninjured 
peers.37,38 Physical activity (PA) and sports participation in the youth population has been
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associated with numerous positive health and social behaviors,47,50 as well as continued physical 
activity into adulthood.46 Advances in wearable technology, specifically accelerometry, allow for 
quantification of PA metrics that provide objective insight into cumulative external loading in an 
individual’s natural environment.170,180 Accelerometry-based measurement of PA is considered 
superior to self-reported PA quantification because it removes recall error bias and is able to 
more objectively quantify the amount and intensity of various forms of PA.165,176,177,215 The most 
common outputs from PA measurement include step counts and moderate-to-vigorous activity 
(MVPA), both measures that give insight into load frequency and duration. 
Examining loading frequency may be especially important in better understanding 
overuse injuries. However, to-date, there are no studies investigating objective measures of 
physical activity in individuals with PT. As the pathoetiology of tendinopathy acts on a 
continuum,9,10 it is possible that individuals at different stages of the continuum (i.e. 
asymptomatic vs. symptomatic, with or without structural pathology) may undertake different 
levels of activity, which may be important in the progression of the condition. Additionally, 
though numerous studies demonstrate that athletes with patellar tendinopathy report high-levels 
of activity related pain on subjective patient-reported outcomes,203,236,245 it is unclear if these 
measures associate with objective measures of physical activity. 
The utility of quantifying load frequency and duration metrics in this population is to 
obtain a more objective understanding of the associations between cumulative load volume and 
clinical manifestations of patellar tendinopathy (i.e. structural pathology and pain). It is possible 
that measuring and tracking cumulative load frequency and duration are critical pieces missing 
from current investigations related to the management of patellar tendinopathy. Previous 
literature has demonstrated that using an objective metric of cumulative load volume (discrete 
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biomechanical measure * load frequency measure) is effective at both predicting the onset of 
musculoskeletal (MSK) disease as well as distinguishing between individuals with and without 
MSK disease.39,246 Maly et al. developed an approach to estimate cumulative knee loading 
demonstrates high reliability.39 Based on the foundational knowledge of tendon as a mechano-
responsive tissue, and growing evidence of altered real-world loading in pathological 
populations, we propose applying the cumulative knee loading metric to evaluate load volume 
measures that have previously been described to differ between individuals with and without 
patellar tendinopathy in traditional biomechanical assessments.19,23,158,247  
Therefore, the primary purpose of this study was to investigate differences in load 
volume, magnitude, duration, and frequency measures between male athletes with and without 
patellar tendinopathy. We hypothesized that, compared to healthy control particitipants athletes 
with symptomatic PT will demonstrate patterns under-loading while athletes with asymptomatic 
PT will demonstrate patterns of over-loading, respectively. 
METHODS 
Participants 
Forty-one male participants with and without patellar tendinopathy were enrolled into 
this study (Table 1). Participants were recruited from the local high school and university 
communities using approved email correspondence and public flyers. All participants were 15-28 
years-old and were required to be actively participating within an organized sport setting, 
quantified by a Tegner Activity Scale of ³ 5, considered to be post-pubertal, quantified by 
Pubertal Development Scale Stage 5 (score >12).106,202 This study was approved by the 
university’s institutional review board and informed consent was obtained by all participants 
prior to study screening. 
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Screening Protocol for Patellar Tendinopathy 
To determine group assignment, all participants underwent a two-part screening protocol. 
Participants were recruited into the symptomatic PT group (SYM-PTA) if they exhibited: 1) pain 
³2/10 on the numeric rating scale (NRS) only in the patellar tendon during performance of the 
Single Leg Decline Squat (SLDS) test110, as selected from a pain map diagram providing a series 
of pictures with various anterior knee pain locations (if bilateral pain, the “worse” limb must 
have been ³ 5/10 and the contralateral limb must have been £ 2/10 on NRS (0-10)), and 2) 
ultrasonographic (US) evidence of a structural proximal patellar tendon abnormality (PTA), as 
defined by the presence of a hypoechoic region (³ 2mm) and/or a maximum thickness of > 7mm, 
evident on both the longitudinal and transverse scans.80,85 All US images were obtained by a 
single trained investigator (L.S.P.). Participants were recruited into the asymptomatic PT group 
(ASYM-PTA) if they were free of SLDS pain but demonstrated US evidence of a PTA. Finally, 
participants were recruited into the healthy control group (CON) if free of SLDS pain and PTA. 
Any participants were excluded if they exhibited any of the following: 1) known 
neurological disorders or cardiopulmonary diseases, 2) a history of any lower extremity surgery, 
3) a history of a lower extremity injury in the prior six-months, 4) an injection to the patellar 
tendon in the prior last three-months, 5) participation in formal rehabilitation for anterior knee 
pain in the prior three-months, 6) presentation of non-tendinopathic knee pain during the SLDS 
test (i.e. patellofemoral pain syndrome presentation), or 7) any other medical condition that 
would prevent them from participation in normal activities of daily living. 
Patient-Reported Outcomes 
The Victorian Institute of Sport Assessment-Patellar Tendon (VISA-P) questionnaire was 
used to quantify self-reported knee function.203,204 The VISA-P consists of 8-items regarding the 
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presence of pain during various daily and sport-related activities. All participants completed this 
questionnaire at the time of the screening session. 
 
Physical Activity Measurement 
Data Collection 
Participants were outfitted with an ActiGraph GT9X Link accelerometer (ActiGraph 
Corporation, Pensacola, FL), a solid-state tri-axial accelerometer with capabilities to capture, 
record, and store high-resolution human activity information.209 The ActiGraph GT9X Link 
accelerometer was used in this study because it has been shown to be a valid and reliable 
accelerometer to capture objective data of steps-per-day and minutes of moderate-to-vigorous 
physical activity (MVPA) in young, active cohorts.38,210,211 
Participants wore the accelerometer in a Velcro pouch via an elastic waist belt at the right 
anterior-superior iliac spine for a 7-day wear period. A seven-day monitoring period is an 
accepted duration commonly utilized in physical activity literature.38,39,211,213 A valid wear period 
was considered to be at least 4 total days (3 weekdays and 1 weekend day) of at least 480 
minutes (8 hours) per day. Participants were instructed to remove the accelerometer for bathing 
and sleeping, but to wear it at all other times throughout the day. Participants were provided with 
an individual docking station to connect via USB to a standard wall outlet for charging. 
Participants were asked to charge the accelerometer each night to ensure consistent battery life 
throughout daily wear periods. Feedback feature display (i.e. steps/day) on the screen of the 
accelerometer was disabled in order to avoid participant bias on their daily performance. To 
maximize the acquisition of quality data, participants were provided with an instructional and 
troubleshooting guide and the principal investigator’s cellular phone number. Finally, 
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participants kept daily physical activity logs, including both exercise and sport-specific activity, 
during the wear period. Following the conclusion of the wear period, participants returned the 
accelerometer and exercise diaries, and data were inspected to ensure they met the wear 
requirements. If insufficient data had been obtained, participants were asked to re-wear the 
accelerometer for an additional 7-day wear period. 
Data Analysis 
The primary outcome variables for this study were average moderate-to-vigorous-activity 
(MVPA) per day (MVPA/day (min)), average steps-per-day (steps/d), and average steps-in-
MVPA-per-day (stepsMVPA/day) during the valid wear period. The ActiGraph GT9X Link 
accelerometer measured accelerations in the range of +/- 8g at a 30 Hz sampling frequency in 
raw acquisition mode with a 60-second epoch parameter (data written to memory every 60 
seconds). After participant use, data were processed and analyzed using ActiLife v6.0.0 
(ActiGraph Corporation, Pensacola, FL), the proprietary actigraphy data analysis software 
platform of ActiGraph. Wear time validation was performed using Choi et al. (2011) 
algorithms,225 which differentiates between periods of valid wear and non-wear time, and 
allowed the principle investigator to ensure that participants met the minimum amount of wear 
time per protocol. Next, Freedson Adult VM3 cut points were applied to classify physical 
activity into light, moderate, vigorous, and very vigorous categories based on the number of 
activity counts per 60-second epoch.248 The number of steps-per-day is calculated within 
ActiLife software based on the vertical acceleration data measured with the GT9X Link monitor. 
All variables of interest were normalized to the number of valid wear days prior to analysis. 
 
 
  160 
 
Three-Dimensional Landing Assessment 
Testing Protocol 
On a separate testing day following the 7-day accelerometer wear period, participants 
visited the laboratory for a three-dimensional biomechanical landing assessment. Participants 
performed a 5-minute warm-up on a stationary bicycle at a self-selected pace. 
Double-Limb Jump Landing Task 
Participants were provided with spandex shorts and tops. Participants wore their own 
athletic shoes. Participants performed five trials of a jump-landing task from a 30 cm box that 
was positioned 50% of the participant’s height from the front edge of the force plates.221 The 
participants were instructed to jump forward off the box to a double-leg landing with one foot on 
each force plate, and immediately perform a maximal vertical jump upon landing.221 A minimum 
of one practice trial was performed; practice trials were performed until the participant and 
investigator ensured correct performance of the jump-landing task.  A total of five jump-landing 
trials were collected, and the middle three trials were averaged for data analysis. If one of the 
middle three trials was not successful, a subsequent trial was utilized for analysis. A successful 
trial required the participant to leave the box with both feet at the same time, land on the force 
plates, and jump straight up in the air as high as possible. 
Participants were outfitted with 20 retro-reflective markers bilaterally on the following 
bony landmarks: acromion process, anterior superior iliac spine (ASIS), greater trochanter, 
medial and lateral femoral condyles, medial and lateral malleoli, calcanei, and the first and fifth 
metatarsal heads.219 A single marker was placed on the manubrium of the sternum and at the L4-
L5 vertebral space. Rigid clusters of three or four markers was placed at the sacrum and on the 
thigh, shank, and foot segments bilaterally. A static trial was captured with the participant 
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standing with arms positioned at 90° of shoulder abduction to estimate the location of the 
landmarks needed to calculate joint centers.219 After the static trial, the single markers on the 
foot, malleoli, femoral condyles, and greater trochanters were removed. 
Data Acquisition 
Three-dimensional kinematic data were collected using a ten-camera motion capture 
system (Vicon Motion Systems, Centennial, CO, USA) sampled at 120Hz and filtered using a 
fourth-order low-pass Butterworth filter with a 12Hz cutoff frequency. Kinetic data were 
sampled at 1200Hz using two floor embedded force plates (Bertec Corporation, Columbus, OH, 
USA). Knee and ankle joint center coordinates were defined as the centroid between the medial 
and lateral condyles and malleoli identified during the static trail. Hip joint center coordinates 
were estimated from the coordinates of the L4-5, right ASIS, and left ASIS markers using the 
Bell method.222 Reference frames for the foot, tibia, and femur were defined based on 3D-
coordinates and segments as follows: 1st and 5th metatarsal heads, ankle joint center, and 
calcaneus (foot); medial and lateral malleoli, knee and ankle joint centers, and shank (tibia); 
medial and lateral femoral condyles, knee and hip joint centers, and thigh (femur). Joint angles 
were defined based on the position of the distal segment relative to the proximal segment using a 
Cardan angle sequence in the following order of rotation: sagittal (y-axis’), frontal (x-axis’), and 
transverse (z-axis’). 
Data Processing & Reduction 
Lower extremity biomechanics for the involved (SYM & ASYM) and dominant (CON) 
limbs were evaluated during the descending phase of the jump-landing task, which was defined 
as the interval from initial contact (IC) to peak knee flexion during the stance phase.223 IC was 
defined as the time point when the vertical ground reaction force (vGRF) exceeded 10N.223  The 
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stance phase was defined as the time from IC until toe off (vGRF <10 N). Peak knee flexion was 
defined as the maximal flexion angle during the stance phase and was used to determine the end 
of the descending loading phase (IC to time of peak knee flexion angle). 
Ground reaction force data and processed segment data were used to calculate net 
internal sagittal and frontal plane knee and hip joint moments using inverse dynamics 
procedures.146 Patellar tendon force (FPT) was estimated using previously defined methodology 
of Nisell and Ekholm, through with FPT is calculated by dividing the internal knee extension 
moment by the patellar tendon moment arm.160 PT moment arms were calculated as a function of 
knee joint angles using the methodology of Herzog and Read.144 
FPT impulse (FPTI) and internal knee extension moment impulse (KEMI) were calculated 
as the area under the FPT and KEM curves, respectively, during the descending phase of the 
landing task. Knee power (J/s) was calculated as the product of the internal sagittal plane knee 
moment (Nm/kgm)*knee flexion velocity (°/millisecond). Negative knee work (KW) (J) was 
calculated as the negative area under the knee power curve during the descending phase of the 
landing task. 
Loading volume variables were estimated based on the methodology of Maly et al.39 
However, because our biomechanical outcome variables were assessed during a dynamic landing 
task, the number of steps-per-day in MVPA (stepsMVPA) was utilized for this study instead of the 
total steps/day (which includes steps in the “light” physical activity category). MVPA has been 
described previously as including activity ranging from weight training to jogging to competitive 
sport.249 Average stepsMVPA/day was divided by two, since the accelerometer captures steps for 
both limbs. Loading volume variables included: patellar tendon load (cFPT), cumulative patellar 
tendon force impulse (cFPTI), internal knee extension moment impulse (cKEMI), knee power 
  163 
 
(cKP), and knee work (cKW). The following equation was utilized, using the variable ‘cFPT’ as 
an example: 
cFPT load estimation: ∫ "#$(&) ∗ )&	 × 	(,-./,0123456 	789	&:;&	<=>?)@5  
where cFPT is the cumulative patellar tendon force per day estimation; FPT(t) is the mean patellar 
tendon force (FPT) across the three jump-landing trials at time (t) from a) initial ground contact, 
to b) peak knee flexion angle. 
Statistical Analysis 
Descriptive characteristics (means, standard deviations, 95% confidence intervals (CI)) 
were calculated for all dependent variables (Table 1). Physical activity and biomechanical 
variables were compared between the three groups (CON, ASYM-PTA, SYM-PTA) using a one-
way analysis of variance (ANOVA). Tukey post-hoc tests for pairwise comparisons of means for 
each dependent variable were performed for significant findings from each ANOVA model. 
Mean differences between groups and associated 95% confidence intervals were calculated. 
Cohen’s d effect sizes were used to evaluate the magnitude of between group differences for 
loading volume variables, classified as weak (d ≤ 0.2), small (d = 0.2-0.5), moderate (d = 0.5-
0.8), or large (d ≥ 0.8).226 Pearson product-moment correlations were utilized to examine the 
relationship between objective physical activity measures and VISA-P score. Statistical 
significance was set a priori at a < 0.05. All statistical analyses were completed in SPSS v22 
(IBM Inc., Armonk, New York, USA). 
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Table 1: Descriptive characteristics of the study population (mean ± sd) 
 
*: statistically significant difference than CON group (p<0.001, MD: -21.49 (-29.97, -13.01)) 
^: statistically significant difference than ASYM group (p<0.001, MD: -17.91 (-26.40, -9.44)) 
 
RESULTS  
Demographic data are presented in Table 1. No significant differences in height, mass, or 
age were observed between groups (p > 0.05). The VISA-P score was significantly lower in the 
SYM-PTA group compared to both the ASYM-PTA and CON groups (p<0.001), and the mean 
difference exceeded the MCID (13 points) for this subjective outcome measure.204 
Results from the load volume analyses are presented in Table 3. Participants with SYM-
PTA demonstrated lesser load volume than CON for all variables (cFPT, cFPTI, cKEMI, cKP, 
cKW) (p<0.05). There were no significant differences in load volume between the SYM-PTA 
and ASYM-PTA groups or the ASYM-PTA and CON groups (p>0.05). Mean differences and 
Cohen’s d effect sizes are presented in Table 4. The magnitude of the effect for SYM-PTA 
compared to CON was considered to be strong and significant for cFPT (d =0.98), FPTI (d = 1.09), 
KEMI (d = 1.09), cKP (d = 10.4), and KW (d = 1.14) (Table 4). 
There were no significant differences between the three groups for the load frequency 
(steps/day, stepsMVPA/day) or duration (MVPA/day) metrics (p>0.05) (Table 2). However, there 
was a non-significant trend of fewer steps/day, stepsMVPA/day, and MVPA/day in the SYM-PTA 
	
 Healthy 
Control 
(n=14) 
Asymptomatic 
Tendinopathy 
(n=14) 
Symptomatic 
Tendinopathy 
(n=13) 
Age (yrs) 19.64 ± 1.60 21.00 ± 1.96 19.62 ± 1.61 
Height (m) 1.84 ± 0.09 1.84 ± 0.07 1.82 ± 0.05 
Mass (kg) 79.91 ± 12.95 81.63 ± 13.03 83.46 ± 5.12 
Tegner Activity Scale (0-10) 8.00 ± 0.88 8.00 ± 1.04 8.00 ± 1.00 
Pubertal Development Scale (0-12) 11.57 ± 0.65 11.86 ± 0.53 11.39 ±0.87 
VISA-P (0-100) 97.64 ± 3.41 94.07 ± 7.85 76.15 ± 13.37*^ 
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group compared to both the CON and ASYM-PTA groups (Table 2). Total wear time was not 
significantly different between groups (p=0.205). All group comparisons were conducted with 
and without controlling for total wear time, and neither model demonstrated statistical 
significance (p>0.05). 
Results from the biomechanical load magnitude analysis are presented in Table 5. The 
SYM-PTA group demonstrated significantly less load magnitude than the CON (p<0.01) and 
ASYM-PTA (p>0.05) groups for all variables (FPTI, KEMI, KW). There were no statistically 
significant differences in these baseline biomechanical load magnitude variables between the 
CON and ASYM-PTA groups (p>0.05). Mean differences and Cohen’s d effect sizes are 
presented in Table 6. The magnitude of the effect for SYM-PTA compared to CON was 
considered to be strong and significant for FPTI (d = 1.40), KEMI (d = 1.42), and KW (d = 1.53). 
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Table 2: Descriptive characteristics for study population for load frequency and duration metrics (mean ± sd, 95% CI) 
 Healthy Control 
(n=14) 
Asymptomatic Tendinopathy 
(n=14) 
Symptomatic Tendinopathy 
(n=13) 
 Mean ± SD 95% CI Mean ± SD 95% CI Mean ± SD 95% CI 
Total steps/day 11,195 ± 1,803 10,154, 12,237 10,143 ± 2,646 8,615, 11,671 10,250 ± 2942 8,472, 12,028 
Steps in MVPA/day 7,028 ± 3,329 5,106, 8,951 5,977 ± 2,723 4,405, 7,549 5,487 ± 1716 4,450, 6,524 
Time in MVPA/day (min) 102.42 ± 20.73 90.45, 114.40 97.60 ± 37.67 75.85, 119.36 94.54 ± 29.10 76.96, 112.13 
Time in MVPA/day (%) 13.27 ± 3.41 11.30, 15.24 11.80 ± 5.57 8.58, 15.02 12.76 ± 4.43 10.08, 15.44 
Total wear time (min) 5,298 ± 968 4,739, 5,859 5,217 ± 881 47,08, 5,725 4,598 ± 1,375 4,700, 5,397 
Valid wear days 6.58 ± 0.51 6.28, 6.87 6.43 ± 0.85 5.94, 6.92 5.92 ± 0.31 5.25, 6.60 
 
*Note: the values reported are unadjusted for total wear time. No statistical difference between groups for total wear time (p=0.205) 
*No statistically significant differences between groups, both with and without controlling for total wear time (minutes) (p>0.05). 
 
Table 3: Descriptive characteristics (mean ± sd, 95% CI) for load volume variables (based on # of stepsMVPA and involved limb 
biomechanics during the double-limb landing task). 
 
Table 3a: 
 Cumulative PTF 
(BW) 
Cumulative PTF Impulse (BW*ms) Cumulative KEM Impulse (Nm*ms) 
Group Mean ± SD 95% CI Mean ± SD 95% CI Mean ± SD 95% CI 
Healthy Control (n=14) -12.3e3 ± 6.17e3 -15.9e3, -8.74e3 -2.27e6 ± 1.24 e6 -2.99e6, -1.56 e6 -10.7e4 ± 5.96e4 -14.1e4, -7.24e4 
Asymptomatic Tendinopathy (n=14) -9.97e3 ± 4.63e3 -12.5e3, -7.45e3 -1.76e6 ± 0.880e6 -2.26e6, -1.25e6 -8.15e4± 4.04e4 -104.9e4, -5.82e4 
Symptomatic Tendinopathy (n=13) -7.81e3 ± 1.94e3* -8.98e3, -6.64e3 -1.22e6 ± 0.566e6* -1.56e6, -8.75e5 -5.70e4 ± 2.56e4* -7.25e4, -4.15e4 
 
Table 3b: 
 Cumulative Knee Power (J*ms) Cumulative Knee Work (J) 
Group Mean ± SD 95% CI Mean ± SD 95% CI 
Healthy Control (n=14) -6.71e3 ± 3.46e3 -8.71e3, -4.72e3 -5.56e5 ± 3.38e5 -7.51e5, -3.60e5 
Asymptomatic Tendinopathy (n=14) -5.31e3 ± 2.59e3 -6.80e3, -3.81e3 -3.70e5 ± 1.72e5 -4.70e5, -2.71e5 
Symptomatic Tendinopathy (n=13) -4.03e3± 1.18e3* -4.74e3, -3.32e3 -2.64e5 ± 1.25e5^ -3.39e5, -1.88e5 
 
*statistically significant difference than the healthy control group (p<0.05) 
^ statistically significant difference than the healthy control group (p<0.01) 
168 
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Table 4: Group comparisons for load volume variables (based on # of stepsMVPA and involved limb biomechanics during the double-
limb landing task). 
 
Table 4a: 
 Cumulative Patellar Tendon Force 
(BW) 
Cumulative Patellar Tendon Force Impulse 
(BW*ms) 
Cumulative Knee Extension Moment 
Impulse (Nm*ms) 
 
Group 
Comparisons 
Mean 
Difference 
95% CI Cohen’s d Mean 
Difference 
95% CI Cohen’s d Mean 
Difference 
95% CI Cohen’s 
d 
CON vs. SYM -4.49e3 -8.76e3, -.21e3 0.98 -10.57e5 -19.44e5, -1.69e5 1.09 -4.99e4 -9.17e4, -.80e4 1.09 
CON vs. ASYM -2.33e3 -6.52e3, 1.87e3 0.44 -5.17e5 -13.88e5, 3.54e5 0.48 -2.54e4 -6.64e4, 1.57e4 0.50 
ASYM vs. SYM -2.16e3 -6.43e3, 2.11e3 0.64 -5.40e5 -14.27e5, 3.48e5 0.73 -2.45e4 -6.63e4, 1.73e4 0.72 
 
Table 4b: 
 Cumulative Knee Power MVPA (J*ms) Cumulative Knee Work MVPA (J) 
Group Comparisons Mean Difference 95% CI Cohen’s d Mean Difference 95% CI Cohen’s d 
CON vs. SYM -2.68e3 -5.13e3, -.23e3 1.04 -2.92e5 -5.11e5. -.74e5 1.14 
CON vs. ASYM -1.41e3 -3.81e3, 1.00e3 0.46 -1.86e5 -4.00e5, .29e5 0.69 
ASYM vs. SYM -1.27e3 -3.73e3, 1.18e3 0.63 -1.07e5 -3.26e5, 1.12e5 0.64 
Group Legend: CON=healthy control, ASYM=asymptomatic tendinopathy, SYM=symptomatic tendinopathy 
Note: The group listed first is the referent group for each mean comparison. 
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Table 5: Group comparisons for load magnitude variables for the involved (SYM & ASYM) and dominant (CON) limbs during the 
double limb landing task. 
 
Internal Knee Extension Moment 
Impulse (Nm*ms) 
Patellar Tendon Force Impulse 
(BW*ms) 
Negative Knee Work 
(J/kg) 
Mean 95% CI Mean 95% CI Mean 95% CI 
Healthy Control (n=15) -29.98 ± 4.91 -32.70, -27.25 -639.20 ± 102.82 -696.14, -582.26 -156.37 ± 34.45 -175.45, -137.29 
Asymptomatic 
Tendinopathy (n=15) -27.13 ± 5.91 -30.41, -23.85 -583.34 ± 129.80 -655.22, -511.46 -126.58 ± 26.81 -141.43, -111.74 
Symptomatic 
Tendinopathy (n=13) -21.19 ± 7.28
*# -16.79, -25.59 -450.81 ± 160.57*# -547.84, -353.78 -98.72 ± 40.67*# -123.30, -74.15 
 
*statistically significant difference compared to CON group (p<0.01) 
#statistically significant difference compared to ASYM group (p<0.05) 
 
 
 
 
Table 6: Effect size calculations for group comparisons for load magnitude variables for the involved (SYM & ASYM) and dominant 
(CON) limbs during the double limb landing task. 
 
 Internal Knee Extension Moment Impulse 
(Nm*ms) 
Patellar Tendon Force Impulse 
(BW*ms) 
Negative Knee Work 
(J/kg) 
Group 
Comparisons 
Mean 
Difference 
95% CI Cohen’s d Mean 
Difference 
95% CI Cohen’s d Mean 
Difference 
95% CI Cohen’s d 
CON vs. SYM -8.79 -14.37, -3.31 1.42 -188.39 -309.80, -66.97 1.40 -57.65 -89.10, -26.19 1.53 
CON vs. ASYM -2.85 -8.22, 2.53 0.52 -55.86 -172.86, 61.14 0.48 -29.79 -8.22, 2.53 0.97 
ASYM vs. SYM -5.94 -11.52, -0.36 0.90 -132.53 -253.94, -11.12 0.91 -27.86 -11.52, -0.36 0.81 
 
Legend: SYM: symptomatic tendinopathy, ASYM: asymptomatic tendinopathy, CON: healthy control 
Note: The group listed first is the referent group for each mean comparison. 
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DISCUSSION 
Our most important finding was that load volume differences were observed across 
groups. Specifically, the symptomatic participants displayed significantly lesser load volume 
compared to the healthy control participants, clearly demonstrating an under-loading profile. In 
contrast to our hypothesis, load volume was not greater in the asymptomatic participants 
compared to either the healthy control or symptomatic participants. Thus, there was no pattern of 
over-loading observed for those with asymptomatic PT. Patterns of reduced load volume in our 
symptomatic participants appear to be driven by lesser biomechanical load magnitude, as FPTI, 
KEMI, and KW were all reduced in symptomatic compared to healthy control participants; 
however, there were no differences in measures of load frequency (steps/day) or duration 
(MVPA/day). To the best of our knowledge, this is the first study to objectively measure load 
volume, frequency, and duration metrics in individuals with patellar tendinopathy, and the results 
reinforce the multifaceted nature of this injury condition. 
The first key finding of this study is that individuals with SYM-PTA demonstrate both 
lesser magnitude and volume of involved-limb patellar tendon loading and knee energy 
absorption than both ASYM-PTA and CON groups. The magnitude of loading we observed is 
consistent with those of Sorenson et al (2010), which found 29% less mechanical energy 
absorption in individuals with tendinopathy compared to healthy controls during landing.19 
Additionally, Bisseling et al. (2007) demonstrated a load-avoiding landing strategy in athletes 
with symptomatic tendinopathy, including reduced knee joint power, work, and lower peak knee 
moments.22 In the present study, we saw large effects (d > 0.8) between the CON and SYM 
groups. Likely driven by pain, this movement pattern reflects a load-avoidance behavior, 
whereby individuals reduce extensor mechanism loading and absorption of mechanical energy 
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during the descending phase of the landing task. Mechanical power and work reflect the 
interaction of load and displacement, which are highly relevant to the sagittal plane demand on 
the patellar tendon during jumping maneuvers. Chronic reduction in energy absorption and 
eccentric stimulus to the tissue may reduce the effectiveness of stretch-shortening cycle and the 
ability of the patellar tendon to appropriately perform force transmission, which may lead to 
other compensatory movement strategies. 
Of particular interest from our analysis is the quantification of the magnitude and rate of 
load across the patellar tendon (PTF and FPTI variables), both discretely and cumulatively, 
demonstrating lesser tissue loading in the symptomatic group. Edwards et al. (2012) found that 
normalized peak patellar tendon forces were significantly greater than peak vertical ground 
reaction forces (VGRF) during the horizontal phase of a stop-jump task, suggesting that using 
VGRF to represent patellar tendon load may underestimate the specific load across the tissue.158 
Our results illustrate that biomechanical under-loading observed in a laboratory setting can be 
perpetuated in an individual’s natural environment. For individuals following soft tissue or joint 
injuries, chronic under-loading may fail to provide the mechanical stimulus needed to maintain 
tissue homeostasis within its envelope of function.64,250 
A novel aspect of the current study is the use of cumulative patellar tendon and knee joint 
loading estimations, which blend biomechanical (load magnitude) and physical activity (load 
frequency and duration) metrics to more objectively quantify load volume. Driven by group 
differences in the magnitude of biomechanical loading, SYM-PTA participants demonstrated 
significantly less loading volume than both ASYM-PTA and CON groups, suggesting chronic 
under-loading in individuals with symptomatic patellar tendinopathy. Regardless of the lack of 
differences in loading frequency and duration (average steps/day and MVPA minutes/day) 
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between groups, lower discrete loading magnitudes on the involved limb in the symptomatic 
group still resulted in cumulative under-loading when extrapolated into the individual’s real-
world environment. Over time, chronic under-loading will lead to reduced tissue capacity 
through stress-shielding, and limit the adaptive potential to the tissue when exposed to high 
loading demands of sport.9,251 The use of the cumulative load estimation emphasizes the 
importance of acknowledging comprehensive load volume, particularly in pathologic 
populations.39 Future work should seek to develop feasible, implementable strategies to identify 
changes in physical activity that may be reflective of trends in either over- or under-loading that 
may result in deleterious outcomes. 
Interestingly, there were no differences in loading frequency and duration between our 
three groups. These findings were in contrast to our hypotheses that the SYM group would 
demonstrate lesser and the ASYM group would demonstrate greater loading frequency and 
duration than the CON group, respectively. It is well-accepted in the literature that the 
development and progression of patellar tendinopathy in athletes is often related to the 
mismanagement of external load over time.9–11,90,251 Though multifactorial, the load-related 
pathoetiology of tendinopathy stems from a discrepancy between the tendon tissue’s load 
capacity and imposed external load.10,90 Our findings may have important clinical implications in 
how clinicians design, prescribe, and manage load exposure in athletes at various stages of 
tendinopathy continuum. 
A study conducted by Visnes and Bahr (2013) tracked training volume prospectively for 
four-years via self-reported training diaries in young elite volleyball players, and found that the 
development of symptomatic patellar tendinopathy associated with higher overall training 
characteristics, specifically number of hours and matches played.36 It is possible that the 
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specificity of the activity-related measures to the sport of volleyball (hours and matches played) 
used by Vises and Bahr better captured the type of load related to tendinopathy development 
than general measures of steps- or MVPA- per-day used in the current study. Tendinopathy is 
most prevalent in athletes participating in jumping sports,5 and the risk of patellar tendinopathy 
is associated with jumping performance.5,36,140,156 However, while there is evidence of sex and 
inter-individual differences in jumping frequency,252 little is known on how jumping frequency 
may influence the risk or progression of patellar tendinopathy. In light of current gaps in existing 
evidence and the current study’s findings, an important next step in load management should 
include serial monitoring of sport-specific movements, such as tracking jump-counts over time, 
which may be more helpful in understanding the effect of real-world load volume on patellar 
tendinopathy. 
Due to the cross-sectional nature of the current study, we are unable to determine if the 
onset of the structural pathology and/or symptoms in the ASYM-PTA and SYM-PTA groups 
was associated with a prior change in physical activity, such as training volume or intensity. At 
the time of enrollment in this study, all participants were participating in sport activity. We 
hypothesized that individuals with symptoms would self-restrict their physical activity due to 
pain-avoidance behavior. However, despite worse VISA-P scores, the SYM-PTA group did not 
differ from the other groups in physical activity. Additionally, VISA-P score was not correlated 
with either physical activity measure (p>0.05). VISA-P scores in the SYM-PTA group (76.15 ± 
13.37 points) were comparable to symptomatic cohorts of similar ages and activity levels in 
previous studies.19,22,140,253 This finding may have important clinical implications, as it suggests 
that individuals who report high levels of pain-related disability do not necessarily limit their 
physical activity. Additionally, our results indicate that patient-reported outcomes may not 
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accurately reflect the influence of pain on physical activity if used in isolation. Longitudinal 
studies that regularly monitor both physical activity and patient-reported function are needed to 
better understand the effects of tendinopathy on sport participation. Proper education for patients 
and athletes that acute spikes in load, particularly sport-specific loads that exceed tissue capacity, 
may increase the risk of negative progression along the tendinopathic continuum is 
important.165,171,173 
On average, each group in the current study met the well-accepted recommendation of 
10,000 steps/day for adults.254 Studies that utilize college-aged participants acknowledge that 
these individuals are highly active due to the nature of their daily activities, such as walking to 
class. Using similar 7-day monitoring procedures, several previous studies have observed healthy 
college-aged participants to average between approximately 8,800 and 10,000 steps/day,37,38,255 
with Mestek et al. (2008) specifically observing an average 10,027 ± 3,535 steps/ day in a cohort 
of 44 college males.255 While comparable, all participant groups in our study completed more 
steps/day than these previous studies, which may be due to our inclusion criteria of a minimum 
Tegner Activity Scale score (5/10), indicating athletic participation at least at the recreational 
level. Additionally, all participant groups were well over the 150 minutes of MVPA activity per 
week recommended by the American College of Sports Medicine.256 
These combined findings suggest that even individuals with symptomatic patellar 
tendinopathy do not significantly limit the frequency or duration of physical activity compared to 
their healthy counterparts. Additionally, there was no evidence of over-loading in asymptomatic 
participants as neither load magnitude, volume, duration, or frequency was higher in this group. 
In fact, there is a non-significant trend for under-loading relative to healthy control participants. 
These findings suggest that reducing load may not be the ideal treatment for asymptomatic 
  174 
 
individuals with structural patellar tendon abnormalities. Rather, progressive loading protocols 
designed to increase the capacity of healthy tendon tissue may be critical for this cohort of 
tendinopathy patients to prevent the development of symptoms. Future research should seek to 
study the effects of using comprehensive strategies, including both load magnitude and volume 
measurements, to determine how to appropriate manage load in individuals at different stages of 
the tendinopathic continuum. 
LIMITATIONS 
This study is not able to offer cause-and-effect evidence that biomechanical movement 
strategies or physical activity levels preceded the development of tendinopathy or result in 
response to the pathologic condition. There are currently no prospective longitudinal studies that 
assess biomechanical profiles and adaptations around the initial development of patellar 
tendinopathy. We are also unable to account for other factors that may have influenced the 
participants’ physical activity levels during the seven-day monitoring period, such as motivation, 
academic demand, or environmental factors related to their sport, or the specific types of activity 
that may have differed between groups. There are obvious limitations to extrapolating seven-
days of physical activity measurement as a reflection of an individuals’ actual physical activity 
over a protracted time-frame. However, a seven-day monitoring period is an accepted duration 
commonly utilized in physical activity literature, and has been shown to improve reliability and 
decreased variability of objective physical activity data.38,39,211,213 Finally, we did not take a daily 
pain assessment during the seven-day physical activity monitoring week, so we are unable to 
determine if daily fluctuations in pain may have influenced physical activity participation in the 
symptomatic group. 
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CONCLUSIONS 
Male athletes with symptomatic patellar tendinopathy do not differ in general measures 
of physical activity frequency and duration compared to both asymptomatic patellar 
tendinopathy and healthy control participants, despite higher self-reported pain levels during 
functional and sport-related tasks. However, lesser magnitudes of patellar tendon force and 
energy absorption across the knee joint during landing in symptomatic individuals results in 
cumulative under-loading over a seven-day monitoring period. This study’s findings highlight 
the importance of a comprehensive approach to load monitoring in individuals with patellar 
tendinopathy, including biomechanical movement profiles, loading volume, and patient-reported 
outcomes. 
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CHAPTER 7: MANUSCRIPT 3 
 
Landing Biomechanics are Not Immediately Altered by an Isometric Patellar Tendon 
Loading Exercise Protocol in Male Athletes with Patellar Tendinopathy 
 
INTRODUCTION 
Tendon adaptation occurs through mechanotransduction, the physiological process by 
which the body translates mechanical load into a cellular response that leads to structural 
change.12,257 Mechanotherapy describes how load can be manipulated to influence the mechano-
transductive events within the tissue.12 As such, load-based exercise is considered the gold-
standard of tendon rehabilitation.10,17,258 Eccentric-based exercise protocols have traditionally 
been utilized in the treatment of chronic tendinopathies.13–15,66 In the degenerative stage of 
chronic tendinopathy, eccentric exercise has been shown to be effective at reducing pain,13–15,186 
increasing force, stiffness,259 and Young’s elastic modulus,187 decreasing tendon thickness,79 and 
improving self-reported function.79  
 Not all tendinopathy patients respond positively to eccentric exercise.77,260–262  
Specifically, athletes continuing to participate in activity while managing patellar tendinopathy, 
the capacity to tolerate high sporting loads plus heavy eccentric exercise treatments may be 
limited.90,260 Current evidence suggests that loading interventions, including type and dosage of 
exercise, should be prescribed based on where a tendon falls on the continuum of pathology.9 
Cook et al. (2016) suggests that ‘phenotyping’ patients based on the presence of pain, structural
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 abnormalities, and self-reported dysfunction may help clinicians direct patient-centered 
treatments to improve short- and long-term patient outcomes.10  
 Emerging evidence supports the use of isometric exercise for individuals with 
symptomatic patellar tendinopathy. Sub-maximal isometric exercise improved pain and self-
reported function and modulates inhibition in adults with symptomatic patellar tendinopathy,16–18 
and demonstrated excellent patient compliance and tolerance when implemented in-season.16 
Isometric exercise is thought to be a more appropriate treatment option than eccentrics for 
painful, competing athletes because it promotes heavy loading to stimulate the mechano-
transductive processes needed for tendon adaptation without being provocative,16,18,90 as often 
occurs with heavy eccentric training.13,261 
We believe that interventions able to modify symptoms may allow for changes in 
biomechanical movement profiles. Specifically, in those with symptomatic patellar tendinopathy, 
an intervention that is able to reduce pain may allow the individual to normalize their loading 
patterns, as athletes with symptomatic patellar tendinopathy are shown to display under-loading 
profiles.19,21 Thus, a load-based exercise intervention may provide three key benefits. First, 
isometric loading increases the volume of stimulus placed on the patellar tendon in a given 
session, which may have positive mechano-transductive effects on the surrounding aligned 
fibrillar tissue.10,80,94 Second, isometric exercise acutely reduces pain and decreases cortical 
inhibition.17 And finally, a reduction in pain may allow for the individual’s biomechanical profile 
to normalize, minimizing the amount of under-loading exhibited during high-energy tasks. 
Consequently, the isolated isometric exercise protocol may encourage greater tendon loading 
during dynamic tasks, which may be an even more powerful and systematic way to improve the 
volume of tissue loading over time during sport-related activities. By selecting the appropriate 
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type of load-based intervention, particularly in early stages of rehabilitation, progressively 
building tissue capacity may be more tolerable to patients and therefore improve the 
effectiveness of other interventions, such as neuromuscular re-education and movement-
retraining.82,94,188,189 
 The effects of an exercise protocol that targets tendon-specific loading on movement 
profiles has not yet been investigated. Therefore, the purpose of this study was to determine the 
acute effects of an acute bout of patellar tendon isometric loading exercise on involved limb 
landing biomechanics in individuals with symptomatic and asymptomatic patellar tendinopathy. 
A secondary purpose was to determine if individuals with symptomatic patellar tendinopathy 
demonstrated changes in pain following the isometric loading exercise. Determining whether 
isometric loading acutely changes movement biomechanics may provide an important next step 
in rehabilitation paradigms for tendinopathy as a method to promote load-tolerance and stimulate 
positive mechano-transductive responses in individuals with tendon pathology 
 
METHODS 
This study utilized a single-blinded, randomized cross-over trial with two intervention 
conditions. Twenty-eight male participants with patellar tendinopathy were enrolled into this 
study (Table 1). Participants were recruited from the local high school and university 
communities using approved email correspondence and public flyers. All participants were 15-28 
years-old and were required to be actively participating within an organized sport setting, 
quantified by a Tegner Activity Scale of ³ 5, a self-reported questionnaire in which the 
participant identifies the highest level of competition and/or physical activity currently 
performing.235 Additionally, all participants were considered to be post-pubertal, quantified by 
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Pubertal Development Scale Stage 5 (score >12).106,202 This study was approved by the 
university’s institutional review board and informed consent was obtained by all participants 
prior to study screening. 
 
Screening Protocol 
Group Assignment 
To determine group assignment, all participants underwent a two-part screening protocol. 
Participants were recruited into the symptomatic PT group (SYM-PTA) if they exhibited: 1) pain 
³2/10 on the numeric rating scale (NRS) only in the patellar tendon during performance of the 
Single Leg Decline Squat (SLDS) test110, as selected from a pain map diagram providing a series 
of pictures with various anterior knee pain locations (if bilateral pain, the “worse” limb must 
have been ³ 5/10 and the contralateral limb must have been £ 2/10 on NRS (0-10)), and 2) 
ultrasonographic (US) evidence of a structural proximal patellar tendon abnormality (PTA), as 
defined by the presence of a hypoechoic region (³ 2mm) and/or a maximum thickness of > 7mm, 
evident on both the longitudinal and transverse scans.80,85 All US images were obtained and 
processed by a single trained investigator (L.S.P.). Participants were recruited into the 
asymptomatic PT group (ASYM-PTA) if they were free of SLDS pain but demonstrated US 
evidence of a PTA. 
Any participants were excluded if they exhibited any of the following: 1) known 
neurological disorders or cardiopulmonary diseases, 2) a history of any lower extremity surgery, 
3) a history of a lower extremity injury in the prior six-months, 4) an injection to the patellar 
tendon in the prior last three-months, 5) participation in formal rehabilitation for anterior knee 
pain in the prior three-months, 6) presentation of non-tendinopathic knee pain during the SLDS 
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test (i.e. patellofemoral pain syndrome presentation), or 7) any other medical condition that 
would prevent them from participation in normal activities of daily living. 
Patient-Reported Outcomes 
The Victorian Institute of Sport Assessment-Patellar Tendon (VISA-P) questionnaire was 
used to quantify self-reported knee function.203,204,236 The VISA-P consists of 8-items regarding 
the presence of pain during various daily and sport-related activities and has demonstrated 
excellent test-retest and interrater reliability.236 All participants completed this questionnaire at 
the time of the screening session. 
Quadriceps Maximum Voluntary Isometric Contraction Assessment 
Quadriceps strength was assessed by measuring the individual’s maximum voluntary 
isometric contraction (MVIC) during the screening session to avoid any confounding effect of 
performing the baseline MVIC just prior to the intervention period. 
MVIC was assessed on the HUMAC Norm Dynamometer (CSMi, Stoughton, MA) on 
the involved limb. All participants were positioned on the dynamometer with the test limb flexed 
to 60°, consistent with previous studies investigating the effects of isometric loading in a patellar 
tendinopathy cohort,17,18 and to minimize added compressive forces across the anterior knee at 
greater knee flexion angles (i.e. 90°) that may instigate pain during contraction.141,145 The thighs, 
hips and torso were firmly stabilized with straps, and the arms folded across the torso to isolate 
the contribution of the quadriceps muscle without extremity movement. The lever arm was 
adjusted so that the ankle strap was 2 finger widths (~3 centimeters) proximal to the lateral 
malleolus.  The knee was positioned so that the lateral femoral epicondyle was aligned with the 
rotational axis of the dynamometer. Measurements of chair position (distance of seat-back 
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position, ankle strap position on lever arm) were recorded to ensure consistency between all 
subsequent assessments using the HUMAC system. 
A series of graded submaximal warm-up isometric contractions were performed at 25%, 
50%, and 75%, respectively, of the participant’s perceived maximal effort but not recorded. For 
the MVIC testing, participants were instructed to “kick as hard and as fast as they can” into the 
dynamometer and to maintain maximal effort for approximately two seconds. The investigator 
provided standardized verbal encouragement for each trial, and participants received real-time 
visual feedback of their torque production on a computer monitor display directly in front of the 
dynamometer. Three MVIC trials were collected. If for a given trial, the participant was able to 
produce torque greater than 10% of the previous trial, this trial was repeated. The peak torque 
(N*m) of the MVIC from the three trials was recorded, and from the average of these trials, 70% 
+/- 5% MVIC was calculated for the isometric intervention. 
 
Pre-Intervention Testing Protocol 
Double-Limb Jump Landing Task 
Participants performed a 5-minute warm-up on a stationary bicycle at a self-selected 
pace, after which they completed the Single Leg Decline Squat (SLDS) and rated their knee pain 
(NRS: 0-10). Participants were then outfitted with 20 retro-reflective markers bilaterally on the 
following bony landmarks: acromion process, anterior superior iliac spine (ASIS), greater 
trochanter, medial and lateral femoral condyles, medial and lateral malleoli, calcanei, and the 
first and fifth metatarsal heads.219 A single marker was placed on the manubrium of the sternum 
and at the L4-L5 vertebral space. Rigid clusters of three or four markers was placed at the 
sacrum and on the thigh, shank, and foot segments bilaterally. A static trial was captured with the 
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participant standing with arms positioned at 90° of shoulder abduction to estimate the location of 
the landmarks needed to calculate joint centers.219 After the static trial, the single markers on the 
foot, malleoli, femoral condyles, and greater trochanters were removed. 
Participants were provided with spandex shorts and tops and wore their own athletic 
shoes. Participants performed five trials of a jump-landing task from a 30 cm box that was 
positioned 50% of the participant’s height from the front edge of the force plates.221 The 
participants were instructed to jump forward off the box to a double-leg landing with one foot on 
each force plate, and immediately perform a maximal vertical jump upon landing.221 A minimum 
of one practice trial was performed; practice trials were performed until the participant and 
investigator ensured correct performance of the jump-landing task.  A total of five jump-landing 
trials were collected, and the middle three trials were averaged for data analysis. If one of the 
middle three trials was not successful, a subsequent trial was utilized for analysis. A successful 
trial required the participant to leave the box with both feet at the same time, land on the force 
plates, and jump straight up in the air as high as possible. 
 
Randomization Procedure 
Randomization for the cross-over was completed by a trained research assistant using 
random number generating software (Random Number Generator, www.Stattrek.com, 2017) 
prior to the start of the study. The research assistant generated a randomization sequence for 32 
participants (16 for each group) to account for potential drop-outs and produced a set of 
sequentially numbered opaque sealed envelopes (SNOSE) with no external markings,208 each 
with a piece of paper enclosed indicating which intervention will occur at each of the two testing 
session. These envelopes remained sealed until the participant’s eligibility was verified. The 
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number on the outside of the envelope will be the participant’s randomization study ID. The 
principle investigator (PI) remained blinded to the knowledge of which intervention condition 
was delivered at each testing session throughout the entirety of data collection and reduction. 
 
Intervention Protocol 
For the intervention protocol, the participant was positioned in the HUMAC chair at the 
same position used during the screening session. Once the participant was appropriately 
positioned, the PI (L.S.P.) stepped out of the laboratory to remain blinded to the intervention 
(isometric or sham-control) for each session. Blinding of the PI was conducted in order to 
remove any potential bias that the PI’s knowledge of the condition may have on collection and 
analysis of post-intervention pain and biomechanics assessments. A trained research assistant 
delivered the intervention. The interventions were only applied to the involved limb. 
 
Isometric Condition 
The isometric protocol was selected based on the work of Rio et al. (2015), which 
demonstrated acute reductions in pain and improvements in quadriceps strength in individuals 
with patellar tendinopathy.17 Instructions were given to the participant prior to the beginning of 
the isometric condition using a standard script. The participant performed 5-sets of a 45-second 
isometric quadriceps contraction at 60° of knee flexion at 70% of their maximum voluntary 
isometric contraction (MVIC). During the 45-second quadriceps contraction, the participant was 
provided with visual biofeedback via the HUMAC Norm software on a computer screen 
positioned directly in front of the chair; this involved a real-time display of their torque output 
(green) and +/- 5% error lines (purple with target zone in black). The participant was instructed 
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to produce a level of quadriceps torque that kept the torque output line as close the target line as 
possible and always between the two error lines. Following each 45-second isometric 
contraction, the participant had 2-minutes of rest, during which their limb remained positioned 
passively at 60° knee flexion. This procedure was completed for 5 sets. 
 
Sham-Control Condition 
A sham-control intervention was utilized to avoid any participant-bias that the isometric 
condition was the experimental condition, as this perception could bias their performance on the 
post-intervention SLDS pain and biomechanics assessments. Participants were positioned in the 
identical position in the HUMAC. A sham transcutaneous electric nerve stimulator (TENS) unit 
(Empi SelectÔ TENS Device; Empi, Inc., St. Paul, MN, USA) was utilized as a sham 
intervention. Two (2” x 2”) electrodes were placed on the medial and lateral side of the involved 
limb patellar tendon, respectively, and connected via a lead wire to the sham-TENS unit which 
was held and controlled by the trained research assistant. Instructions were given to the 
participant prior to the beginning of the sham-control condition using a standard script. The same 
time parameters used in the isometric condition were used for the sham-control condition. 
 
Post-Intervention Testing Protocol 
Immediately following the conclusion of the intervention protocol, participants repeated 
the same pre-intervention protocol assessments using identical methodology as described above 
in the following order: 1) SLDS pain assessment and 2) Double-limb jump landing task. 
Testing sessions were conducted 7-10 days apart in order to ensure no carry-over effects 
from the intervention condition performed during the first testing session. Participants were 
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asked to maintain their physical activity and sport participation during this time. At the second 
testing session, the same aforementioned procedures were conducted, with the exception of the 
assignment for the intervention protocol; the participants performed the intervention condition 
that they did not perform during the first testing session. 
 
Data Processing 
Data Acquisition 
Three-dimensional kinematic data were collected using a ten-camera motion capture 
system (Vicon Motion Systems, Centennial, CO, USA) sampled at 120Hz and filtered using a 
fourth-order low-pass Butterworth filter with a 20Hz cutoff frequency. Kinetic data were 
sampled at 1200Hz using two floor embedded force plates (Bertec Corporation, Columbus, OH, 
USA). Knee and ankle joint center coordinates were defined as the centroid between the medial 
and lateral condyles and malleoli identified during the static trail. Hip joint center coordinates 
were estimated from the coordinates of the L4-5, right ASIS, and left ASIS markers using the 
Bell method.222 Reference frames for the foot, tibia, and femur were defined based on 3D-
coordinates and segments as follows: 1st and 5th metatarsal heads, ankle joint center, and 
calcaneus (foot); medial and lateral malleoli, knee and ankle joint centers, and shank (tibia); 
medial and lateral femoral condyles, knee and hip joint centers, and thigh (femur). Joint angles 
were defined based on the position of the distal segment relative to the proximal segment using a 
Cardan angle sequence in the following order of rotation: sagittal (y-axis), frontal (x-axis), and 
transverse (z-axis). 
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Data Reduction 
Marker coordinate and ground reaction force data was transferred into The Motion 
Monitor software (Innovative Sports Training, Chicago, Illinois) to build three-dimensional link-
segment models for biomechanical data analysis and reduction. Lower extremity biomechanics 
for each limb were evaluated during the stance phase, which was defined as the interval from 
initial contact (IC) to toe-off.223 IC was defined as the time point when the vertical ground 
reaction force (vGRF) exceeded 10N and toe-off as the time point when vGRF dropped 
below10N.223 
Sagittal plane knee angle (°) was extracted at IC, peak, and displacement across the 
descending phase (peak knee flexion angle (°) – knee flexion angle at IC (°)). Ground reaction 
force data and processed segment data were used to calculate net internal sagittal and frontal 
plane knee and hip joint moments using inverse dynamics procedures.146 Peak sagittal and frontal 
plane internal hip and knee moments and vGRF were extracted. Patellar tendon force (FPT) was 
estimated using previously defined methodology of Nisell and Ekholm, through which FPT is 
calculated by dividing the internal knee extension moment by the patellar tendon moment arm.160 
PT moment arms were calculated as a function of knee joint angles using the methodology of 
Herzog and Read.144 Internal moments were normalized to the product of the participant’s body 
weight and height (N*m[kg*m]-1), while vGRF and FPT was normalized to body weight (BW). 
Knee power (J/s) was calculated as the product of the internal sagittal plane knee moment 
(N*m[kg*m]-1) * knee flexion velocity (°/millisecond). 
FPT impulse (FPTI) and internal knee extension moment impulse (KEMI) were calculated 
as the area under the FPT and KEM curves, respectively, during the descending phase of the 
landing task. Knee power (J/s) was calculated as the product of the internal sagittal plane knee 
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moment (Nm/kg*m) * knee flexion velocity (°/millisecond). Negative knee work (KW) (J) was 
calculated as the area negative under the knee power curve during the descending phase of the 
landing task. 
Change scores for biomechanical dependent variables were calculated for each 
intervention condition as: change score (∆) = meanpost – meanpre. 
 
STATISTICAL ANALYSIS 
Demographic data was compared across groups using a one-way analysis of variance and 
Tukey post-hoc tests for pairwise comparisons. All pre- and post-intervention and change scores 
for biomechanical data were inspected for normality using the Shapiro-Wilk Test and normal Q-
Q plots. We established four a priori comparisons to investigate both within-group and between-
group effects of each intervention condition (isometric and sham-TENS). A mixed-model 
repeated measures ANOVA with 1 between (group: SYM, ASYM) and 1 within (intervention: 
isometric, sham-TENS) was conducted to compare change scores with an a priori alpha level of 
0.05. Post hoc testing of significant group-by-intervention interactions was performed using t-
tests with Bonferroni correction (a = 0.05/4 = 0.0125) to account for pre-planned comparisons 
between groups for each intervention. Independent t-tests were used to compare between groups 
for each intervention and dependent t-tests were used to compared between interventions for 
each group. Cohen’s d effect sizes were used to evaluate the magnitude of between group 
differences for loading volume variables, classified as weak (d ≤ 0.2), small (d = 0.2-0.5), 
moderate (d = 0.5-0.8), or large (d ≥ 0.8) (Table 4).226  Due to group differences in several 
baseline biomechanical variables (manuscript 1), secondary analysis including a mixed-model 
repeated-measures analysis of covariance (ANCOVA) was conducted to compare change scores 
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for each biomechanical variable of interest while controlling for the baseline value for a given 
biomechanical variable. All statistical analyses were completed using SPSS v22 (IBM Inc., 
Armonk, New York, USA). 
Table 1: Descriptive characteristics of the study population. 
 
 
*statistically significant difference than ASYM group (p<0.001, MD: -18.25 (-26.41, -10.08)) 
 
Table 2: Single leg decline squat (SLDS) pain scores (NRS: 0-10) during each testing session. 
 
 
 
 
 
 Asymptomatic 
Tendinopathy 
(ASYM) 
(n=15) 
Symptomatic 
Tendinopathy 
(SYM) 
(n=13) 
Age (yrs) 21.13 ± 1.88 19.62 ± 1.61 
Height (m) 1.84 ± 0.07 1.82 ± 0.05 
Mass (kg) 81.45 ± 13.26 83.46 ± 5.12 
Tegner Activity Scale (0-10) 7.93 ± 1.03 8.00 ± 1.00 
Pubertal Development Scale 
(0-12) 
11.87 ± 0.52 11.39 ±0.87 
VISA-P (0-100) 94.40 ± 7.72 76.15 ± 13.37* 
 
  Asymptomatic 
Tendinopathy 
(ASYM) 
(n=15) 
Symptomatic 
Tendinopathy 
(SYM) 
(n=13) 
 Screening Session 0 3.23±1.21 
Isometric 
Intervention 
Session 
Pre-Landing Protocol 0 2.54±1.76 
Pre-Isometric Intervention 0.40±1.55 2.34±2.10 
Post-Isometric Intervention 0.60±1.68 1.62±1.89 
Isometric Intervention Change Score 0.20±0.77 -0.73±0.72 
Sham-TENS 
Intervention 
Session 
Pre-Landing Protocol 0.33±1.29 3.07±1.85 
Pre-Sham TENS Intervention 0.33±1.29 3.03±1.98 
Post-Sham TENS Intervention 0.33±1.29 2.42±1.63 
Sham-TENS Intervention Change Score 0 -0.62±1.12 
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RESULTS 
The CONSORT diagram for recruitment and enrollment is detailed in Figure 1. 
Descriptive characteristics and pain scores are presented in Table 1 and Table 2, respectively. No 
significant differences in height, mass, or age were observed between groups (p > 0.05). The 
VISA-P score was significantly lower in the SYM group than the ASYM group (p<0.001), and 
the mean difference exceeded the MCID (13 points) for this subjective outcome measure (Table 
1).204 There were no group x intervention interactions for change in SLDS NRS pain (F(1, 26) = 
0.555, p=0.463) (Table 2). Group and individual participant pre- and post-intervention and 
change scores for NRS pain are visualized in Figures 2-5. 
Descriptive characteristics for group and intervention condition are detailed in Table 3. 
For our within-group comparisons, there was one significant group x intervention interaction for 
VGRF (F(1, 26) = 5.33, p = 0.029). However, post-hoc testing with Bonferroni correction (a = 
0.05/4 = 0.0125) demonstrated no statistical significance. Dependent-samples t-tests for each 
group demonstrated no statistical significance (ASYM: t = -1.7, p = 0.107; SYM: t = -1.679, p = 
0.119). Independent t-tests demonstrated no statistical significance (isometric: t = -2.58, p = 
0.016; sham-TENS: 0.72, p = 0.460). There were no further significant group x intervention 
interactions (p>0.05). Additionally, the ANCOVA analyses, including baseline biomechanical 
variables as co-variates, demonstrated the same outcome, as there were no significant group x 
intervention interactions observed (p>0.05). 
  190 
 
Table 3: Descriptive characteristics (mean difference, standard deviation, 95% CI) for each biomechanical variable change score for 
the symptomatic and asymptomatic groups for the isometric and sham-TENS intervention conditions. 
 
 
 
Legend: ∆: change; IC: initial contact; VGRF: vertical ground reaction force; KEM: knee extension moment; FPT: patellar tendon 
force 
*statistically significant at p <0.05. 
 
 
 Isometric Condition Sham-TENS Condition Group x Condition 
Biomechanical Variable Group Mean ∆ SD 95% CI Mean ∆ SD 95% CI F  p-value 
Knee flexion angle @ IC (°) SYM -2.61 3.02 -4.44, -0.78 -1.67 3.15 -3.57, 0.24 1.56 0.223 ASYM -4.32 4.45 -6.78, -1.86 -1.57 4.14 -3.87, 0.72 
Peak knee flexion angle (°) SYM -3.58 4.91 -6.55, -0.61 -0.79 4.24 -3.35, 1.77 0 0.995 ASYM -4.36 7.45 -8.48, -0.23 -1.57 4.72 -4.19, 1.03 
Knee flexion displacement (°) SYM -0.97 5.99 -4.59, 2.64 0.88 3.97 -1.52, 3.27 0.44 0.511 ASYM -0.04 6.56 -3.67, 3.60 -0.01 4.82 -2.67, 2.65 
Peak VGRF (BW) SYM 0.46 0.47 0.18, 0.75 0.21 0.23 0.08, 0.35 5.33 0.029* ASYM -0.04 0.54 -0.34, 0.26 0.32 0.50 0.04, 0.60 
Peak Internal KEM (N*[kg*m]-1) SYM -0.007 0.26 -0.023, 0.009 0.007 0.03 -0.01, 0.02 2.41 0.132 ASYM 0.005 0.01 -0.003, 0.01 0.002 0.02 -0.01, 0.02 
Peak FPT (BW) SYM -0.14 0.43 -0.40, 0.12 0.20 0.46 -0.08, 0.47 4.06 0.054 ASYM 0.13 0.32 -0.05, 0.31 0.10 0.38 -0.12, 0.31 
Peak knee power (J/s) SYM -0.07 0.38 -0.30, 0.16 -0.03 0.44 -0.29, 0.24 0.21 0.651 ASYM 0.03 0.28 -0.13, 0.18 -0.02 0.38 -0.24, 0.19 
KEM impulse (Nm*ms) SYM -0.44 5.65 -3.85, 2.97 1.63 3.76 -0.64, 3.90 1.86 0.185 ASYM 2.22 4.56 -0.30, 4.75 1.47 3.93 -0.71, 3.65 
FPT impulse (BW*ms) SYM -6.84 123.19 -81.28, 67.60 35.29 80.96 -13.63, 84.21 1.70 0.204 ASYM 51.13 102.60 -5.68, 107.95 33.94 87.62 -14.58, 82.47 
Negative knee work (J/kg) SYM -2.75 26.54 -18.78, 13.29 8.69 25.02 -6.43, 23.81 2.89 0.101 ASYM 11.71 21.50 -0.20, 23.61 3.85 19.99 -7.22, 14.92 
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Table 4: Cohen’s d effect sizes for mean differences (pre-post) within each group for the isometric and sham-TENS intervention 
conditions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Isometric 
Condition 
Sham-TENS 
Condition 
Biomechanical Variable Group Cohen’s d Cohen’s d 
Knee flexion angle @ IC (°) SYM -0.37 -0.22 
ASYM -0.92 -0.39 
Peak knee flexion angle (°) SYM -0.30 -0.06 
ASYM -0.38 -0.10 
Knee flexion displacement (°) SYM -0.08 0.07 
ASYM 0.003 0.08 
Peak VGRF (BW) SYM 0.67 0.29 
ASYM -0.04 0.50 
Peak Internal KEM (N*[kg*m]-1) SYM -0.25 0.24 
ASYM 0.18 0.09 
Peak FPT (BW) SYM -0.27 0.33 
ASYM 0.27 0.21 
Peak knee power (J/s) SYM -0.14 -0.05 
ASYM 0.05 -0.03 
KEM impulse (Nm*ms) SYM -0.06 0.23 
ASYM 0.37 0.18 
FPT impulse (BW*ms) SYM -0.05 0.23 
ASYM 0.39 0.19 
Negative knee work (J/kg) SYM -0.07 0.22 
ASYM 0.40 0.09 
193 
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Figure 1: Study CONSORT Diagram 
 
 
 
 
 
 
 
 
 
 
Screened for
Study Enrollment
(n=101)
Symptomatic
(n=39)
Asymptomatic
(n=62)
Symptomatic
with PTA
(n=18)
Asymptomatic
with PTA
(n=17)
Asymptomatic 
without PTA
(n=40)
ASYM-PTA 
Group
(n=15)
CON
Group
(n=15)
SYM-PTA
Group
(n=13)
Excluded
Non-tendinopathic pain (n=21)
Excluded
Activity level (Tegner <5) (n=3)
Hx lower extremity surgery (n=1)
Age > 28 years-old (n=1)
Excluded
Study Group Full (n=25)
Excluded
Bilateral tendinopathic pain (n=5)
Lost due to:
MCL Sprain (n=1)
Personal reasons (n=1)
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Figure 2: Individual participant SLDS pain (NRS: 0-10) change scores following the isometric (blue open circles) and sham-TENS 
(open red circles) interventions with median group change (black horizontal line). 
    
Figure 3: Mean and 95% confidence intervals for change scores for isometric and sham-TENS conditions for the SYM and ASYM 
groups. 
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Figure 4: Individual participant pre- and post-isometric intervention SLDS pain scores (NRS 0-10) with mean (dark blue line) and 
95% confidence bounds (shaded area) 
 
      
*Note: 2 participants reported pre- and post-NRS=0   *Note: 13 participants reported pre- and post-NRS=0 
2 participants reported pre- and post-NRS=1 
3 participants reported pre-NRS=1 and post-NRS=0 
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Figure 5: Individual participant pre- and post-sham-TENS intervention SLDS pain scores (VAS 0-10) with mean (dark red line) and 
95% confidence bounds (shaded area) 
      
*Note: 2 participants reported pre-NRS=2 post-NRS=1  *Note: 14 participants reported pre- and post-NRS=0 
 1 participant reported pre- and post-NRS=3  
 1 participant reported pre- and post-NRS =2  
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DISCUSSION 
We originally hypothesized that a single dose of an isometric loading intervention would 
result in reduced pain in the SYM group. As a result, we further hypothesized that the SYM 
group would demonstrate increased loading on the involved limb during the landing task, 
including increased FPT impulse, KEM impulse, negative knee work, and knee power. We did 
not expect to observe any other changes between conditions for either intervention group. In 
agreement with our hypotheses, there were no changes in biomechanics following the sham-
TENS intervention in either group, and there was only one significant change in the ASYM 
group following the isometric intervention (reduced knee flexion angle at IC). Contrary to our 
hypothesis the SYM group did not demonstrate significant changes in pain or in knee loading 
biomechanics following the isometric intervention.  
The SYM group has previously been shown to demonstrate a reduced biomechanical 
loading profile on the involved limb, including lesser knee flexion, patellar tendon force, and 
knee power in comparison to healthy control participants. Thus, there was the opportunity for 
increasing biomechanical loading in the SYM group following the isometric intervention. 
However, our results demonstrate weak to small effect of the isometric intervention in the SYM 
for our key variables of interest, specifically sagittal plane knee motion variables (d: -0.08 to -
0.37), sagittal plane knee extension loading variables (d: -0.06 to -0.25), and patellar tendon 
loading variables (d: -0.05 to -0.27). Our results demonstrated a group x intervention condition 
interaction for VGRF, but post-hoc testing revealed no significant between- or within-group 
differences. 
Furthermore, examining mean differences for these key biomechanical variables indicates 
few change scores that would be considered clinically meaningful. As noted in manuscript 1, the 
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SYM group demonstrated lesser knee flexion motion than the CON group for the majority of the 
stance phase at baseline testing (8-76%, d: 1.14±0.12, MD: 15.83±2.71°). However, there was 
only a mean change of 2.61° following the isometric intervention. So though the SYM group 
demonstrated a significantly different profile than the CON group on several key measures of 
knee loading, their profiles were not altered due to the intervention. Therefore, it appears that a 
single bout of isometric loading is not effective at changing landing biomechanics to increase 
loading magnitude during landing. There are several possible explanations for this finding. 
The first consideration is the relatively lower baseline pain levels in the SYM group. 
Prior research by Rio et al. examining the same isometric intervention demonstrated significant 
immediate reductions in pain with large effects (d: 4.64) in adult male volleyball athletes (n=6).17 
In this study, the cohort presented with higher baseline pain (7.0/10 ± 2.04/10), considerably 
greater than in our cohort. Our SYM group demonstrated less pain prior to the isometric 
intervention (2.34/10 ± 2.10/10) and consequently displayed smaller effects from the isometric 
intervention (d: 0.36). In other research, van Ark et al (2015) showed reductions in pain and 
improvements in self-reported function in competing athletes following a four-week isometric 
loading intervention, but their baseline pain scores were also higher than our cohort (median: 
6.3/10, IQR: 5.3-7/10).16 
We are confident that we identified individuals with symptomatic patella tendinopathy as 
we used a rigorous, evidence-based inclusion criteria battery (SLDS pain ≥ 2/10 and ultrasound 
evidence of PTA). All athletes in the SYM group met our inclusion criteria of at least 2/10 SLDS 
at the screening session (mean±sd: 3.23±1.21) and also demonstrated reduced VISA-P scores 
(76.15 ± 13.37). However, on average, our cohort was on the low end of the pain spectrum 
compared to prior research. Therefore, we suspect that due to the low-levels of pre-intervention 
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pain in our cohort, there was not adequate room for a change in symptoms following the 
isometric loading intervention. 
It is common for tendon pain to fluctuate across activities or time periods, particularly in 
competing athletes, which contributes to the challenge of managing this condition.9,90 All athletes 
in the SYM group met our inclusion criterion of at least 2/10 SLDS at the screening session 
(mean ± sd: 3.23±1.21). A numeric rating scale (NRS) change score of 2 points has been 
associated with the concept of “much better” improvement of pain intensity in patients with 
chronic musculoskeletal pain, and is considered an appropriate cut-point for minimal clinically 
important difference (MCID) in pain.206 The screening session occurred on a separate day 
approximately one week prior to the first intervention session. However, there were no 
differences in screening and pre-isometric (mean difference: 0.88±1.78 points, p=0.099) or pre-
sham-TENS (mean difference: 0.19±1.75 points, p=0.699) pain scores. 
Importantly, no SYM participants reported an increase in pain following the intervention 
(Figure 2) and while there was an average decrease in pain post-intervention (pre: 2.34 ± 2.10, 
post: 1.62 ± 1.89, mean change: -0.73 ± 0.72) (Figure 4), the magnitude of pain reduction did not 
meet the MCID of 2 points.206 We performed a secondary analysis to determine associations 
between pre-intervention pain and change in pain in the symptomatic group around the isometric 
intervention, and these variables were not associated (r = -0.437, p = 0.136). This suggests that in 
our cohort, pre-intervention pain level did not associate with response to isometric intervention, 
likely attributable to the large range of pre-intervention pain scores (0-6). Additionally, we used 
a rigorous, evidence-based inclusion criteria battery (SLDS pain ≥ 2/10 and ultrasound evidence 
of PTA) for the SYM group. With further consideration of the SYM group’s VISA-P score 
(76.15 ± 13.37), we feel confident that we correctly identified individuals with symptomatic 
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patellar tendinopathy. However, on average, our cohort was on the low end of the pain spectrum. 
Therefore, we suspect that due to the low-levels of pre-intervention pain in our cohort, there was 
not an adequate opportunity for a change in symptoms that may have influenced biomechanics in 
our cohort. 
The second key consideration is that a single intervention may not be sufficient to change 
movement profiles in individuals with PT. Due to the cross-sectional nature of this study, we 
cannot determine the onset of structural abnormalities and/or pain in either group, which may 
influence how rooted an individual’s potentially-altered movement profile may be. Previous 
research has demonstrated a pattern of under-loading in athletes with symptomatic PT.19,21 
Additionally, as discussed in manuscripts 1 and 2, our SYM cohort demonstrated reduced 
loading on the involved limb compared to healthy controls, including less knee flexion motion, 
patellar tendon force, and energy absorption supported by large effect sizes, while our ASYM 
cohort did not demonstrate patterns of overloading. Thus, the SYM cohort had room for 
improvement in their involved limb loading. 
These findings reinforce that the presence of symptoms is a key factor that influences 
reduced magnitude of loading during landing tasks in those with PTA. We hypothesized that, 
regardless of duration of symptoms, the isometric protocol would invoke an improved 
willingness to load during the landing task, as isometrics have been shown to acutely reduce 
cortical inhibition without a decline in quadriceps muscle performance.17 The ability to increase 
biomechanical load magnitude during functional tasks may be an important aspect of 
interventions shown to reduce pain. By modifying symptomatic participants’ biomechanical load 
profiles during landing, there is the potential to augment the amount of tendon loading and 
ultimately further facilitate positive mechano-therapeutic effects on tendon capacity. However, 
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we did not observe these changes in biomechanical loading magnitude following a single bout of 
isometric loading in either the SYM or ASYM group. It is possible that multiple sessions of the 
isometric protocol over time may be necessary to realize the potential of this intervention to 
change biomechanics. 
Additionally, there were no differences between the SYM and ASYM groups in the 
response to the isometric intervention. We hypothesized that the larger effects of the isometric 
protocol would be seen in the SYM group due to the presence of pain and the analgesic effect of 
the intervention. However, as discussed previously, the relatively low levels of baseline pain in 
the SYM group resulted in little room for clinically significant pain reduction. This ceiling effect 
in the SYM group may be responsible for the lack of group differences noted due to the 
isometric intervention. 
The lack of significant findings in the current study highlights the need for future studies 
investigating the effects of isometric loading on landing biomechanics in athletes with higher 
baseline pain levels, as well as accounting for duration of symptoms. Future research may also 
consider investigating which modes of intervention are most effective, as it is possible that a 
load-based intervention plus verbal- and/or visual-feedback on important features of landing may 
be provide both the mechano-transductive and motor learning input needed to invoke change in 
movement. Finally, studying the effects of a longer duration isometric intervention (i.e. 3-
4x/week for 4 weeks) on landing biomechanics may also have helpful clinical implications for 
rehabilitation protocols. While this study design was novel in terms of including three distinct 
groups, the magnitude of baseline pain in our symptomatic cohort may not have been adequate to 
elicit analgesia as previously demonstrated,16,17 limiting the potential for influencing movement 
profiles.  
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LIMITATIONS 
We acknowledge several limitations to this study. Though having reported moderate 
levels of activity related disability on the VISA-P, our symptomatic cohort was relatively 
functional, with only low to moderate pain levels reported before each intervention condition. 
While robust inclusion criteria were utilized to define our tendinopathy groups, we did not 
account for duration of symptoms in the SYM group, which may have influenced how long an 
individual may have developed and instilled aberrant movement profiles in response to persistent 
pain. Participants with greater pain may portray a different response to the isometric intervention 
than our cohort. 
Additionally, the cross-sectional design of this study prevents us from determining 
whether the observed movement profiles were present prior to the development of PTA with or 
without symptoms, so we are unable to determine a cause-and-effect mechanism between 
biomechanics and patellar tendinopathy. While our estimation of patellar tendon force was 
chosen based on accepted models,23,144,158,160 it is possible that these models underestimate the 
actual force acting through tendon. Finally, this study was conducted only on college-aged males 
so its findings cannot be extrapolated to females or males of a different age range. 
 
CONCLUSIONS 
The results of this study demonstrate that an isometric patellar tendon loading exercise 
protocol did not have acute effects on landing biomechanics in male athletes with symptomatic 
or asymptomatic tendinopathy. Though isometric tendon loading is a tolerable and analgesic 
treatment option for athletes with symptomatic patellar tendinopathy,16–18 our findings suggest 
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that patient selection and duration of intervention implementation may be important factors if 
using isometric exercise to influence movement profiles. 
Future research should examine the effects of a longer-duration isometric exercise 
intervention program on athletes with higher tendon pain and associated disability. 
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APPENDICES 
Appendix 1. Pubertal Development Scale 
Five Question Method 
 
 Questions 
 
1. “Would you say that your growth in height: __” 
2. “Would you say that your body hair growth: __” (body hair means anywhere 
other than your head. 
3. “Have you noticed any skin changes, especially pimples: __” 
FOR BOYS: 
4. “Have you noticed deepening of your voice?” 
5. “Have you begun to grow hair on your face?” 
FOR GIRLS: 
4.    “Have you noticed that your breasts have begun to grow?” 
5a.  “Have you begun to menstruate (started to have your period)?” 
5b.  “If yes, how old were you when you started to menstruate)?” 
 
Scoring Criteria 
 
Items 1-4 on girls’ version and all items on the boys’ version will be provided 
with response options of: 
1 point = not started 
2 points = barely started 
3 points = definitely underway 
4 points= seems completed 
  Items 5 on the girls’ version will be scored as: 
   1 point = no 
   4 points = yes 
 
  Pubertal Stages 
 
Stage 1: PDS Score = 3: pre-pubertal 
Stage 2: PDS Score = 4 or 5: pubertal 
Stage 3: PDS Score = 6, 7, or 8: pubertal 
Stage 4: PDS Score = 9, 10, 11: pubertal 
Stage 5: PDS Score = 12: puberty complete 
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Appendix 2. Tegner Activity Level Scale. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TEGNER ACTIVITY LEVEL SCALE  
 
Please indicate in the spaces below the HIGHEST level of activity that you participated in 
BEFORE YOUR INJURY and the highest level you are able to participate in CURRENTLY. 
 
BEFORE INJURY:    Level__________          CURRENT:     Level___________ 
 
    
Level 10 Competitive sports- soccer, football, rugby (national elite) 
Level 9 Competitive sports- soccer, football, rugby (lower divisions), ice hockey, 
wrestling, gymnastics, basketball 
Level 8 Competitive sports- racquetball or bandy, squash or badminton, track and 
field athletics (jumping, etc.), down-hill skiing 
Level 7 Competitive sports- tennis, running, motorcars speedway, handball 
 
Recreational sports- soccer, football, rugby, bandy, ice hockey, basketball, 
squash, racquetball, running 
Level 6 Recreational sports- tennis and badminton, handball, racquetball, down-hill 
skiing, jogging at least 5 times per week  
Level 5 Work- heavy labor (construction, etc.) 
 
Competitive sports- cycling, cross-country skiing,  
 
Recreational sports- jogging on uneven ground at least twice weekly 
Level 4 Work- moderately heavy labor (e.g. truck driving, etc.) 
Level 3 Work- light labor (nursing, etc.) 
Level 2 Work- light labor 
 
Walking on uneven ground possible, but impossible to back pack or hike 
Level 1 Work- sedentary (secretarial, etc.) 
Level 0 Sick leave or disability pension because of knee problems 
      
Y Tegner and J Lysolm.  Rating Systems in the Evaluation of Knee Ligament Injuries.  Clinical Orthopedics and    
     Related Research.  Vol. 198: 43-49, 1985. 
 
 
SURGICAL HISTORY 
 
Have you had any additional surgeries to your knee other than those performed by Dr. Stone? 
 
Yes  /  No 
If Yes: 
 
What procedure(s) were performed?                                                                                                     .      
 
When was the surgery performed?                                                                                                        . 
 
Who performed the surgery?                                                                                                                  . 
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Appendix 3. International Physical Activity Questionnaire (IPAQ) 
INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE 
 
We are interested in finding out about the kinds of physical activities that people do as 
part of their everyday lives.  The questions will ask you about the time you spent being 
physically active in the last 7 days.  Please answer each question even if you do not 
consider yourself to be an active person.  Please think about the activities you do at 
work, as part of your house and yard work, to get from place to place, and in your spare 
time for recreation, exercise or sport. 
 
Think about all the vigorous activities that you did in the last 7 days.  Vigorous physical 
activities refer to activities that take hard physical effort and make you breathe much 
harder than normal.  Think only about those physical activities that you did for at least 
10 minutes at a time. 
 
1. During the last 7 days, on how many days did you do vigorous physical activities 
like heavy lifting, digging, aerobics, or fast bicycling?  
 
_____ days per week  
 
   No vigorous physical activities  Skip to question 3 
 
 
2. How much time did you usually spend doing vigorous physical activities on one 
of those days? 
 
_____ hours per day  
_____ minutes per day  
 
  Don’t know/Not sure  
 
 
Think about all the moderate activities that you did in the last 7 days.  Moderate 
activities refer to activities that take moderate physical effort and make you breathe 
somewhat harder than normal.  Think only about those physical activities that you did 
for at least 10 minutes at a time. 
 
3. During the last 7 days, on how many days did you do moderate physical activities 
like carrying light loads, bicycling at a regular pace, or doubles tennis?  Do not 
include walking. 
 
_____ days per week 
 
   No moderate physical activities  Skip to question 5 
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4. How much time did you usually spend doing moderate physical activities on one 
of those days? 
 
_____ hours per day 
_____ minutes per day 
 
  Don’t know/Not sure  
 
Think about the time you spent walking in the last 7 days.  This includes at work and at 
home, walking to travel from place to place, and any other walking that you might do 
solely for recreation, sport, exercise, or leisure. 
 
5. During the last 7 days, on how many days did you walk for at least 10 minutes at 
a time?   
 
_____ days per week 
  
   No walking     Skip to question 7 
 
 
6. How much time did you usually spend walking on one of those days? 
 
_____ hours per day 
_____ minutes per day  
 
  Don’t know/Not sure  
 
The last question is about the time you spent sitting on weekdays during the last 7 days.  
Include time spent at work, at home, while doing course work and during leisure time.  
This may include time spent sitting at a desk, visiting friends, reading, or sitting or lying 
down to watch television. 
 
7. During the last 7 days, how much time did you spend sitting on a week day? 
 
_____ hours per day  
_____ minutes per day  
 
  Don’t know/Not sure  
 
This is the end of the questionnaire, thank you for participating. 
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Appendix 4. Knee Injury History Form. 
Subject Number ___________________________     Date _____________ 
 
Please Circle (Yes or No) regarding your situation.  
 
Yes No Have you had an injury to either leg (other than patellar tendinopathy) that 
has altered you function in the past 6 months? 
Yes No Have you had a surgery to either leg (knee, ankle, hip) in the past 1 year? 
Yes No Have you had an injection (corticosteroids, plasma-rich-protein, etc.) to 
the patellar tendon in the last 3 months? 
Yes No Do you have any knee ligaments that have not been reconstructed? 
Yes No Do you have any nerve injuries in your legs or lower back? 
Yes No Do you have any known muscular abnormalities? 
Yes No Do you have a heart condition that would stop you from exercising? 
Yes No Have you ever been diagnosed with cancer over your knee or thigh? 
Yes No Do you currently have an infection over your thigh or in your knee? 
Yes No Do you know of a hypersensitivity to electrical stimulation? 
 
1. Have you ever had a knee injury? 
When (month / year): ____________________ 
Explain:_______________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
 
2. Have you ever had a knee surgery? 
When (month / year):  ____________________ 
Explain:_______________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
 
3. Have you participated in formal rehabilitation (physical therapy) for patellar tendinopathy in 
the last 3 months? 
 
When did you start (month / year)?  ____________________ 
For How Long?    ____________________ 
 
4. Have you ever had an injury/surgery to your ankle, hip or lower back? 
 
When (month/ year):  _______________________ 
Explain: 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
  208 
 
Appendix 5. Percentage of predicted mature height calculation  
 
 
Predicted % of mature height = !"#$%&'(	$%*+$#,-.#$%&'(	$%*+$#/ 	x	100 
 
(Malina et al, 2007)263 
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Appendix 6. Victorian Institute of Sport Assessment-Patellar Tendon questionnaire.  
 
 
V I C T O R I A N   I N S T I T U T E   O F   S P O R T 
A S S E S S M E N T   S C A L E   
1.  For how many minutes can you sit pain free? 
 
0 mins  100 mins  Points F 
    
  0    1    2    3    4    5    6    7    8    9   10 
 
2.  Do you have pain walking downstairs with a normal gait cycle? 
 
strong 
severe  no pain  Points F 
pain  
   0    1    2    3    4    5    6    7    8    9   10   
 
 
3.  Do you have pain at the knee with full active non-weightbearing knee extension? 
 
strong 
severe  no pain  Points F 
pain  
   0    1    2    3    4    5    6    7    8    9   10   
 
 
4. Do you have pain when doing a full weight bearing lunge? 
 
strong 
severe  no pain  Points F 
pain  
     0    1    2    3    4    5    6    7    8    9   10 
 
5. Do you have problems squatting? 
 
Unable  no problems Points F 
 
   0    1    2    3    4    5    6    7    8    9   10 
 
 
6. Do you have pain during or immediately after doing 10 single leg hops? 
 
strong severe  no pain Points F 
pain/unable     
    0    1    2    3    4    5    6    7    8    9   10   
 
 
7. Are you currently undertaking sport or other physical activity? 
0  ❒  Not at all 
4  ❒  Modified training ± modified competition 
7  ❒  Full training ± competition but not at same level as when symptoms began 
10  ❒  Competing at the same or higher level as when symptoms began 
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8. Please complete EITHER A, B or C in this question. 
 
• If you have no pain while undertaking sport please complete Q8a only. 
 
• If you have pain while undertaking sport but it does not stop you from completing the 
activity, please complete Q8b only. 
 
• If you have pain that stops you from completing sporting activities, please complete 
Q8c only. 
 
8a. If you have no pain while undertaking sport, for how long can you train/practise? 
 
NIL  1-5 mins  6-10 mins  7-15 mins  >15 mins 
 
❒  ❒   ❒   ❒   ❒    Points F 
 
0  7    14    21    30  
 
OR 
 
8b. If you have some pain while undertaking sport, but it does not stop you from 
completing your training/practice for how long can you train/practise? 
 
NIL  1-5 mins  6-10 mins  7-15 mins  >15 mins 
 
❒  ❒   ❒   ❒   ❒ 
 
0  4    10    14    20  Points F 
 
OR 
 
8c. If you have pain which stops you from completing your training/practice for how long 
can you train/practise? 
 
NIL  1-5 mins  6-10 mins  7-15 mins  >15 mins 
❒  ❒   ❒   ❒   ❒ 
0  2    5    7    10  Points F 
 
_________________________________________________________________________ 
 
TOTAL VISA SCORE ❒ 
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Appendix 7. Pain map. 
Utilized for participant to determine location of pain immediately following single-limb decline 
squat. Selections ‘E’ and ‘G’ will be considered (+) for patellar tendon pain and will meet study 
inclusion criteria. 
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Appendix 8. Algorithm for patellar tendon abnormality diagnosis. 
 
Criteria decision-making in current study to characterize patellar tendon structural pathology 
using conventional ultrasound imaging (from Docking and Cook, 2015).80 
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Appendix 9. ActiGraph Wear Position 
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Appendix 10. Supplementary material for manuscript 3. 
 
Manuscript 3: Secondary Analysis 
The following data reflect a secondary analysis, by which 4 total participants were removed from the sample: 
• ASYM (n=1) due to PFPS reported at the pre- and post-intervention (6/10 isometric, 5/10 sham-TENS) time points (after 
having 0/10 pain at both screening and at pre-landing time points) 
• SYM (n=3) due to not meeting the screening inclusion criteria of at least 2/10 pain at the pre-landing time point. 
• This results in samples of ASYM: n=14 and SYM: n=10. 
 
 
Table 1: Descriptive characteristics of the study population. 
 
 
 
 
 
 
 
 
 
 
 
*statistically significant difference than ASYM group (p<0.001, MD: -20.77 (11.91, 29.63)) 
 
 
 
 
 
 
 
 
 
 Asymptomatic 
Tendinopathy 
(n=14) 
Symptomatic 
Tendinopathy 
(n=10) 
Age (yrs) 21.00±1.88 19.50±1.78 
Height (m) 1.84±0.07 1.83±0.03 
Mass (kg) 81.54±13.76 83.18±5.17 
Tegner Activity Scale (0-10) 8.00±1.04 7.90±0.99 
Pubertal Development Scale (0-12) 11.86±0.53 11.40±0.84 
VISA-P (0-100) 95.57±6.48 74.80±14.13* 
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 Table 2: Single leg decline squat (SLDS) pain scores (NRS: 0-10) during each testing session. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Asymptomatic 
Tendinopathy 
 (n=14) 
Symptomatic 
Tendinopathy 
(n=10) 
 Screening Session 0 4.2±0.92 
Isometric 
Intervention 
Session 
Pre-Landing Protocol 0 3.20±1.40 
Pre-Isometric Intervention 0 2.95±2.01 
Post-Isometric Intervention 0.21±0.80 2.00±2.00 
Isometric Intervention Change Score +0.21±0.80 -0.95±0.69 
Sham-
TENS 
Intervention 
Session 
Pre-Landing Protocol 0 3.20±1.75 
Pre-Sham TENS Intervention 0 3.35±2.03 
Post-Sham TENS Intervention 0 2.65±1.67 
Sham-TENS Intervention Change Score 0 -0.70±1.25 
217 
  216 
 
Table 3: Descriptive characteristics (mean difference, standard deviation, 95% CI) for each biomechanical variable change score for 
the symptomatic and asymptomatic groups for the isometric and sham-TENS intervention conditions. 
 
 
 
Legend: ∆: change; IC: initial contact; VGRF: vertical ground reaction force; KEM: knee extension moment; FPT: patellar tendon 
force 
*statistically significant at p <0.05. 
 
 
 Isometric Condition Sham-TENS Condition Group x Condition 
Biomechanical Variable Group Mean ∆ SD 95% CI Mean ∆ SD 95% CI F p-value 
Knee flexion angle @ IC (°) SYM -2.21 3.30 -4.57, 0.15 -0.91 2.90 -2.98, 1.16 0.615 0.441 
ASYM -3.65 3.74 -5.80, -1.49 -1.07 3.79 -3.25, 1.12 
Peak knee flexion angle (°) SYM -3.57 4.08 -6.49, -0.66 -0.53 4.33 -3.64, 2.57 0.038 0.847 
ASYM -4.05 7.63 -8.46, 0.36 -1.57 4.90 -4.40, 1.25 
Knee flexion displacement (°) SYM -1.37 5.96 -5.63, 2.90 0.38 4.38 -2.75, 3.51 0.358 0.556 
ASYM -0.40 6.65 -4.24, 3.43 -0.51 4.58 -3.15, 2.34 
Peak VGRF (BW) SYM 0.51 0.53 0.13, 0.89 0.26 0.24 0.08, 0.43 4.441 0.047* 
ASYM -0.03 0.56 -0.36, 0.29 0.36 0.50 0.08, 0.65 
Peak Internal KEM (N*[kg*m]-1) SYM -0.007 0.03 -0.03, 0.01 0.008 0.02 -0.01, 0.02 1.882 0.184 
ASYM 0.002 0.01 -0.004, 0.009 0.001 0.02 -0.01, 0.02 
Peak FPT (BW) SYM -0.14 0.49 -0.49, 0.21 0.18 0.40 -0.11, 0.46 2.513 0.127 
ASYM 0.07 0.24 -0.06, 0.21 0.08 0.40 -0.15, 0.31 
Peak knee power (J/s) SYM -0.063 0.43 -0.37, 0.24 0.01 0.32 -0.22, 0.25 0.278 0.603 
ASYM 0.002 0.28 -0.16, 0.16 -0.03 0.40 -0.26, 0.19 
KEM impulse (Nm*ms) SYM 0.60 4.83 -2.86, 4.05 1.35 3.75 -1.34, 4.03 0.313 0.581 
ASYM 1.60 4.02 -0.73, 3.92 1.44 4.08 -0.92, 3.79 
FPT impulse (BW*ms) SYM 16.73 103.14 -57.06, 90.52 29.03 79.57 -27.89, 85.96 0.224 0.641 
ASYM 37.52 91.33 -15.22, 90.25 33.20 90.88 -19.27, 85.67 
Negative knee work (J/kg) SYM -4.51 21.67 -20.01, 11.00 6.81 26.67 -12.27, 25.89 2.442 0.132 
ASYM 9.16 19.82 -2.28, 20.61 3.79 20.74 -8.18, 15.77 
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Table 4: Cohen’s d effect sizes for mean differences (pre-post) within each group for the isometric and sham-TENS intervention 
conditions. 
 
 
 
 
	
 Isometric 
Condition 
Sham-TENS 
Condition 
Biomechanical Variable Group Cohen’s d Cohen’s d 
Knee flexion angle @ IC (°) SYM -0.29 -0.11 
ASYM -0.78 -0.34 
Peak knee flexion angle (°) SYM -0.34 -0.04 
ASYM -0.35 -0.10 
Knee flexion displacement (°) SYM -0.13 0.03 
ASYM -0.03 0.04 
Peak VGRF (BW) SYM 0.79 0.37 
ASYM -0.04 0.56 
Peak Internal KEM (N*[kg*m]-1) SYM -0.27 0.24 
ASYM 0.10 0.07 
Peak FPT (BW) SYM -0.28 0.27 
ASYM 0.16 0.19 
Peak knee power (J/s) SYM -0.13 0.03 
ASYM 0.005 -0.05 
KEM impulse (Nm*ms) SYM 0.09 0.19 
ASYM 0.27 0.17 
FPT impulse (BW*ms) SYM 0.12 0.19 
ASYM 0.29 0.18 
Negative knee work (J/kg) SYM -0.12 0.17 
ASYM 0.32 0.08 
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Summary of Results of Secondary Analysis 
 
A mixed-model repeated measures ANOVA with 1 between (group: SYM, ASYM) and 1 within (intervention: isometric, 
sham-TENS) was conducted to compare change scores with an a priori alpha level of 0.05. Post hoc testing of significant group-by-
intervention interactions was performed using t-tests with Bonferroni correction (a = 0.05/4 = 0.0125) to account for pre-planned 
comparisons between groups for each intervention. Independent t-tests were used to compare between groups for each intervention 
and dependent t-tests were used to compared between interventions for each group. 
From this analysis, there was one significant group x intervention interaction for peak VGRF (F(1, 22) = 4.441, p = 0.047). 
Dependent-samples t-tests for each group demonstrated no statistical significance (ASYM: t = -1.8, p = 0.095; SYM: t = -1.317, p = 
0.22). Independent t-tests demonstrated no statistical significance (isometric: t = -2.4, p = 0.025; sham-TENS: t = 0.683, p = 0.503). 
Therefore, the findings of this secondary analysis demonstrate that there were no statistically significant effects of the isometric 
intervention in either group. Removing the individuals that no longer met screening level criteria from the analysis did not change our 
original findings. 
 
Figure 1: Individual participant SLDS pain (NRS: 0-10) change scores following the isometric and sham-TENS interventions for each 
group median group change (black horizontal line). 
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Figure 2: Individual participant pre- and post-isometric intervention SLDS pain scores (NRS: 0-10) with mean (dark line) and 95% 
confidence bounds (shaded area) 
 
  
 
Figure 3: Figure 2: Individual participant pre- and post-sham-TENS intervention SLDS pain scores (NRS: 0-10) with mean (dark 
line) and 95% confidence bounds (shaded area). 
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